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abstract
is work examines tissue oxygenation (StO2), as measured by near infrared spec-
troscopy (NIRS), as tool for assessing trauma patients, with particular emphasis
on its use in the deployed military environment.
Resting StO2 values were examined and found to vary signicantly between
monitoring sites. Exercise was associated with a signicant increase in StO2. Com-
paring the sensitivities of dierent NIRS monitoring sites in detecting simulated
hypovolaemia, the forearm and deltoid were found be the most sensitive sites.e
thenar eminence and brain were not sensitive to mild degrees of hypovolaemia.
e administration of morphine was found to attenuate the StO2 response to
hypovolaemia at all sites.
In a porcine trauma model changes in StO2 recorded from both injured and
uninjured muscle sites phase led those of base excess and lactate by 31–37 minutes,
and demonstrate that injured monitoring sites can be used to accurately track
patients’ response to resuscitation.
In the deployed military setting NIRS was found to be a robust, easy to use
technique for the initial assessment of patients. Although StO2 was not demon-
strable superior to a combination of pulse rate and blood pressure it has several
practical advantages that make it a useful adjunct to contemporary trauma care.
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Part I
introduction
1. the problem of trauma
Globally major trauma is one of the leading causes of morbidity and mortality,
presenting signicant challenges to the delivery of medical care and social policy
in both the Western and Developing World. When assessing the literature on the
causes and prevalence of trauma it should be appreciated that most descriptions
are conned to a single centre/population or are based on datasets which are
inconsistent, incomplete or fragmented. Even national databases fail to capture
all of their relevant population: the National Trauma Data Bank® in the USA
represents only two-thirds of the population while the Trauma Audit and Research
Network (TARN) in the UK covers less than half of its respective population
(Søreide, 2009). With these limitations understood, this chapter will introduce
the problem of trauma in modern society and outline the need for better methods
of assessing and managing the trauma patient.
1.1 epidemiology of major trauma
e accepted denition of major trauma is that where the individual’s Injury
Severity Score (ISS) exceeds 15 (Søreide, 2009). While there are many criticisms
of ISS as an approach to dening and categorising trauma, as exemplied by
the number of other scoring systems that have evolved in an attempt to address
its perceived deciencies, it remains a useful standard, not least for allowing
comparisons of trauma outcomes between dierent datasets and with historical
standards.
In clinical practice trauma is most commonly considered as an individual
aiction, but seen from a public health perspective it is a pandemic disease with a
unique capacity to suddenly strike anyone regardless of age, sex, race, or socioeco-
nomic status. Despite advances inmedical practice and improved safety legislation,
trauma retains its position as one of the leading global causes of morbidity and
mortality in both developed and developing nations (Sherry, 2003).
In the western world major trauma is currently the most common cause of
death in individuals below the age of 35 years, with the burden of disease being
particular high in males between the ages of 15–24 years (Polinder et al., 2007).
is preponderance for a young population, particularly men, i.e. a major eco-
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nomic productive population, combined with the frequently complex long term
care/rehabilitation needs of survivors results in disproportionately high cost bur-
den on society compared to most other disease processes.
Internationally unintended injury is ranked as the sixth leading cause of death
and the h leading cause of moderate to severe disability (World Health Organiz-
ation, 2008). Considered another way, injury accounts for 9% of worldwide deaths
and 12% of the global burden of disease (Peden et al., 2002). In 2004 this equated to
over 45 million individuals, more than 2000 people every hour, suering moderate
to severe injuries as a result of trauma, and there are few signs that this pattern
is going to change. In 2004 road trac collisions and conict were ranked as
the ninth and sixteenth leading causes of disability adjusted life years (DALYs),
respectively (World Health Organization, 2008). With increasing numbers of
motor vehicles, population and conict, these are projected to rise to the third and
eighth positions by 2020 (Murray and Lopez, 1997), producing an even greater
demand on civilian and military medical resources and on the society that must
bear the long term cost of caring for and rehabilitating victims of trauma.
Within western civilian practice, certainly within Europe, blunt trauma pre-
dominates, as would be expected where falls and motor vehicle collisions are the
most common injury mechanisms (Polinder et al., 2007). Penetrating trauma is
relatively uncommon, estimated in one European study to account for only 13% of
major traumas, withmost of these being self-inicted or suicidal in nature (Søreide
et al., 2007). e exceptions to this occur in nations with less strict gun/knife
laws, such as parts of the USA and South Africa, where epidemics of penetrating
trauma can be found (Søreide, 2009). In patients subject to blunt trauma, severe
thoracic and/or abdominal injuries occur in approximately 20% of cases. Where
intra-abdominal solid organ damage is present, this is most likely to involve the
liver (36%), spleen (32%) or kidneys (24%) (Smith et al., 2005).e signicance
of these cases is that they are the ones most likely to present with uncontrolled
(uncompressible) haemorrhage requiring early operative intervention to salvage.
Penetrating injuries have a higher frequency of intra-thoracic/abdominal organ
injury and consequently are associated with a high early fatality rate with most
deaths occurring within 72 hours of hospital admission (Kauvar and Wade, 2005).
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1.2 distribution and causes of death associated with major trauma
1.2.1 e Tri-modal Distribution of Trauma Deaths
e classic tri-modal distribution of trauma deaths was rst described by Trunkey
(1983), who identied three mortality peaks occurring aer trauma (illustrated in
Figure 1.1):
1. a rst peak corresponding to ‘immediate deaths’, occurring at scene or
within the rst 60 minutes, i.e. prehospital or very shortly aer admission
to hospital.ese account for the majority (approximately 50%) of trauma
deaths, usually as a result of unsurvivable central nervous system (CNS)
injuries or massive haemorrhage (McGwin et al., 2009). Medically there is
little that can be done to change the outcome in these patients, although pub-
lic health measures, changes in social attitudes, legislation and engineering
developments, may reduce their incidence.
2. a second peak of ‘early deaths’, those patients surviving to hospital but
dying with the rst 1–4 hours.ese make up approximate 30% of deaths.
Within this time-frame CNS injuries are the most common cause of death,
accounting for 40–60% of fatalities, with haemorrhage constituting the next
largest group causing 30–40% of deaths (Heckbert et al., 1998). Deaths in
this group are generally considered the most preventable and are the main
target for medical interventions to reduce mortality.
3. a third lower peak of ‘late deaths’ occurring sometime aer the rst week
as a result of sepsis or multiple organ dysfunction syndrome (MODS), ac-
counting for the remaining 20% of trauma deaths (McGwin et al., 2009).
Subsequent, more contemporaneous studies have called into question the tri-
modal distribution. Most of the current evidence suggests that, at least in mature
trauma systems, the pattern tends towards a bimodal distribution with the third
peak of late trauma deaths absent in most modern descriptions (Meislin et al.,
1997; Søreide et al., 2007; McGwin et al., 2009; Pfeifer et al., 2009; Chalkley et al.,
2011). Meislin et al. (1997) performed long term follow up of trauma patients
and proposed a ‘fourth’ peak/phase of trauma deaths occurring up to a year aer
4
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Figure 1.1:e classic tri-modal distribution of trauma deaths described by Trunkey (1983).
hospital discharge, particularly in the over 65 years age group.is would suggest
that in the elderly trauma has acute and long term inuences on mortality. Søreide
et al. (2007) argues, that in fact the survival distribution pattern is a function of
the analysis model used, in particular the time interval bin sizes.eir data from
a civilian population in Norway showed a bimodal distribution when analysed
with the same intervals used by Trunkey, but when deaths were stratied by
cause, a weak third peak due to MODS could be seen in the second week (see
Figure 1.2). What is conrmed in all studies is that immediate deaths (within the
rst hour) account for the majority of fatalities, with ‘early deaths’ making up
most of the remainder.e exact denition of early deaths varies between reports,
but most studies show the second peak shied to the right, occurring slightly
later than Trunkey reported, but still within 48 hours. No single reason for these
dierences have been identied, although a great deal has changed in trauma care
since Trunkey’s original description and common explanatory innovations cited
include: the wide spread adoption of the American College of Surgeons’ Advanced
Trauma Life Support (ATLS®); 24 hour access to computed tomography (CT)
imaging; and the establishment of regional trauma centres. Despite questions as
to its validity, the tri-modal distribution remains a conceptually important model
for examining trauma deaths and planning the delivery of trauma services.
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Figure 1.2: Distribution and causes of trauma deaths within a Scandinavian civilian popu-
lation, demonstrating a bimodal distribution with mortality peaks occurring at <1 hour
and 1–2 days. When stratied by cause of death a third peak due to MODS can be seen at
2 weeks, adapted from Søreide et al. (2007).
1.2.2 Causes of Death Following Trauma
Figure 1.2 illustrates the distribution of trauma deaths classied by cause from
an evaluation of 260 consecutive trauma autopsies in a Scandinavian civilian
population. e trends seen in this dataset are broadly representative of the
current global patterns described by Pfeifer et al. (2009) in a review of the global
literature published between 1980 and 2008. As can be seen CNS injuries account
for the majority of deaths (21.6 – 71.5% in the global literature) — predominately
occurring in the immediate and early phases.ere has been little change in this
gure in the past 30 years.e reasons for this are unclear but are probably in part
due to the fact that many of the deaths, particularly those occurring in the rst
fours hours, are as a result unsurvivable CNS injuries, and therefore not amenable
to change produced by improvements in trauma care.
Exsanguination is the next most common cause of death (12.5–26.6%). In
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Søreide et al. (2007) series these individuals had the highest Abbreviated Injury
Score in the thoracic and abdominal regions, which would be consistent with
exsanguination from uncompressible haemorrhage. Like CNS injuries, at scene
deaths probably represent unsurvivable haemorrhage not amenable to intervention
other than preventative measures. Deaths from haemorrhage aer the rst hour
represent an important group as these include individuals in whom targeted
intervention may change outcome.is premise would appear to be supported
by the fact that deaths in the early haemorrhage group have fallen over the last
30 years. It is reasonable to assume that further improvements in the delivery of
trauma care would have the biggest impact on mortality in this group.
Although much less signicant in terms of absolute numbers, MODS (1.6–9%
of deaths) and sepsis (3.1–17% of deaths) remain the leading causes of mortality
aer the rst week following trauma (Pfeifer et al., 2009). Although the incidence
of deaths from these causes has been falling in recent decades, they have become
an increasing problem in the elderly — the emerging phenomenon of ‘geriatric
trauma’ (Søreide, 2009).
In summary the greatest benet to survival rates in major trauma patients
from any single intervention is likely to be achieved from innovations directed
towards the management of early hypovolaemia secondary to haemorrhage. Not
only would this reduce deaths from exsanguination, but as Jaicks et al. (1997)
demonstrated early correction of hypovolaemic shock also improves the clinical
outcome in patients with associated severe head injuries, although this does not
necessarily translate into improved mortality rates as the historical evidence has
shown. Similarly, since prolonged periods of tissue ischaemia are known to result
in a number of metabolic disturbances directly associated with increased mortality
(Rixen et al., 2001), improvements in the early management of hypovolaemia are
also likely to have an impact upon late survival rates.
1.3 problems with the management of trauma associated
hypovolaemia
One of the main challenges during trauma resuscitation is the restoration and
maintenance of adequate oxygen delivery to tissues.is is of paramount import-
ance since prolonged periods of tissue ischaemia lead to metabolic dysfunction
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that manifest in a number of deleterious consequences, for example:
1. individual organ system failure and multiple organ dysfunction syndrome.
2. enhanced inammatory response, potentially causing damage to organ
systems not directly injured by the initial insult, leading to increased post-
operative complications and prolonging the requirement for intensive care
(Davis et al., 1996; Krishna et al., 1998).
3. coagulopathy due to both activation of protein C (leading to hyperb-
rinolysis (Brohi et al., 2007, 2008)) and metabolic acidosis, reducing the
eectiveness of clotting enzymes/factors and attenuating clot formation
(Cosgri et al., 1997; Dempe and Borggrefe, 2007; Lier et al., 2008).
e net result of these complications is a higher mortality.ese problems can be
mitigated by restoration and maintenance of adequate tissue oxygenation via uid
resuscitation. Leaving aside the complex arguments as to what type of resuscitation
uid should be administered, the challenge for clinicians is determining how
much uid should be administered, and how quickly, to adequately restore tissue
perfusion.
1.3.1 Fluid Resuscitation in Trauma
Severe haemorrhagic shock causes microvascular injury which allows uid loss
into the extracellular space and results in a uid decit greater than can be at-
tributed to the volume of blood loss alone (Bacter et al., 1970). Based on this
understanding, early proponents for aggressive blind uid resuscitation of the
type epitomised by the previous ATLS® guidelines (Amercian College of Surgeons,
1997), argued that the benets of improved cardiac output and tissue perfusion,
and reduced endothelial dysfunction outweighed the risks of inducing further
haemorrhage (‘popping the clot’) produced by restoration of normal blood pres-
sure (Krausz, 2006). is practice has now largely fallen out of favour, with a
number of animal models of uncontrolled haemorrhage demonstrating it to be
associated with increased bleeding, haemodynamic decompensation and higher
mortality (Bickell et al., 1991; Stern et al., 1993; Solomonov et al., 2000), and that
better mortality outcomes are achieved with an initial period of hypotensive re-
suscitation (Kowalenko et al., 1992). Similar ndings have also been reported
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in randomised trials in prehospital trauma patients, where those receiving early
aggressive uid resuscitation were found to have a higher mortality than those
receiving no uid before arrival in hospital (Martin et al., 1992; Bickell et al., 1994).
However once in the hospital environment, where denitive means of haemor-
rhage control are available, there appears to be no survival benet to continuing
hypotensive resuscitation (Dutton et al., 2002). It should be appreciated that these
studies relate to patients with uncontrolled haemorrhage, and should not be inter-
preted as promoting the withholding of uid resuscitation in those individuals
with a controlled source of bleeding, or advocating prolonged hypotensive resus-
citation, which recent animal models suggest is associated with a higher mortality
(Garner et al., 2010). Rather, uids should be restricted in those patients with
uncontrolled haemorrhage until the source of bleeding can be controlled, at which
point the restoration of normal tissue perfusion should be the goal∗.
e early recognition and eective management of hypovolaemia is funda-
mental to preventing the immediate and late complications associated with inad-
equate tissue perfusion in trauma patient. As simple and obvious as this statement
appears, the failure to recognise the magnitude or even the presence of blood
loss has long been identied as a signicant cause of preventable death in trauma
patients (Anderson et al., 1988). Unfortunately this problem cannot be solved by
the indiscriminate administration of large volumes of uid which may precipitate
new bleeding and push the patient’s cardiac function o the right side of the
Frank-Starling curve. Fluid resuscitation must be titrated to the individual needs
of the patient and the goal of achieving adequate tissue perfusion.e problem for
clinicians at present is that all commonly available tools for assessing resuscitation
are either poor proxy indicators of end organ perfusion or have major practical
limitations in the trauma setting.
∗Most of the evidence for this practice comes from civilian studies of trauma in urban environments,
where transport to hospital times were generally under one hour. In the military environment or
remote rural civilian practice evacuation timelines may be considerable longer. For this reason
British Military operational practice, circa 2011, has been for ‘novel-hybrid resuscitation’: one
hour of hypotensive resuscitation, aer which normotensive resuscitation should be attempted
regardless of patient location or predicted evacuation timelines.
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1.3.2 Conventional Measures of Physiological Status in Trauma
Traditional clinical signs of hypoperfusion include capillary rell rate, features
of elevated sympathetic nervous system activity such as pallor, sweating and as-
sessment of cerebration. While these have value when assessed as part of the
whole clinical picture, they are highly subjective and used in isolation lack either
specicity or sensitivity.
Pulse rate is the simplest objective clinical sign of volume state in trauma. It
is highly reproducible and relatively easy and simple to record continuously in
real time, as such it is widely used. Despite its ubiquity, the heart rate response to
haemorrhage is widely misunderstood (Secher and Bie, 1985). A small reduction in
central blood volume fromhaemorrhage, but equally as a result of postural changes,
causes a modest increase in the pulse rate (<100 bpm). Once the reduction in
central blood volume approaches 30% there is a ‘paradoxical’ drop in pulse rate and
blood pressure mediated by a Bezold-Jarish-like∗ vagal reex associated with a loss
of peripheral (muscle) sympathetic activity (Campagna and Carter, 2003). Only
with greater reductions in the central blood volume is there an increase in heart rate
and a concomitant drop in the blood pressure, signalling the transition towards
irreversible shock. In the young or athletic, of which the military population
represents both, this biphasic response may be absent as they compensate very
well initially for small volumes of blood loss.e interpretation of heart rate is
further complicated by the fact that the initial baroreex can be over ‘overridden’
by the sympathetic response associated with pain or tissue damage. Although
commonly used, heart rate can be seen to be an unreliable indicator of volume
state with signicant haemorrhage occurring in the presence of tachycardia, a
normal heart rate or even a relative bradycardia.
Along with pulse rate, blood pressure is the other most commonly misunder-
stood parameter for assessing volume state. Again this demonstrates the biphasic
response to blood loss, and has many of the same problems in interpretation as
pulse rate. Blood pressure is frequently preserved in young individuals during
∗e Bezold-Jarish reex, originally described by Albert von Bezold (1836–1868) and Ludwig Hirt
(1844–1907) and subsequently conrmed by Adolf Jarish (1850–1902), strictly describes the triad
response of apnoea, bradycardia and hypotension observed in experimental animals following the
administration of veratrum alkaloids (Aviado and Aviado, 2001).
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mild tomoderate haemorrhage particularly when associated with signicant tissue
injury, but may drop suddenly in these individuals as they progress to uncom-
pensated shock. Compounding the physiological problems with the interpretation
of blood pressure in trauma patients are the practical limitations associated with
the most common methods of measuring it. e gold standard for measuring
blood pressure is intra-arterial monitoring, however this is invasive and time con-
suming to establish and calibrate and thus is not typically available during the early
stages of resuscitation. As a result non-invasive blood pressure monitoring is oen
used during the early stages of resuscitation. Measurements are usually taken by
an automated blood pressure device, the accuracy of which in the trauma patient
have been questioned with one study having shown automated measurement to
be signicantly higher than those recorded manually (Davis et al., 2003). e
technique is further limited by the time taken to obtain a measurement: most
automated machines typically provide intermittent recordings on a ve minute
rolling cycle, which makes accurate interpretation of the patient’s response to
interventions very dicult. Despite the convenience and widespread availability of
non invasive blood pressure monitoring there is oen a signicant delay in obtain-
ing the rst measurement. In a 2009 audit on trauma care in Selly Oak Hospital,
Birmingham (a regional trauma centre), the average time from patient arrival in
the emergency department (ED) to the rst blood pressure measurement was 11
minutes (Prof K Porter, personal communication).ere is also wide variation in
the limit of agreement between invasive and non-invasive blood pressure monit-
oring (MacFarlane et al., 2010).is makes interpreting the literature dicult as
many major trauma patients will transition from non-invasive to invasive blood
pressure measurements as their care progresses, but the distinction as to when
this occurs and the potential for dierences between the two techniques is rarely
made clear.
Central venous pressure (CVP) monitoring and pulmonary artery catheters
oer an accurate means of assessing volume state in patients, and can be used
to guide uid replacement in trauma, although pulmonary artery catheters are
rarely used for this purpose in the UK.e main limitation of CVP monitoring
is that it provides no indication of cardiac output (CO), and a low CVP may be
a reection of low central volume or reduced myocardial contractility, of which
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trauma is associated with both (Abou-Khalil et al., 1994; Yang et al., 2004). For
this reason it is oen suggested that a pulmonary catheter is required to provide
the distinction. Unfortunately the insertion and calibration of these lines requires
specialist skills and is time consuming, as a result their use is largely conned to
the theatre and ITU settings, and they are rarely available to guide the early stages
of resuscitation.
Arterial pH, lactate and base excess are indicators of anaerobic metabolism
occurring as result of tissue hypoperfusion in shock. Of the three lactate is con-
sidered to provide the most accurate reection of tissue oxygen delivery (Husain
et al., 2003). Some authors suggest that lactate can be raised in trauma due to
mechanisms other than anaerobic glycolysis secondary to hypoperfusion, and in
these circumstances it may be a misleading end point of resuscitation (James et al.,
1999). Such theoretical concerns appear to be less of a problem in clinical practice,
however lactate is still not commonly used due to a lack of widespread availability
when compared to base excess and other arterial blood gas parameters. For this
reason the application of base excess in assessing trauma resuscitation has received
much more attention in the literature. Attempts to directly compare base excess
to lactate have yielded conicting results (Davis, 1994; Mikulaschek et al., 1996).
e principle problem is that base excess can be aected by the administration of
large amounts of saline. Base excess appears to be a useful surrogate for lactate as
long as its changes are a result of alterations in tissue perfusion. When changes in
base excess occur secondary to hypercholoraemic acidosis associated with saline
administration, or lactate is inuence by ketoacidosis or renal dysfunction, this
relationship can become discordant (Chawla et al., 2010). Despite these problems,
base excess has been shown to correlate better than conventional haemodynamic
parameters with other indicators of oxygen delivery and utilisation in traumamod-
els (Davis et al., 1991) and human trauma patients (Kincaid et al., 1998). Moreover
venous base excess correlates well with arterial base excess in trauma, making
it useful when arterial samples are not available (Davis, 1994).e limitation of
all arterial or venous blood gas measurements is that they are invasive, provide
intermittent ‘snapshots’ of patients’ resuscitation status and take time to process —
due to this practical constraint and the nature of the samples themselves ABG
measurements typically lag behind the true clinical picture. In addition, processing
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ABGs requires carefully calibrated equipment and a degree of logistical support
that may not be available in the military or prehospital environment.
1.4 trauma in the military environment
Trauma management in the military environment follows many of the same prin-
ciples as that practiced in the civilian setting, however the nature of war, the
injury pattern, evacuation timelines and patient population, all pose additional
challenges.
War is characterised by a high volume of multiply injured casualties sustaining
massive trauma of a type rarely seen in civilian practice. Penetrating ballistic
wounds and blast trauma — the hallmarks of modern warfare occur much more
commonly than in civilian practice.e nature of the injuries seen are conven-
tionally associated with the intensity of the conict. In full-scale war blast injuries
are common, while in small scale conicts penetrating wounds due to gun shots
predominate (Ryan, 2000). However, the experience of the early part of the 21st
century has seen a reversal of this pattern with patient data from Afghanistan
demonstrating a high proportion of injuries occurring due to improvised explosive
devices (IEDs) as a consequence of a change in Taliban tactics.e result is an
injury pattern composed of a mixture of gun shot wounds (GSWs) and blast injury,
oen associated with single or multiple traumatic limb amputations (Hodgetts
et al., 2007).
In addition to the problems of managing one or more potentially multiply
injured casualties, the delivery of medical care in the military setting is further
complicated by the oen austere and resource constrained nature of the environ-
ment, particularly in the forward role. Initial care may have to be performed in the
presence of a persistent threat and under tactical conditions, e.g. minimal noise
and limited articial light. Even in the eld hospital logistical constraints limit the
resources and expertise available for care.ere is oen delayed access to denitive
care, and where evacuation does take place this will be under forward operating
constraints. When transporting casualties by helicopter the problems of noise
and vibration severely limit the type and extent of care that can be undertaken,
although this problem is not unique to the military.e net result, certainly for
conicts in the 20th century for which accurate data exists, is a higher mortality
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for haemorrhagic shock when compared to civilian settings, 65% vs 50% and a
high mortality before reaching care at Role 2∗ or above (Champion et al., 2003).
Military trauma practice does have one major advantage over its civilian coun-
terpart: the vast majority of the population are young, physical t males, who
have been medically screened to exclude signicant comorbidities and are up-to-
date with their vaccinations. Hence the population tends to have much greater
physiological reserves, will tolerate a greater injury burden and has better rehab-
ilitation potential. e problem working with such a group is that it can make
translation of research from the civilian world to military environment, or vice
versa, dicult.e exception to dealing with young healthy individuals occurs
when the military is required to manage allied forces, the local civilian popula-
tion, or expatriates/contractors who enter the medical evacuation chain. Under
these circumstances the population will more closely resemble that seen in civilian
practice. However this can present dierent management issues, particularly in
the case of local civilian populations in third world nations, where problems with
chronic malnutrition, unmanaged major/advanced comorbidities, or opiate use
are much more common than that seen in western medical practice.
In summary, the constraints of the military environment present many addi-
tional challenges to the management of trauma patients. New techniques intro-
duced to improve care need to be robust, able to survive the logistical chain and
preferably simple to use or interpret with the minimum of specialist support.
∗Role 2 is one of the four tiers in which medical support is organised, as dened by NATO. Role 2
is the smallest facility at which a surgical capability is provided, usually of a damage control nature.
Above this would be Role 3, typically provided by a eld hospital, and Role 4 a facility capable of
providing denitive care across the full range of specialities, most commonly this refers to health
care facilities located in the country of origin.
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2. oxygen dynamics and the properties of
haemoglobin
e previous chapter discussed the limitations of current techniques used to guide
resuscitation in the trauma patient —mainly that they are all only surrogate mark-
ers of end organ/tissue perfusion.is chapter outlines some of the physiology of
tissue oxygen delivery and examines the role of goal directed therapy in trauma
resuscitation.
2.1 oxygen delivery
Oxygen is an essential substrate for oxidative cellular metabolism. Although
some tissues are capable of anaerobic respiration in the face of inadequate oxygen
delivery, the process is inecient and produces toxic byproducts such as lactate.
Increased concentrations of such compounds have deleterious eects in the trauma
patient, e.g. lactic acidosis and coagulopathy, compounding the physiological
disturbance that gave rise to their production in the rst place.
Oxygen delivery to end organs is described as ‘owing down’ an oxygen
cascade from high concentrations of oxygen in the atmosphere along a series
of physiological transport steps to the relatively low partial pressures found in
peripheral tissues (see Figure 2.1).is process of oxygen diusion can be broken
down into ve simple stages, with movement between each stage occurring in
accordance with basic physical laws (Bersten and Soni, 2009):
1. Ventilation
2. Oxygen uptake from the lungs
3. Reversible binding of oxygen to haemoglobin
4. Convective transport of oxygen to the tissues
5. Diusion of oxygen into cells
Step 1: Ventilation
is describes the mechanical process of moving air by convection into the alveoli
of the lungs where gaseous exchange can take place. At sea level the partial pres-
sure of oxygen in arterial blood (PaO2) is around 21 kPa. During inspiration it is
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Figure 2.1:e oxygen cascade. Oxygen diuses ‘downhill’ along the transport chain, with
each step existing at a lower partial pressure of oxygen than the one before. Disruption
of one or more of the steps will result in a reduction in oxygen delivery to end organs,
adapted fromMartin and Windsor (2008).
humidied and mixed with CO2 such that the partial pressure at the alveolar level
is reduced to around 13 kPa.
Step 2: Oxygen uptake
Oxygen diuses from the alveoli, across the alveolar-capillary membrane into the
blood in accordance with Fick’s Law:
Rate of gas transfer∝ kA∆P
D
where k is the diusion constant for oxygen, A is the surface area over which
diusion takes place, ∆P is the partial pressure gradient and D is the thickness of
the alveolar-capillary membrane.e net result of each of these factors on oxy-
gen diusion results in a typical pulmonary capillary PaO2 being around 12 kPa.
For diusion to occur eectively there must be adequate oxygen present in the
alveoli (delivered in step one) and sucient capillary perfusion to maintain the
diusion gradient. Critically these two processes have to occur in the same place
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at the alveolar level. Failure to achieve this is referred to a ventilation-perfusion
(V/Q) mismatch. Trauma patients have several challenges at this level: global
hypovolaemia results in inadequate perfusion of the lung parenchyma; in addition
reduced ventilation secondary to chest wall trauma, a supine position, or positive
pressure ventilation all serve to exacerbate the V/Qmismatch.
Step 3: Reversible binding of oxygen to haemoglobin
Oxygen is poorly soluble in plasma and only around 3% is carried in this way, the
rest being transported bound to haemoglobin. e properties of haemoglobin
and its role in oxygen carriage are discussed in Section 2.3. e concentration
of oxygen in the blood (CaO2) is the sum of the quantities of oxygen bound to
haemoglobin and that dissolved in plasma.is can be expressed as:
CaO2 = ([Hb] × 1.34 × SaO2)´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
O2 bound to Hb
+ (0.003 × PaO2)´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
O2 dissolved in plasma
where [Hb] is the concentration of haemoglobin in g/dl, 1.34 is a constant ex-
pressing the quantity of oxygen in mls bound by 1 g of haemoglobin and SaO2 is
the percentage saturation of haemoglobin. It can therefore be seen that the next
major constraint on oxygen delivery in the trauma patient is the haemoglobin
concentration, which will be reduced in any patient suering moderate to severe
haemorrhage.
Step 4: Convective transport of oxygen to tissues
Tissues have a limited capacity for storing oxygen and depend upon on a continu-
ous supply being delivered by the cardiovascular system. Oxygen delivery (D˙O2)
to tissues is dependant upon two factors:
1. the cardiac output (CO)
2. local controls on regional blood ow to tissues
Mathematically D˙O2 can be expressed as:
D˙O2 = 10 × CO × CaO2
where D˙O2 is expressed in ml/min and CO as l/min (a conversion factor of 10
is used to balance the units). In a normal adult at rest D˙O2 is approximately
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1000 ml/min. In the trauma patient CO will be reduced in accordance with Ohm’s
Law∗ which, as can be seen from the equation above, will be associated with a
proportionate reduction in D˙O2.
Step 5: Diusion of oxygen into cells
Over 90% of aerobic metabolism takes place in the mitochondria. At the point
of utilisation in mitochondria the partial pressure of oxygen can be as low as
0.1 kPa.is creates a diusion gradient down which oxygen will move into the
cell in accordance with the principles of Fick’s Law and the state of the oxygen
haemoglobin dissociation curve. Assuming that oxygen supply exceeds demand,
the amount of oxygen taken up by a cell will be determined by its metabolic needs
and not amount of oxygen available.
Examining the ve steps above it can be appreciated that there are several
potential challenges to oxygen delivery in the trauma patient. Ventilation is not
usually a problem, unless there is tracheobronchial disruption or other signicant
chest injury, but at every step aer that problems can occur. Hypovolaemia, a
supine position and positive pressure ventilation will all contribute to a V/Q
mismatch. Low concentrations of haemoglobin (as a result of haemorrhage) and
the eects of acidosis and hypothermia will reduce oxygen carriage in the blood.
Low arterial pressure is associated with a concomitant reduction in CO, which
ultimately results in a narrowing of the oxygen diusion gradient at the end organ
level.
2.2 oxygen consumption
Oxygen consumption (V˙O2) is oen used synonymously with whole body oxygen
demand, although the two are not the same. Demand is related to need, and the
two terms are only equivalent when demand for oxygen exceeds supply. V˙O2 can
be expressed in terms of CO and the dierence between the oxygen content of
∗Ohm’s Law describes the relationship between ow and pressure. In terms of cardiovascular
physiology it can be expressed as: CO = arterial pressure/total peripheral resistance. CO is directly
proportionally to arterial pressure therefore a reduction in arterial pressure, associated with
hypovolaemia, will lead to commensurate reduction in CO.
18
2.3. the properties of haemoglobin
arterial (CaO2) and venous blood (CvO2):
V˙O2 = CO × (CaO2 − CvO2)
where CvO2 can be expressed as:
CvO2 = ([Hb] × 1.34 × SvO2)´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
O2 bound to Hb
+ (0.003 × PvO2)´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
O2 dissolved in plasma
where SvO2 is the haemoglobin-oxygen saturation of mixed venous blood and the
PvO2 is the partial pressure of oxygen in the venous blood. Since the quantity of
oxygen dissolved in the plasma is negligible, the major determinants of CvO2 are
SvO2 and the concentration of haemoglobin ([Hb]).
e ratio of oxygen delivery to consumption is referred to as the oxygen
extraction ratio (ER):
ER = V˙O2
D˙O2
In a normal individual at rest the ER is around 25%, which means that 25% of
the oxygen delivered in arterial blood is taken up by the tissues and the remaining
75% remains in the venous blood. Under these condition V˙O2 and D˙O2 are
independant. However as the extraction ratio increases (in the trauma patient
this would be as a result of a reduction in CO and haemoglobin concentrations),
a critical D˙O2 is reached. V˙O2 becomes dependant upon D˙O2 and anaerobic
metabolism occurs (Žaja, 2007).
2.3 the properties of haemoglobin
Haemoglobin is the principle oxygen carrying compound in most vertebrates
(others being myoglobin and neuroglobin). Except when in the presence of haem-
olytic disease, haemoglobin is contained almost exclusively within red blood cells
(erythrocytes). Human red cells take the shape of a biconcave disc with a diameter
of 6–8 µm. Atmaturity red cells possess no nucleus or other intracellular organelles,
the intracellular volume being largely taken up by haemoglobin, as such red cells
incapable of repair and have a typical life span of around 120 days.
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Figure 2.2:e structure of haemoglobin A. Demonstrating the tetramer structure with
four globin subunits (α shown in red and β shown in blue).eir associated iron containing
haem groups are shown in green.
2.3.1 e Structure of Haemoglobin
Haemoglobin is a complex metalloprotein, composed of an iron containing haem
group associated with a globin protein chain. Haemoglobin exists as tetramer
with a molecule weight of 64,458 (for HbA) composed of four protein subunits,
each with molecular weight of approximately 16,000 (see Figure 2.2). Each subunit
consist of one of four possible globin chains (α, β, δ and γ). Each globulin chain
contains a hydrophobic pocket into which one iron containing haem group is
inserted, which is the part that actually binds oxygen. In adults, approximately
97% of haemoglobin exists in the HbA form, which is composed of two α and two
β subunits. Up to 2.5% of haemoglobin is HbA2 (composed of α and δ chains),
and the remainder HbF or foetal haemoglobin (composed of α and γ chains), so
named because this is the predominant form of haemoglobin in late foetal and
early neonatal life.
2.3.2 Oxygen Carriage by Haemoglobin
emain function of haemoglobin is to carry oxygen, although it is also involved in
several other processes such as the transport of CO2 and the buering of acid-base
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changes in the blood. Each haem unit in the active ferrous (Fe2+) form is capable of
reversibly binding a singlemolecule of oxygen, therefore the haemoglobin tetramer
is capable of binding up to four molecules of oxygen.is is not an all or nothing
process, and there is no requirement that every haemunit be simultaneously bound
to an oxygen molecule. Oxygen carriage by haemoglobin is usually expressed in
terms of percentage saturation (SpO2):
SpO2 = HbO2Hb +HbO2
where HbO2 is concentration of oxyhaemoglobin and Hb the concentration of
deoxyhaemoglobin.
SpO2 is governed by many factors, the most important of which is the par-
tial pressure of oxygen. SpO2 and the partial pressure of oxygen demonstrate
a sigmoidal relationship, as expressed in the oxygen-haemoglobin dissociation
curve shown in Figure 2.3. At low oxygen tensions the SpO2 is also low, however
the binding of oxygen to haemoglobin produces a conformational change in the
protein structure facilitating the binding of further oxygen molecules. is is
known as cooperative binding and accounts for the dierence between the early
and middle portions of the curve. At high oxygen concentrations haemoglobin
approaches full saturation, and it becomes increasingly dicult for further oxygen
binding to take place, accounting for the plateauing of the curve. Under normal
conditions the saturation of haemoglobin in arterial blood will be in excess of 97%.
e partial pressure of oxygen at which haemoglobin is 50% saturated is re-
ferred to as the P50, which is a conventional measure of the anity of haemoglobin
for oxygen. A shi in the P50 to the right is associated with a decreased anity of
haemoglobin for oxygen, and occurs in association with a fall in pH (when this
is due a rise in CO2 it is referred to as the Bohr Eect), a rise in temperature or
the concentration, of 2,3-diphosphoglyceric acid (2,3-DPG) an anionic organic
phosphate found in red blood cells. Conversely a shi to the le is associated with
a higher anity for oxygen and occurs with a rise in pH/CO2, a fall in temperature,
or the concentration of 2,3-DPG.
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Figure 2.3: e oxygen-haemoglobin dissociation curve. e dashed curves represent
shis in the anity of haemoglobin for oxygen associated with changes in pH, temperature,
or 2,3-DPG concentrations (see text for details). A shi in the curve to right indicates
a lower anity of haemoglobin for oxygen and a shi to the le a higher anity. e
P50 is a partial pressure of oxygen at which haemoglobin is 50% saturated, it provides a
conventional measurement for comparing the anity of haemoglobin for oxygen under
dierent conditions.
2.4 local tissue oxygenation
Asdiscussed inChapter 1 the goal of trauma resuscitation is to achieve adequate end
organ perfusion, or for all practical purposes an adequate local tissue oxygenation
(StO2) in the target organ. StO2 can be derived from the ratio of HbO2 to total
haemoglobin in the target tissue, expressed as:
StO2 = HbO2Hb +HbO2
is is the same equation as that for calculating SpO2 presented on page 21, except
here the haemoglobin concentration relates to the combined concentrations in the
arterial, capillary and venous compartments. StO2 can be considered analogous to
a mixed venous saturation taken at a microcirculatory level. In reality the redox
state of several other oxygen carrying compounds (such a myoglobin) may also
inuence StO2. Fortunately the contributions of such compounds to the NIRS
signal are usually small, and they are oen ignored. A more detailed consideration
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of the inuence of other oxygen carrying compounds on StO2 is presented in
Section 3.3.
From the previous discussion regarding oxygen delivery, it can be appreciated
that StO2 in the trauma patient will be inuenced by three factors:
1. Haemoglobin-oxygen saturation of arterial blood
In most patients the partial pressure of oxygen in alveoli, if breathing room
air, is around 13 kPa. From the oxygen-haemoglobin dissociation curve
presented in Figure 2.3 it can be seen that this is associated with a haemo-
globin saturation in excess of 97%. In reality all trauma patients receive
oxygen therapy as a rst line treatment resulting in much higher oxygen
partial pressures and a near constant 100% haemoglobin saturation, unless
there is signicant airway or pulmonary injury.erefore the oxygen satur-
ation of arterial blood can usually be considered a constant and does not
contribute to changes in StO2 in the tertiary/Role 3 environment.
2. Haemoglobin-oxygen saturation of capillary/venous blood
Haemoglobin saturation in capillary/venous blood is dependant upon two
factors:
a) e saturation of arterial blood delivered to the capillary bed. In the
trauma patient receiving oxygen therapy this will typically be 100%
and is not usually a determinant unless there are signicant ventilatory
problems.
b) e oxygen extraction ratio. Low CvO2, associated with a reduced
haemoglobin and low CO, results in an increase in the oxygen extrac-
tion ratio reducing the haemoglobin oxygen saturation in the venous
compartment.
3. Ratio of blood volume in the arterial, capillary and venous compartments
It is believed that inmost tissues the blood volume is distributed between the
arteriolar, capillary and venular compartments in a ratio of 10:20:70 (Wiede-
man, 1963).erefore StO2 is predominantly a reection of oxygen satura-
tions in the venous compartment. Since there are signicant dierences in
the oxygen saturations of the arterial (typically around 100%) and venous
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systems (typically 60–80%) a change in the ratios of blood volume between
these two compartments will aect StO2.
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3. near infrared spectroscopy
Near infrared spectroscopy (NIRS) is a technique that can be applied in clinical
medicine to provide a non-invasive, real-time continuous estimate of local tissue
oxygenation (StO2).is chapter describes some of the background to the tech-
nique and discusses the theory of its application in medical practice. Parts of this
chapter, in particular Section 3.2, include material previously published in the
Journal Trauma under the title ‘e Diagnosis of Acute Lower Limb Compartment
Syndrome: Applications of Near Infrared Spectroscopy’ (Barker et al., 2011).
3.1 a brief history of the development of nirs
e history of NIRS for measuring StO2 is one encompassing innovations from
the elds of astronomy, physics, chemistry, physiology, and only relatively recently
that of clinical medicine. Its development spans nearly 350 years, from Newton’s
early work on optics to current day medical practice.
3.1.1 e Discovery of the NIR Range
In 1665 Newton’s∗ work on optics demonstrated that white light was not the
homogeneous matter previously thought, but a composite of the all visible colours
of the electromagnetic spectrum. However it was William Herschel†, with the
presentation of his seminal work ‘Experiences on the Refrangibility of the Invisible
Rays of the Sun’ (Herschel, 1800) to the Royal Society in 1800, who is credited
with the discovery of the infrared range.
In an elegant experiment Herschel projected the visible spectrum onto a bench
with the aid of a prism and proceeded to measure the heating eect of dierent
parts of it. He found that the temperature increased as the thermometer was
moved from violet to red and reached a maximum beyond the range of the visible
spectrum (see Figure 3.1). Herschel correctly surmised that sunlight must contain
more than just the visible spectrum, referring to his new discovery as ‘radiant
heat’ and the ‘thermometrical spectrum’, but mistakenly believed that this energy
∗Sir Isaac Newton PRS (1642–1727), English physicist and mathematician, Lucasian Professor of
Mathematics at the University of Cambridge.
†Sir Fredrick William Herschel FRS (1738–1822), German born English Astronomer and Composer.
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Figure 3.1: An illustration taken from Herschel’s original description of his experiments
identifying energy associated with the infrared range of the electromagnetic spectrum.
Sunlight is diracted through a prism so as to project a rainbow on the bench. ree
thermometers are positioned such that the rst records the temperature of a band of
radiation, while the other two lie outside of the spectrum intended to act as controls.
was fundamentally dierent to visible light. It was Ampère∗ who, in 1835 using the
recently developed thermocouple, demonstrated that near infrared (NIR) waves
had the same properties as visible light, and that they were in fact part of the same
phenomenon (Hindle, 2007). But it would take over a century more before the
technology would be available to allow the acquisition of spectra outside of the
visible spectrum.
3.1.2 e Early Development of Spectroscopy
e rst spectroscope was constructed by the German optician Joseph von Fraun-
hofer† in 1814. By replacing the mirror of a theodolite with a hollow prism, he was
able to use this equipment to observe dark lines appearing in the solar spectrum,
subsequently shown to be atomic absorption lines which still bear his name today.
Fraunhofer also developed a wire diraction grating that allowed the separation
∗André-Marie Ampère (1775–1936), French mathematician and physicist.
†Joseph Ritter von Fraunhofer (1787–1826), German optician.
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Figure 3.2: Bunsen and Kirchho’s spectroscope.
of light of dierent wavelengths with high resolution, transforming spectroscopy
from a qualitative art to a quantitative science (Stepanov, 1977).
In 1859 Bunsen∗ and Kirchho† began studying the emission spectra of heated
elements (the design of their spectroscope is shown in Figure 3.2). Together they
discovered caesium in 1861, and shortly aerwards radium (Weeks, 1932). e
techniques they pioneered would be responsible for the direct discovery of several
other elements. Although not the rst to use spectroscopy, Bunsen and Kirchho’s
collaboration is arguably the most famous and their work led to an explosion of
interest in the new eld, however the lack of suitable detection equipment limited
progress outside of the visible spectrum.
In the early 1880s an important step was made when it was realised that the
photographic plate, invented in 1829 by Niépce‡ and Daguerre§, had some NIR
sensitivity. Abney¶ and Festing‖ exploited this discovery early on and from 1881
began recording spectra of organic liquids in the range of 1–1.2 µm (Abney and
Festing, 1881).eir work was signicant in that not only did it represent the rst
serious measurements in the NIR range, but also that they were the rst to realise
∗Robert Bunsen (1811–1899), German Chemist, recipient of the Copley Medal.
†Gustav Robert Kirchho (1824–1887), German Physicist, recipient of the Rumford Medal.
‡Nicéphore Niépce (1765–1833), French inventor and photographer.
§Louis-Jacques-Mandé Daguerre (1787–1851), French designer and photographer.
¶William de Wiveleslie Abney FRS (1843–1920), English army ocer, chemist, and photographer.
‖Major-General Edward Robert Festing FRS (1839–1912), English army ocer and chemist.
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the importance of hydrogen bonds in the NIRS spectrum (Hindle, 2007).
Building on the work of Abney and Festing the American Physicist William
Coblentz∗ constructed a spectrometer highly sensitive to vibration and thermal
disturbances. Taking measurements with this device was a laborious process, the
equipment being so sensitive that Coblentz would have to leave the room to allow
it to settle, and it would take an entire day to acquire a single spectrum (Hindle,
2007). Nevertheless by 1905 he had recorded the spectra of several hundreds
compounds in the 1–15 µm wavelength range. Coblentz recognised that no two
compounds share the same spectra and that certain molecular groupings absorbed
specic and characteristic IR wavelengths. In time this discovery would provide
a tool by which chemists could obtain structural information about compounds
based on their spectra.rough his spectroscopy work Coblentz was also probably
among the rst, if not the rst person, to verify Planck’s Law† (Plyler, 1962).
3.1.3 e Development of Oximetry and Medical NIRS
Shortly aer Bunsen and Kirchho’s publications, the German physiologist and
chemist Ernst Felix Hoppe-Seyler‡ began studying the absorption patterns of
coloured substances in solution. His work on the absorption spectrum of haemo-
globin, was further developed byGeorgeGabriel Stokes§, an experimental physicist
occupying Newton’s old chair at Cambridge. Stokes was the rst to appreciate the
signicance of the dierent absorption spectra between arterial and venous blood.
Reproducing these changes in vitro, he demonstrated that reducing haemoglobin
in the test tube altered its absorption spectrum, and that these changes could be
reversed by shaking the sample in air (Stokes, 1864).
e rst person to actually measure human blood oxygenation in vivo was
the German physiologist Karl von Vierordt¶. From 1874 he began using what
was probably the rst true spectrophotometer, recording measurements from
haemoglobin as well as bile and urine. In 1876 he observed changes in the solar
∗WilliamWeber Coblentz (1873–1962), American physicist.
†Planck’s Law describes the spectral radiance of electromagnetic radiation at all wavelengths from
a black body at a specied temperature.
‡Ernst Felix Immanuel Hoppe-Seyler (1825–1895).
§Sir George Gabriel Stokes, 1st Baronet FRS (1819–1903), English mathematician and physicist.
¶Karl von Vierordt (1818–1884), Professor of theoretical medicine and later professor of physiology
at the University of Tübingen.
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spectrum transmitted through the ngers of his hand, noting that the amount of red
light transmitted decreased when the hand was made ischaemic. Unfortunately
complexity of Vierordt equipment and skill required to obtain measurements
meant that much of this pioneering work went largely undeveloped until the 1930s.
e 1930s saw several innovations. Lead sulphide (PbS) compound semicon-
ductors were developed, which allowed the production of highly sensitive detectors
in the 1–2 µm wavelength, i.e. the infrared and near infrared ranges. Kurt Kramer∗
built a spectrometer using tiny at photocells, resulting in a signicant reduction
in the size of the equipment required to acquire spectra. Using this equipment he
demonstrated it was possible to monitor oxygen saturation to within a 1% accuracy
(Severinghaus, 2002), however his equipment was not able to compensate for
changes in haemoglobin concentration. Karl Matthes† overcame this problem by
using two wavelengths of light — one red and one green.e green wavelength,
being oxygen independent, compensating for variations in the transmission of red
light other than those caused by haemoglobin.
e onset of the Second World War produced an acceleration in the devel-
opment of non-invasive oximetry associated with the war eort, in particular
the requirement to monitor pilots ying at high altitude in unpressurised cab-
ins. Glen Millikan‡ developed the rst portable ear oximeter at the University of
Pennsylvania, and also coined the term ‘oximetery’ (Cohn, 2007). Ultimately his
device was to prove impractical for aviation use due to the requirement for a mo-
tion sensitive galvanometer to measure the current, but subsequent improvements
led to one of the rst commercial successful products — the Hewlett Packard Ear
Oximeter (Severinghaus, 2002).
At this point the development of oximetry diverged. In 1972 Takuo Aoyagi’s§
discovery that arterial oxygen saturation was a direct function of the absorbency
ratios of red and infrared light led directly to the development of modern pulse
oximetry (Tremper, 1989). e origins of StO2 monitoring began in 1977 with
the work of Frans Jöbis¶. Jöbis, had originally set out to the study redox centres
∗Kurt Kramer (1906–1985), German physiologist.
†Karl Matthes (1905–1962), German physician.
‡Glenn Allan Millikan (1906–1947), American physiologist.
§Takuo Aoyagi (1936–), Japanese engineer.
¶Frans Jöbis-vanderVliet (1929–2006), American physician and physiologist.
29
3.2. principles of spectroscopy
of cytochrome oxidase in the open heart, but the realisation that NIR photons
would penetrate much more deeply than those of visible light and may in eect
provide an optical window to study the deep tissues of the body led him to pursue
a dierent line of enquiry. In a landmark paper he described how light in the near
infrared range could be transmitted through the intact head of a cat, and noted the
dierential spectral absorption of haemoglobin and the mitochondrial enzyme
cytochrome oxidase (CtOx) (Jöbsis, 1977). Subsequent work by his group improved
their algorithm enabling the resolution of the respective spectra of haemoglobin
and CtOx, although only as ratios of their respective signal and not absolute values,
as this would have required knowledge of the pathlength which was not possible
to establish with the technology of the time (Jöbsis-vanderVliet, 1999).
Since Jöbsis’ early work, algorithms have continued to improve, the use of ‘time
of ight’ analysis has allowed the determination to eective optical pathlength,
and the development of reectance techniques have allowed the study of tissues
where transmission spectroscopy was not possible. But ultimately it was advances
in micro-processing that nally allowed the miniaturisation of monitoring devices
to the extent that bedside commercial NIRS devices became a reality in the last
decade of the twentieth century.
3.2 principles of spectroscopy
Spectroscopy (or more strictly spectrometry) is a technique used to identify un-
known substances in a compound, or the concentration of known substances in a
compound, based upon their absorbed or emitted spectra. For the purposes of this
discussion only absorption spectroscopy will be considered, i.e. that technique
which measures the absorption pattern of a chromophore∗ when exposed to parts
of the electromagnetic spectrum.
3.2.1 Transmission/absorption Spectroscopy
e physical basis for spectroscopy is provided by the Beer-Lambert Law, which
states that for a non-scattering medium there is a logarithmic dependence between
∗A chromophore is that part of a compound which absorbs light and is therefore responsible for its
spectra, in the visible spectrum this would be interpreted as the compound’s colour. In the context
of spectroscopy the term is oen loosely applied to a compound of interest in its entirety rather
than the specic part that accounts for its spectrum.
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the transmission (T) of light through a substance and the product of the molar
absorptivity of the chromophore (ε), the chromophore concentration (c) and the
thickness of the substance (i.e. the optical path length, ℓ).e molar absorptivity,
also known as the molar extinction coecient, is a measure of how strongly
a chromophore absorbs light at a given wavelength. e product of the molar
absorptivity and the chromophore concentration (cℓ) is the absorption coecient
of the substance being investigated. Mathematically the Beer-Lambert law is
expressed as:
T = I
I0
= 10−εcℓ
where I0 is the intensity of the incident light and I the intensity of the emergent
light. More usually this relationship is expressed in terms of absorbance (A) for
the substance being examined where A = −log10T so that:
A = log10 ( I0I ) = εcℓ
In a medium containing several dierent chromophores the overall extinction
coecient of the compound is merely the sum of the contributions of each chro-
mophore:
A = log10 ( I0I ) = (ε1c1ℓ + ε2c2ℓ + ε3c3ℓ + . . .)or
A = Σεcℓ
is relationship holds true for conventional transmission/absorption spec-
troscopy where the light travels in straight lines and completely traverses the
substance being investigated, as shown in Figure 3.3. Unfortunately in the human
body, where light frequently cannot pass completely through the structure being
investigated and must traverse tissues of dierence densities, the situation is a little
more complex.
3.2.2 Reectance Spectroscopy
Human tissue acts as a scattering media. is is in part due to the fact that
photons have to traverse several dierent tissue interfaces in the optical path, each
with diering propensities to absorb or scatter photons. e net result is that
photons do not pass through tissues in straight lines, but instead are repeatedly
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I0
I
εc
ℓ
Figure 3.3: A diagrammatic representation of the elements of the Beer-Lambert Law. I0 is
the intensity of incident light, I the intensity of emergent light, ε the chromophore molar
absorptivity, c the chromophore concentration, ℓ the eective optical pathlength.
reected, resulting in the eective optical path length being considerably greater
than the tissue thickness traversed.is situation is further complicated by the
fact that transmission spectroscopy is not practical for many medical monitoring
applications. Although near infrared light can penetrate to a depth of several
centimetres, it is unable to completely traverse many sites likely to be interest to
the clinician. Even if transmission spectroscopy was possible, the emergent spectra
would be an amalgamation of all the structures along the optical path, meaning
that spectral features of ischaemia in the tissues of interest could be easily masked
by a non-ischaemia signal from other structures. To get around this problem the
technique of reectance spectroscopy is used.
In reectance spectroscopy the light source and receptor lie in the same plane
and the optical path approximates a parabolic, or banana-shaped, course through
the tissues (see Figure 3.4).e eective optical pathlength and depth of tissues
from which spectra are recorded is a function of the interoptode distance. To
quantify the optical pathlength in reectance spectroscopy, a number of theoretical
mathematical models describing light transport in tissues have been developed.
One of the most widely used models describing light transport in tissues, is
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Muscle
Skin
NIRS Probe
Figure 3.4: A diagrammatic representation of reectance spectroscopy, showing a NIRS
probe attached to the skin overlying a section of muscle. Note that once light enters the
tissue it is repeatedly reected and scattered, the vast majority being dissipated throughout
the muscle and never reaching the receiver. ose photons that do reach the receiver
follow an oen convoluted course several times greater than the interoptode distance,
although the overall optical path approximates to a parabola.
the dierential pathlength factor (DPF) method.e DPF model assumes that
for any single recording site the tissue structure, and hence the eective optical
pathlength, remains constant.us changes in the light signal at the detector will
be a reection of changes in chromophore concentration. An obvious problem
with this assumption is that any change in the tissue geometry or structure, such
as movement, may aect the eective optical pathlength and consequently be mis-
interpreted as a change in chromophore concentration. A further limitation is that
without knowledge of the pathlength, the model as described so far only allows a
qualitative measurement of chromophore concentrations. To obtain quantitative
recordings the DPF (a value >1) correcting for the dierence between the interop-
tode spacing and the eective optical pathlength must be known (van der Zee
et al., 1992). Once this has been established the relationship between the sum of
all the chromophores contributing to the signal and the tissue absorbance can be
calculated from a modication of the Beer-Lambert Law:
A = ∑ εcdDPF
where d is the interoptode distance and DPF represents the dierential pathlength
factor, the product of these two variables therefore describe the eective optical
pathlength.
e DPF is dependant upon the interoptode distance and the scattering prop-
erties of tissues along the optical path. In human tissues DPF values typically fall
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between 4–7.50 (muscle usually having a DPF at the lower end of this range and
brain at the higher end) (Duncan et al., 1995; Zhao et al., 2002).e DPF requires
recalculating for each interoptode and tissue combination, and there are number
of approaches for achieving this including time of ight analysis and spatially
resolved spectroscopy. It is not necessary that the end user of NIRS devices under-
stand the details of these techniques, as the DPF will have already been established
and incorporated into the interpretation algorithm by equipment manufacturers.
It should be realised however, that dierent manufacturers/investigators use dier-
ent techniques for NIRS monitoring and establishing the assumptions upon which
their algorithms are based, the validity of some of which are still open to debate
(Ward et al., 2006).e end result is that absolute NIRS recording from dierent
devices are unlikely to be immediately comparable, and even trends recorded in
the same individual may show slight variation (Matcher et al., 1995).
3.2.3 Dual Beam NIRS Algorithms
One of the clinical problemswith spectroscopy techniques is that the recorded StO2
is an amalgamation of values from all of the tissues traversed in the optical path,
e.g. skin, fat and muscle. Adipose tissue is relatively avascular, and demonstrates
limited changes in perfusion in response to an alteration in clinical condition.
Hence recordings taken from the body surface of obese individuals may be a
poor reection of the underlying muscle perfusion.is problem can be partially
circumvented by a good choice of monitoring site, which is one of the principal
reasons the thenar eminence has become a popular site for StO2 monitoring in
trauma patients. However in many trauma subjects the thenar eminence may be
injured (the eects of monitoring from an injured site in trauma are at present
unknown and thus best avoided) or amputated, and the clinician may be forced
to monitor at a more proximal site with a greater quantity of subcutaneous fat.
Equally clinicians monitoring tissues for specic local changes in StO2, such as the
anterior compartment of the leg in compartment syndrome, are limited in their
choice of probe position. To attempt to correct for this problem researchers and
manufacturers have developed dual beam, or supercial extraction, algorithms
where the light is passed in two paths through the tissue: one supercial and the
other deep.e supercial reading is then subtracted from the deep reading to isol-
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Muscle
Skin
Fat
NIRS Probe
Figure 3.5: A diagrammatic representation of dual beam reectance NIRS. Two beams
of light are shone through the tissue, one supercial and one deep. e signal from
the supercial beam is extracted from that of deep beam theoretically removing the
contributions of the skin and supercial tissues, e.g. fat, and isolating a measurement from
a deep block tissue, approximating to the region illustrated by the dashed yellow line.
ate the StO2 recording from the deeper target tissue (see Figure 3.5). Although this
technique has theoretical advantages there is currently no evidence demonstrating
its superiority in clinical situations.
3.3 measuring haemoglobin concentrations in mammalian tissues
Every chromophore has its own absorption spectrum which describes its absorp-
tion at dierent wavelengths of light. Water is the most abundant chromophore
in the human body, and its spectrum determines the wavelength range of light
that can be utilised to interrogate tissues.e absorptivity of water is relatively
low between 200–900nm. It gradually increases to an initial peak at 970nm, with
subsequent higher peaks occurring at 1500nm and above 1800nm (Delpy and
Cope, 1997), see Figure 3.6. Hence water is oen described as having a ‘window’ of
transparency between 200–900nm through which spectroscopic measurements
can be made. While it is possible to use visible light (450–700nm) to interrogate
tissues, it has a very little tissue penetration. NIR light (700–1200nm), by contrast,
can penetrate tissue to a depth of several centimetres, even through bone such
as the skull. More importantly, within the NIR wavelength oxygen dependant
transitions of the metalloproteins of three important compounds in mammalian
tissue can be detected:
1. haemoglobin
2. myoglobin (which has an identical absorption spectra to haemoglobin)
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Figure 3.6: e absorption spectra of pure water. Note the absorption peak at 970nm,
shown in detail in the right-hand gure, belowwhich the ‘window’ forNIRSmeasurements
of tissue oxygenation occurs.
3. cytochrome oxidase (cytochrome aa3— the terminal enzyme in the respir-
atory chain)
e extinction coecients at dierent NIR wavelengths for deoxyhaemoglobin
(HHb), oxyhaemoglobin HbO2 and cytochrome oxidase (CtOx) are shown in
Figure 3.7, as can be seen HHb demonstrates a weak absorbance peak at 760nm
where as HbO2 does not (Jöbsis, 1977; Kuenstner and Norris, 1994). Figure 3.7
also illustrates that HHb strongly absorbs light in the 650 nm wavelength range,
although, as has been mentioned, this light has very little tissue penetration, and
therefore this phenomenon is of limited clinical use.e dierential absorption of
HHb and HbO2 provides the basis for calculating the StO2 which is taken as the
ratio of HbO2 to total haemoglobin expressed as a percentage:
HbO2
HbO2 +HHb × 100
is is referred to as the functional haemoglobin saturation, because it ignores
the contributions of the two haemoglobin species which do not contribute to
functional oxygen carriage: methemoglobin and carboxyhaemoglobin (Tremper,
1989).
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Figure 3.7:e absorption spectra of HbO2, HHb and CtOx.
It is believed that in most tissues the blood volume is distributed between the
arteriolar, capillary and venular compartments in a ratio of 10:20:70 (Wiedeman,
1963), and that as large vessels (>1 mm) absorb NIR light completely they can be
excluded from the StO2 measurement.erefore the NIRS signal predominantly
reects oxygenation in the venous compartment in a similar fashion to a mixed
venous blood gas. Since there is an inverse linear relationship between venous
saturation and oxygen extraction, StO2 values recorded by NIRS are a reection of
both oxygen delivery (D˙O2) and oxygen consumption (VO2) in the tissue sample.
3.3.1 e Problems of Other Chromophores
Several other compounds in human tissues have spectra similar to haemoglobin
and can interfere with the measurement of StO2. e most important of these
compounds are considered below.
3.3.1.1 myoglobin As has been mentioned previously, the absorption spectra
of haemoglobin and myoglobin are practically identical. While this is not an issue
when monitoring tissues with little or no myoglobin, such as the brain, when
monitoring skeletal muscle this creates the problem of identifying the exact con-
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tribution of myoglobin to the overall NIRS reading, and thus the extent to which
the StO2 reects intracellular (i.e. myoglobin) or intravascular (i.e. haemoglobin)
oxygenation. Although some researchers/manufacturers claim to be able to dis-
tinguish between the contributions of myoglobin and haemoglobin to the NIRS
signal, the algorithms for doing this have not been widely published and technic-
ally these claims are very dicult to validate. In reality the exact contribution of
myoglobin to the NIRS signal remains unresolved and probably varies under dier-
ing conditions of regional oxygen supply. Most NIRS algorithms circumvent the
problem of distinguishing between haemoglobin and myoglobin by considering
the two species together, so that StO2 is eectively calculated as:
HbO2 +MbO2
HbO2 +MbO2 +HHb +Mb × 100
e concentration of myoglobin in muscle is relatively stable and does not change
signicantly following injury. Since the P50∗ of myoglobin is very low (5 mmHg), it
should remain fully saturated undermost clinical conditions.e practical result of
this is that changes in StO2 values predominantly reect changes in theHHb/HbO2
ratio, and the contribution of myoglobin can eectively be ignored (Ward et al.,
2006).
3.3.1.2 cytochrome oxidase CtOx is a large transmembrane protein complex
found in mitochondria. It is the terminal enzyme in the respiratory electron trans-
port chain, receiving an electron from each of the four cytochrome c molecules
which it transfers to an oxygen molecule, this then binds 4 protons to produce
one molecule of water. e translocation of protons across the mitochondrial
membrane contributes to the electrochemical potential used by ATP synthase
to produce ATP. When oxygen is abundant electrons ow from CtOx and it is
oxidised, when oxygen is limiting electrons cannot move away and the enzyme
exists in it reduced form, the balance between these two conditions is referred to
as the redox state (Michel et al., 1998).
CtOx has a low Km (Michaelis constant) and is sensitive to mitochondrial, (not
tissue or cytosolic) PO2, requiring relativity low oxygen tensions before entering
its reduced state, by contrast haemoglobin deoxygenates much more readily. CtOx
∗P50 is the PO2 at which a compound is 50% saturated with oxygen
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is therefore less likely to be of value as an early indicator of hypoxia, however
measuring its redox state may have value as a true indicator of tissue hypoxia at a
cellular level — haemoglobin desaturations that do not result in a reduction of
CtOx are unlikely to be clinically signicant (Cooper and Springett, 1997). Since
the concentration of CtOx in tissues does not change, at least not in the short term,
it is only necessary to know the dierence between the absorption spectra of the
oxidised and reduced form of the enzyme, i.e. the redox state.
Unfortunately the monitoring of CtOx presents several problems.e oxidised
spectrum of CtOx is characterised by a broad peak centred at 830nm, which is
absent in the reduced form of the enzyme. e magnitude of the extinction
coecient for CtOx is similar to that of haemoglobin or myoglobin, however
since it exists in concentrations many times smaller than that of haemoglobin or
myoglobin (Sato et al., 1976), the measurement of CtOx spectra is no simple feat
being subject to interference from these other chromophores.
3.3.1.3 melanin Melanin contained within the skin is a highly eective ab-
sorber of light. Although this absorption can be considered constant and oxygen
independent for measurements taken from the same location in the same indi-
vidual, melanin in the skin will reect and scatter light aecting its transmission
into the tissues below. On this basis it has been suggested that NIRS signal quality
may be impaired by darker skin pigmentation. is has been demonstrated in
at least one human study where NIRS devices failed to register tissue saturations
in nine out 17 deeply pigmented volunteers undergoing simulated lower limb
ischaemia, with failure occurring more commonly in the darker skinned individu-
als.e authors concluded that ‘NIRS StO2 measurements should be interpreted
with caution, as melanin clearly interferes with the quality of the reected NIRS
signal’ (Wassenaar and den Brand, 2005). Similar problems have commented on
incidentally by other authors (Shuler et al., 2009), but to date there have been no
clinical studies specically addressing this issue.
3.4 comparison to pulse oximetry
It is important that StO2, as measured by NIRS, is distinguished from SpO2 as
recorded by pulse oximetry. Pulse oximetry also uses infrared light, but diers
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in that it separates the pulsatile arterial waveform from the non-pulsatile signal,
which is assumed to be background artefact and excluded from the calculation
of oxygen saturation (Tremper, 1989). us SpO2 is a quantication of arterial
haemoglobin saturation — a systemic measurement which should be consistent
between monitoring sites. StO2 by contrast is a local measure reecting only the
oxygenation of the illuminated block of tissue. StO2 therefore varies from site to
site depending upon local tissue conditions, however StO2 will also be inuenced
by the global haemodynamic state of the subject, which is the basis upon which
NIRS is used to detect hypovolaemia in trauma.
In addition to the clinical dierences in the oxygenation index measured by
the two techniques, there are several technical dierences between how pulse oxi-
metery and NIRS are implemented. Pulse oximetery uses two wavelengths of light:
red light in the visible spectrum (660 nm) and infrared light (940nm). By contrast,
NIRS uses several wavelengths over the visible red and NIR range to separate the
overlapping signals of oxy/deoxyhaemoglobin and other chromophores. Pulse
oximetery requires a pulsatile signal to obtain a reading, and in clinical practice
is used with a transmission technique. NIRS has the advantage of not requiring
a pulse, but instead has the problem of separating the spectrum of haemoglobin
from that of other oxygen carrying compounds since it does not use the pulsatile
arterial signal to separate them. While transmission spectroscopy with NIRS is
possible, it is predominantly used with a reectance technique in clinical practice.
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resuscitation
e central premise of NIRS when applied to trauma resuscitation is that in the
hypovolaemia patient StO2 will fall as a result of inadequate tissue perfusion. In
peripheral tissues StO2 may also fall as a result of sympathetic mediated vasocon-
striction to preserve blood ow to vital organs. As the patient is resuscitated, and
adequate tissue perfusion restored, StO2 values rise again towards normal levels.
Since StO2 can be measured continuously in real time, it should be theoretically
possible to accurately monitor the patient’s response and titrate resuscitation
accordingly.
is chapter discusses current developments in the eld of NIRS, as applied to
trauma resuscitation, and examines areas for further work.
4.1 the range of sto2 measurements in normal subjects
Before StO2 measurements in trauma subjects can be fully interpreted the range of
StO2 values in normal subjects should be rst evaluated. At present there is only
one published study describing data for StO2 values in a normal population at rest.
Crookes et al. (2005)measured StO2 from the thenar eminences of 707 ambulat-
ory volunteers using an InSpectra™ Tissue Spectrometer (Hutchinson Technology).
Subjects were drawn from a population of individuals encountered walking the
grounds of the University of Miami Hospital and were predominately composed of
university and hospital sta, hospital visitors (including outpatients) and patrons
of local businesses. Hospital inpatients were excluded from the study.e ambient
conditions on the study days were described as warm and sunny.
e mean thenar StO2 in the study population was 87 ± 6% with a skew le
distribution as illustrated in the published histogram of results (reproduced in
Figure 4.1.) Unfortunately, the study description does not make clear how they
established StO2 values for each subject, e.g. was the rst recorded value used, the
mean or median of a range of measurements, etc.
Signicant dierences were found between male (mean StO2 88.38 ± 5.51%)
and female subjects (mean StO2 85.4 ± 6.69%), p <0.001; and between smokers
(mean StO2 89.59 ± 4.57%) and non-smokers (mean StO2 86.03 ± 6.54%), p <0.001.
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Figure 4.1: Histogram of thenar StO2 values in normal human volunteers, adapted from
Crookes et al. (2005).
Signicant dierences in thenar StO2 was also evident between ethnic groups,
classied for the purposes of the study as: black; white; Indian; and Hispanic.
Although statistically signicant dierences in StO2 values were demonstrated
between several dierent sub-populations, all sub-population means fell within
one standard deviation of the overall population mean StO2 and, as the authors
recognised, the dierences demonstrated were probably a product of the statistical
power provided by the large sample and unlikely to be of any clinical signicance.
It should be appreciated that the results of this study relate to recordings made
with an InSpectra™ Tissue Spectrometer (a single beam NIRS monitor, although
the exact model is not specied) and will not necessarily correlate with dual beam
algorithms or other manufacturers’ devices. Also the results are only relevant to
measurements taken from the thenar eminence. Several researchers have used
this data as the basis of normal values for studies involving other anatomical sites,
despite there being no evidence that such an extrapolation is valid. In fact Crookes
et al. (2005) report their own previous animal work as evidence that baseline StO2
values vary between dierent muscle groups. Exactly how StO2 varies between
muscle groups/anatomical sites in humans is not currently known.
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4.2 non-trauma human hypovolaemia studies
Studying hypovolaemia in human subjects experimentally is challenging as it is
rarely ethical to subject individuals to controlled haemorrhage. However, one area
where it does take place is during blood donation, and a few groups have taken
advantage of this to study StO2 changes during this process.
Torella et al. (2002) monitored calf and cerebral (frontal lobe) StO2 in 40
volunteers undergoing a 470 ml blood donation (roughly equivalent to class I
haemorrhage) with a Somanetics INVOS® 4100 System (a dual beam monitor).
In a group of 27 males and 13 females the mean estimated blood loss was 10%
(range 9–12%) of the total circulating volume, as calculated from height and weight
nomograms.ere was a statistically signicant fall in StO2 at both sites following
blood donation: 3% (p<0.001) in the calf; and 2% (p<0.001) in the frontal lobe.
Drops in StO2 were also recorded during the blood donation, the authors reporting
that a statistically signicant fall of 1.4% in the calf aer 2% blood loss by volume.
e frontal lobe appeared less sensitive to change, with a statistically signicant
fall in StO2 of 0.9% only becoming observable at 6% total blood volume loss.
e authors hypothesise, that the diering sensitivities between the calf and the
frontal lobe of the brain are probably related to the brains vascular auto-regulatory
functions in the face of hypovolaemia.
ese results suggest that NIRS is sensitive to theminimum blood loss volumes
usually considered clinically signicant, and indeed is able to detect much smaller
blood losses. However the changes in StO2 are quite small, the largest mean
dierence being 3%, as recorded in the calf. Somanetics reports the sensitivity of
their later generation NIRS monitors as being ±1%. Assuming a similar sensitivity
for the 4100 model used in this study, it is questionable how clinically useful a 3%
fall in StO2 would be. Falls in StO2 of the magnitude 0.9%, which are less than the
tolerances of the machine, are almost certainly clinically meaningless.
Jeger et al. (2010) performed a similar experiment using a Hutchinson InSpec-
tra™ Model 650 (a single beam monitor) recording StO2 values from the thenar
eminence before and aer 500 ml blood donation. In their study of 20 young
women there was no signicant change in StO2 following donation, the median
StO2 dropping only 0.5% (p=0.34) from 79.0% to 78.5% between measurements.
is is a surprising nding in light of Torella et al. (2002) results and those of
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other studies, which have shown NIRS able to detect volume losses in the range
of 500 ml (Soller et al., 2008b) — especially as the decision to include women
in this study was on the basis that their lower body mass renders them more
susceptible to absolute volume losses. It is not possible to separate the factors that
may account for these diering ndings, although the dierences in the NIRS
monitoring protocol are notable.e two studies demonstrating NIRS sensitivity
to detect 500 ml blood loss both use dual beam monitors on large muscle groups,
the calf (Torella et al., 2002) and the forearm (Soller et al., 2008b), while Jeger
et al. (2010) used a single beam machine recording from the thenar eminence.
is raises the question as to which of these factors is more important: anatomical
location or monitoring algorithm. To date there have been only a few reported
attempts to answer this question by comparing NIRS recordings at dierent sites.
In a simple experiment Bezemer et al. (2009) monitored StO2 from the thenar
eminence and forearm (over the brachioradialis muscle) in the supine and stand-
ing positions. Measurements were taken with a Hutchinson InSpectra™ Monitor,
the exact model is not specied, but it must have been a 325 or pre-production
model as these were the only Hutchinsonmachines with themulti-depth recording
probes available at the time. StO2 measurements were taken with probes with
an interoptode distance of 15 and 25 mm, the larger interoptode distance equat-
ing to a greater depth at which the recording was taken. Upon standing there
was a signicant increase in heart rate, the only other haemodynamic parameter
measured. StO2 in the forearm fell by 7.1% (s.d. 4) for the 15 mm probe separation,
p<0.05, and 8.6% (s.d. 4.5) for the 25 mm probe separation, p<0.01. ere was
no signicant change in StO2 values recorded from the thenar eminence.ese
results would suggest that the forearm is a more sensitive site for measurement,
however the hypovolaemic stress in this experiment was small, and in the ab-
sence of any haemodynamic data other than pulse rate dicult to quantify. Soller
et al. (2008a) examined StO2 values from the thenar eminence and the forearm
in eight volunteers subject to a simulated hypovolaemia by means of exposure
to progressive increments of lower body negative pressure (LBNP).ey found
that StO2 values in the forearm decreased by 75% at maximal LBNP, while the
thenar values remained statistically unchanged throughout the whole protocol.
Unfortunately each element of the study was performed on dierent (albeit case
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matched) subjects, and the authors used a single beam Inspectra™ device on the
thenar eminence and their own design of dual beam monitor on the forearm.
is makes a practical interpretation of their ndings dicult, however given
that there is very little fat overlying the thenar eminence, the principle reason
for choosing this a monitoring site, signal attenuation from subcutaneous tissues
should be minimal giving weight to the authors’ argument that ‘oxygen saturation
determined from deep muscle, not thenar tissue, is an early indicator of central
hypovolaemia in humans’. Bartels et al. (2011) performed a similar experiment
but recorded StO2 from the thenar eminence and forearm using a Hutchinson
InSpectra™ StO2 Tissue Oxygenation Monitor. StO2 measurements were taken
using probes with an interoptode distance of 15 and 25 mm. ey found that
forearm StO2 was more sensitive to LBNP induced hypovolaemia than the thenar
eminence but, in contrast to the other two studies, sensitivity was unrelated to
depth of measurement.
Torella and McCollum (2004) examined the dierences between cerebral
(frontal lobe of the brain) and calf StO2 in response to haemorrhage during surgery,
with an INVOS® 4100 System monitor. Surgical procedures were selected on the
basis of a large predicated blood loss. Although the exact nature of individual
procedures was not specied, they appear to have been mostly spinal operations.
Median blood loss during procedures was 650ml. Mean calf StO2 fell by a 3.3%, but
this was not statistically signicant (p=0.16), mean cerebral StO2 fell by 8.4% which
was statically signicant (p=0.016). ese results are interesting, rstly for the
calf ndings which conict with the group’s previous study (Torella et al., 2002),
and secondly for demonstrating a signicant fall in cerebral StO2. Falls in cerebral
StO2 are oen perceived as counterintuitive in the light of what is known about
cerebral autoregulation, however it is unknown exactly how StO2 relates to the
autoregulatory process or what level of relative tissue hypoperfusion is tolerated
in dierent parts of the brain. One of the aws of the study is that the general
anaesthetic was not controlled for between cases which, given the known eects
of anaesthetic agents on cerebral blood ow, is a major confounding factor.
Drawing conclusions from the conicting results of these studies is dicult.
While it seems NIRS has the potential to detect relatively minor degrees of haem-
orrhage, the absolute change in StO2 in all studies was small, and mean pre and
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post haemorrhage StO2 values frequently overlap.e reason signicant changes
were detectable in these studies is that baseline StO2 values for each subject were
known prior to haemorrhage. While establishing baseline StO2 values is possible
in the elective surgical patient, it is a luxury not available in the trauma setting,
and this fact may signicantly limit the clinical applications of NIRS for detecting
blood loss in this patient group.
4.2.1 Lower Body Negative Pressure as Model for Simulating Hypovolaemia
Lower body negative pressure (LBNP) is a standard experimental technique for
modelling controlled haemorrhage in human subjects.
In LBNP studies volunteers are placed supine with the their lower body, from
the waist down, sealed in an airtight chamber. Negative pressure is then applied to
the chamber in graduated increments (usually in the range of -10 to -100 mmHg).
is leads to a redistribution of blood from the upper body and peripheries to the
lower body, in particular the large capacitance veins of the pelvis, inducing central
hypovolaemia. Higher negative pressures correspond with increasing degrees of
simulated hypovolaemia, and the technique has the advantage that not only can
dierent increments of pressure be used, but also the time period over which
each increment is maintained. is allows comparisons of the haemodynamic
responses to sudden simulated central hypovolaemia and slowly progressive blood
loss, although to date no such study has been performed.e down side of such
exibility is that there is no standardised protocol for the pressure increments
used and the time between steps, which means that many studies cannot be easily
compared. One of the limitations of LBNP is that it must be performed in the
supine position, however since virtually all trauma patients a ultimately monitored
and managed in this position, this serves to reect the practicalities of trauma
care.
LBNP can be combined with a head-up tilt. Such a combination was originally
designed as a more aggressive means of testing orthostatic tolerance than simple
tilt testing (el Bedawi and Hainsworth, 1994). However the eect of tilting is very
similar to a LBNP increment, and a head-up tilt has been used in hypovolaemia
studies as a further stressor to push individuals to presyncope. A limitation of
LBNP for the purposes of modelling hypovolaemia in trauma is that it induces a
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Pressure (mmHg) Approximate Blood Loss (ml)
10–20 400–550 (≈10% of total blood volume)
20–40 550–1000 (≈10–20% of total blood volume)≥40 > 1000 (> 20% of total blood volume)
Table 4.1: LBNP pressures and their estimated blood loss equivalent, adapted from Cooke
et al. (2004).
pure hypovolaemia without the neurohumoral responses associated with tissue
trauma which occur in real patients. Although injuries may be simulated by
such means as the application of tourniquets to the limbs, at present there are no
published studies using this approach.
e individual response to LBNP is inuenced by numerous personal factors
including: age, sex, build, physical conditioning and hydration (Cooke et al., 2004).
For this reason approximations between pressure increments and the degree of
hypovolaemia, as shown in Table 4.1, are dicult and typically demonstrate a
wide range. However the response of the same individual to LBNP appears to be
very consistent. In one study exposing individuals to the same LBNP pressure on
two separate occasions the dierence in times to syncope was only 1.1 ± 0.6 mins
(el Bedawi and Hainsworth, 1994).
e physiological responses to simulated hypovolaemia have been demon-
strated to accurately mimic those observed during real haemorrhage. A summary
of the response of common physiological parameters to LBNP and a comparison
to known responses during haemorrhage is shown in Table 4.2.ere is a good
correlation between all parameters, although the heart rate response can vary
between subjects depending upon the degree of hypovolaemia (as discussed in
Section 1.3.2). In true haemorrhage, advanced stages of hypovolaemia may be asso-
ciated with tachycardia or bradycardia, the tachycardic response being associated
with poor outcome. In the LBNP bradycardia typically occurs immediately before
syncope, at which point the experiment is stopped.
4.2.2 Lower Body Negative Pressure Hypovolaemia Studies
In human volunteers exposed to simulated haemorrhage with LBNP, peripheral
StO2 values recorded from the forearm (exor digitorum profundus) and stroke
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Grade of Shock
Parameter Grade I Grade II Grade III Grade IV
Heart Rate ↑ ↔ ↑ ↑ ↑ ↑ ↑↓ ↑
Mean Arterial Pressure ↔↔ ↑↔ ↑ ↑ ↓ ↓
Stroke Volume ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
Cardiac Output ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
Central Venous Pressure ↓ ↓ ↓ ↓ ↓ ↓ ↓↔ ↓↔
Sympathetic Nerve Activity ↑ ↑ ↑ ↑ ↑ ↑ ↓ ↓
Norepinephrine ↑ ↑ ↑ ↑ ↑ ↑↔ ↓ ↓
Peripheral Vascular Resistance ↑ ↑ ↑ ↑ ↑ ↑ ↓ ↓
Arginine Vasopressin ↔↔ ↔↔ ↔ ↑↔ na ↑
Plasma Renin ↔↔ ↔↔ ↔ ↑↔ na ↑
Angiotensin II na↔ na↔ na ↑ na ↑
Pancreatic Polypeptide Hormone ↔↔ ↔↔ ↑ ↑ ↑ ↑
Table 4.2: Comparison of systemic physiological responses to LBNP and haemorrhage.
Responses to haemorrhage are shown in red and responses observed during LBNP in black.↑ indicates an increase in the monitored parameter, ↓ a decrease, and↔ an equivocal
response, some parameters may show more than one response, adapted from Cooke et al.
(2004).
volume (SV) were shown to be the most sensitive early indicators of simulated
haemorrhage from a range of physiological measurements that also included pulse
rate, blood pressure and SpO2. Changes in StO2 and SV were observed during
the rst LBNP increment (-15 mmHg), by comparison there was no signicant
change in heart rate until the third pressure increment (-45 mmHg), and in mean
arterial pressure until the forth pressure increment (-60 mmHg). StO2 was found
to correlate well with stroke volume, and was inversely correlated with total peri-
pheral resistance (Soller et al., 2008b).is suggests that early changes in StO2
occur as a result of vasoconstriction mediated reductions in oxygen delivery.e
study used an experimental NIRS device, jointly developed by the University of
Massachusetts Medical School (UMMS) and Luxtec Corporation (Massachusetts),
to measure StO2, which means absolute StO2 values cannot be compared directly
with commercial devices. As discussed in Section 4.2 the group also compared
StO2 measurements from the thenar eminence, recorded using a Hutchinson In-
Spectra™ machine, to forearm measurement using the UMMS machine (Soller
et al., 2008a). Leaving aside the previously discussed limitations of this study, the
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only denitive conclusion that could be drawn was that StO2 measurements from
the forearm recorded with the UMMSmachine (a dual beammachine) were more
sensitive to simulated haemorrhage than those recorded from the thenar eminence
with InSpectra™machine (a single beammachine). However a subsequent study by
Bartels et al. (2011) using an InSpectra™ machine to monitor both sites did conrm
what Soller et al. (2008a) study suggests: that the forearm is a more sensitive site
than the thenar eminence, although the depth at which the measurement was
taken appeared unimportant in this study.
In a larger review of their LBNP work involving 30 subjects Soller et al. (2012)
have conrmed the nding of their earlier studies, principally that StO2 and SV
decrease proportionally with increments of LBNP, and inversely to total peripheral
resistance. Of the physiological parameters recorded StO2 and SV are the most
sensitive to haemodynamic changes induced by LBNP. Similar changes in haemo-
dynamic parameters during LBNP induced hypovolaemia have also been reported
in a number of other studies (van Hoeyweghen et al., 2001; Convertino et al., 2004;
Bartels et al., 2011).
Although these studies appear to demonstrate the superiority of NIRS over
conventional haemodynamic parameters, the changes observed in StO2 are all
relatively small. e fact that any change can be detected at all in the lower
increments of LBNP is by virtue of the subjects baseline measurements being
available for comparison. As has been mentioned previously, this is a luxury not
available in the acutely injured patient, and as a result of this, the promise of these
studies may not translate well to the emergency trauma scenario.
4.3 animal hypovolaemia models
NIRS responses to more profound degrees of hypovolaemia than are possible to
test in humanmodels, have been examined in a number of animal studies. In resus-
citation models where animals have been exposed to controlled haemorrhage and
resuscitated to end points determined by conventional haemodynamic parameters,
it has been shown in both porcine and rabbit models that peripheral muscle StO2
correlates strongly with oxygen delivery. StO2 recorded from visceral organs (e.g.
liver) do not demonstrate such a strong correlation, instead showing a blunted re-
sponse to haemorrhage (Beilman et al., 1999; Rhee et al., 1997).is is presumably
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a result of mechanisms preserving the blood supply to central organs in the face
of hypovolaemia. As part of the same phenomenon, peripheral vasoconstriction
probably accounts for some of the reduction in StO2 in distal monitoring sites
during the early stages of haemorrhage.
Experimental work examining the role of NIRS as a triage tool in hypovolaemia
has demonstrated that StO2 values recorded from the hind limbs of 20 pigs be-
low 40% distinguished resuscitatable animals from non-resuscitatable animals
with a sensitivity of 80% and specicity of 100%, but only aer the rst bolus
of resuscitation uids (Taylor et al., 2005). StO2 measurements taken from the
stomach wall using a modied nasogastric tube demonstrated a similar pattern,
although the results aer the rst uid bolus were not statistically signicant. StO2
measurements taken from the liver were able to distinguish between resuscitat-
able and non-resuscitatable animals but only following the second bolus of uid
resuscitation, which again suggests an element of preservation of blood ow to
the central organs in keeping with the ndings of Beilman et al. (1999). In this
model while CO, D˙O2 and lactate all deteriorated during the shock phase of the
experiment, only mixed venous oxygen saturation (SvO2) diered signicantly
between survivors and non-survivors.
Motivated by work indicating the StO2 debt might be predictive of multi-organ
dysfunction syndrome (MODS) in human trauma patients (Cohn et al., 2007),
Zenker et al. (2007) examined whether the same phenomenon may be predictive
of non-survivors before uid resuscitation is commenced. To estimate the StO2
debt the authors used a mathematical model they referred to as the threshold area
over the curve (TAOC).e model requires integration of the area of the StO2
curve below a predetermined threshold before a given time-point — in this case
the onset of resuscitation (shown schematically in Figure 4.2).e greater the area
over the curve, the larger the presumed StO2 decit, which it was hypothesised
would be inversely correlated with survival. To test this hypothesis 14 piglets
were subject to a controlled haemorrhage for 90 minutes before receiving colloid
resuscitation. StO2, pulse rate and invasive measures of blood pressure were
recorded. MAP was found to be the best discriminator of survival at the point
of resuscitation, but was unable to distinguish survivors from non-survivors for
time-points prior to two minutes before resuscitation. StO2 and TAOC (using
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Figure 4.2: A diagrammatic representation of the threshold area over the curve (TAOC)
calculation.e area of interest falls below a specied threshold StO2 and the StO2 curve
before the time-point of interest. TAOC is hypothesised to provide an estimate of StO2
debt, adapted from Zenker et al. (2007).
a threshold value of 75%) measurements performed similarly at resuscitation,
however TAOC demonstrated a greater predictive capability prior to resuscitation,
outperforming all other indices at time points greater than 10 minutes before the
onset of resuscitation. One limitation of this study is that the authors repeatedly
performed the TAOC analysis for all StO2 thresholds between 40–100% before
analysing them for signicance and nding that StO2 thresholds between 67–75%
yielded positive results. While the TAOC concept demonstrates promise it has yet
to be validated, and there appears to be no further published work developing this
concept.
In an experiment to determine if NIRS could be used to guide the resuscitation
of hypovolaemic subjects, Chaisson et al. (2003) created a computer controlled
closed-loop resuscitation system with infusion volumes and rates being automatic-
ally titrated to physiological endpoints.e study was unique in using conscious
sheep as subjects, rather than anaesthetised animals used in most other studies,
thereby preventing the problems associated with anaesthetic agents modifying the
response to shock. Twelve sheep were exposed to an uncontrolled haemorrhage
using a 4 mm aortotomy and aer 20 minutes were resuscitated with crystalloid
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to either 100% of baseline CO or a peripheral StO2 of 49% as an endpoint.e
authors do not explain how these endpoints were determined, other than they
were based on preliminary work. However, in choosing a lower than normal
StO2 they make the interesting point that their earlier experiments demonstrated:
baseline StO2 levels are not achieved following resuscitation for haemorrhage
(presumably using crystalloid only resuscitation) despite achieving baseline or
supranormal CO. All but one of the animals survived to the end of the study,
the one death occurring early in the StO2 endpoint group apparently as a result
of heart failure. Unsurprisingly mean uid resuscitation volumes were lower in
the StO2 endpoint group (100% of haemorrhage volume) compared to the CO
group (180% of haemorrhage volume). Skeletal muscle and brain StO2 were similar
between the two groups despite theMAP and CO being greater in the CO endpoint
group. Base excess fell during the haemorrhage and recovered during resuscita-
tion. Despite showing a greater fall during haemorrhage in the StO2 group, base
excess recovered more fully in this group at the end of resuscitation (p<0.05).is
work demonstrates that StO2 can be used to guide resuscitation, and conrmed
what is only more recently becoming accepted: that limited resuscitation to lower
than normal physiological parameters may be associated with equivalent or better
outcomes than conventional resuscitation.
4.4 human clinical studies of nirs in trauma resuscitation
Despite the good body of work validating NIRS as a tool for detecting blood loss
from a known baseline, there have been relatively few published clinical studies
examining NIRS in human trauma subjects. In one of the earliest of these studies
McKinley et al. (2000) examined subcutaneous tissue and skeletal muscle StO2 and
compared them to systemic oxygen delivery index (DO2I) in a small group (n=8) of
severely injured patients. Other indicators of physiological status recorded during
the study, included base decit, lactate and mixed venous saturations (SvO2).
ey found that over a 24 hour period of resuscitation skeletal muscle StO2 (as
recorded from the deltoid), but not subcutaneous StO2, was highly correlated with
improvements in DO2I (r=0.95), the only other parameter changing signicantly
being lactate. Although this seems to validate muscle recordings of StO2 from
the deltoid as a legitimate indicator of systemic oxygen delivery, there are several
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concerning elements in their results.e nding of an initial muscle StO2 of 15±2%
appears inconsistent with the recorded SvO2 levels greater than 70%. If StO2 is a
measure of arterial and venous oxygenation at a capillary level, SvO2 would be
expected to be much lower.e reported subcutaneous StO2 (average 78–87%)
were close to the expected normal range and did not change signicantly during
resuscitation, a nding inconsistent with other reports which have demonstrated
signicant falls in subcutaneous pO2 following haemorrhage (Ward et al., 2006).
Crookes et al. (2005) examined the ability of thenar eminence muscle StO2 to
identify degrees of shock in trauma patients.ey rst established normal ranges
in 707 health subjects, demonstrating a mean StO2 of 87 ± 6%, and also nding stat-
istically signicant dierences betweenmales and females (p <0.001), smokers and
non-smokers (p <0.001) and between dierent ethnic groups.ey then examined
145 trauma patients who were categorised on the basis of haemodynamic data into
one of four groups: no shock; mild shock; moderate shock; and severe shock. It
was found that while NIRS could identify the severely shocked patients (for the
purposes of this study dened as a systolic blood pressure less than 80 mmHg),
it could not dierentiate between the no, mild and moderate shock groups.e
reasons for this are unclear. It may be a consequence of classication bias occurring
as a result of the author’s dependence upon haemodynamic parameters (which
in themselves are poor indicators of the degree of hypoperfusion for the reasons
discussed in Section 1.3.2) to classify the degree of shock. It may be due to inherent
problems with NIRS, a lack of suitability of the thenar eminence as monitoring site,
dierences in ethnically related skin pigmentation or the confounding inuence
of myoglobin’s contribution to the NIRS signal. Although the thenar eminence is
oen accepted as a site for recording peripheral StO2 in trauma, there is evidence
suggesting it may be less sensitive in detecting changes compared to other sites, and
its use is largely one of practicality: it is readily accessible; has little pigmentation
(anecdotally reported to interfere with StO2 measurements) (Wassenaar and den
Brand, 2005; Shuler et al., 2009)); and has limited overlying fat.
Cohn et al. (2007) evaluated how well StO2 predictedMODS in patient present-
ing withmajor torso trauma.eymonitored thenar eminence StO2 for the rst 24
hours in 383 trauma patients meeting any of the following inclusion criteria: blood
transfusion requirement within 6 hours of admission; a base decit ≥6 mEq/L; at
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least one of pelvic fracture, two or more long bone fractures, multiple rib fractures
or pulmonary contusion, or major blunt or penetrating torso trauma. Additional
clinical data collected included: heart rate; systolic blood pressure; pH; base decit;
INR; and temperature. Fiy patients in the study developed MODS. It was found
that minimum StO2 values recorded within the rst hour of admission could
identify patients likely to go on to develop MODS with a sensitivity of 78% and
specicity of 39%.e negative predictive value of StO2 was 91%, but the positive
predictive value was only 18% (i.e. StO2 had a high false positive rate of predicting
MODS). StO2 had the same power predictingMODS as blood pressure and arterial
base decit, with a greater sensitivity but lower specicity. e conclusion was
that NIRS performs similarly to conventional measurement of perfusion status in
predicting MODS, but has the advantage of being continuous and non-invasive.
e same group reported what is presumably the same dataset (identical time
period, inclusion criteria and number of patients), reporting the results for the
subgroup analysis of those patients undergoing massive transfusion (dened by
the study as more than 3000 ml or 10 units of packed red cells administered in the
rst 24 hours) (Moore et al., 2008). Of the original 383 patients, 30% (114) required
massive transfusion. All parameters recorded, with the exception of temperature,
demonstrated a signicant dierence between the massive transfusion and no
massive transfusion groups, although there was a large degree of overlap in all
measurements between groups. Using amultivariate logistic regression process the
authors builtmodels using data at 30 and 60minutes to predict the need formassive
transfusion. Five signicant independant predictors of massive transfusion were
found: systolic blood pressure; ISS; transfer fromother hospital; INR (only in the 30
minutemodel); and pH (only in the 60minutemodel). Obviously thesemodels are
of little practical use as ISS is not available in the early stages of resuscitation, and
transfer from another hospital can only be a useful parameter within their trauma
system. StO2 was not found to be useful as a predictor of massive transfusion in
their model, despite demonstrating signicant dierences between groups.e
outcomes of patient undergoing massive transfusion were categorised as either
poor (MODS and/or death) or good (survival without MODS). StO2, age and pH
were shown to be signicant predictors of poor outcome, however StO2 was the
only measurement demonstrating this consistently at one, two and three hours.
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Ultimately the results appear to show that although it is possible to predict the
need for massive transfusion, a model involving several measurements is required
to achieve this accurately. StO2 appears to be a useful predictor of poor outcome in
these patients, but it is probably best interpreted in context of other measurements.
Although most attempts at clinical assessment of NIRS have been made in the
civilian environment, there are now two reports of its use in a deployed military
setting. In a small (n=8) case series report, casualties suering from battleeld
injuries were monitored with StO2 recordings taken from the thenar eminence.
StO2 levels below 70% were found to be eective in tracking the response to re-
suscitation, although the nature of the study design and the small number of
subjects meant the value of StO2 in guiding resuscitation prospectively could not
be assessed (Beilman and Blondet, 2009). In a larger study, 147 combat casualties
managed at a single US Army combat support hospital had their thenar eminence
StO2 measured to determine if NIRS could predict the need for ‘life-saving in-
terventions’ or transfusion.e severity of injuries in the study was mixed with
only 49% of patients requiring life-saving intervention and 29% requiring a blood
transfusion. StO2 was not found to be a useful predictor of the need for life-saving
intervention, transfusion or massive transfusion. But in the cohort of patients
with a systolic blood pressure greater than 90 mmHg, it did identify patients who
subsequently required a blood transfusion, suggesting that NIRS may have a triage
role, particularly in those patients who appear initially haemodynamically stable
(Beekley et al., 2010).
4.5 effect of exercise on nirs measurements
Major trauma frequently occurs following a period of prolonged or intense exer-
tion. In civilian practice this may take the form of the runner or cyclist injured on
the roads during training or while engaged in other recreational pursuits. In the
military environment contemporary conicts have been characterised by injuries
occurring following prolonged periods of patrolling or while being engaged in a
re-ght.
Exercise is known to modulate the physiological response to haemorrhage.
In models of haemorrhage using lower body negative pressure, prior exercise
has been shown to attenuate the reduction in blood pressure associated with
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the redistribution of blood. ese eects appear to persist for at least 24 hour
following completion of exercise (Convertino and Adams, 1991; Convertino, 2003).
Various mechanisms have been proposed to account for these protective eects,
including an increase in α-1 adrenoreceptor responsiveness (Convertino, 2003) or
baroreceptor sensitivity (Engelke et al., 1995) induced by exhaustive exercise.
Wade (2010) examined the cardiovascular response to a controlled haemor-
rhage of 37% blood volume in swine subject to a one hour run at a workload of 70%
maximum heart rate. He reported a lower reduction in mean arterial pressure in
the exercised animals (26±9 mmHg) compared to rested controls (49±2 mmHg)
despite a similar reduction in CO in both groups.e increase in plasma adren-
aline was also lower in the exercised animal, suggesting that the dierences in
blood pressure between the groups were due to increased peripheral vasocon-
striction occurring as a result of enhanced receptor sensitivity in the exercised
animals.
NIRS has been extensively studied in exercising muscles across a range of
athletic disciplines although mostly focusing on highly controlled endurance
exercises such as cycling, rowing and arm cranking.e StO2 response to exercise
has been described in four stages (Özyener, 2002). In phase I there is an immediate
increase in StO2 from baseline values at the onset of zero load exercise. During
phase II there is a gradual decline in StO2 in working muscles. Similar changes
have also been seen in the inactive biceps brachii muscle during cycling (Ogata
et al., 2007).e fall in StO2 levels out at phase III despite increases in work load
unless V˙O2max is achieved. Phase IV describes recovery and is associated with a
rise in StO2 values to above baseline values (presumably as a result of a hyperaemic
response) which return to baseline levels within 2–3 minutes (Chance et al., 1992).
Understanding the StO2 changes during recovery, particularly in non-exercising
muscle, are important for interpreting StO2 values recorded in trauma patients
who have been exercising, yet this is the least understood phase of the exercise
response. Nagasawa (2008a) examined the eects of 20 minutes of cycling at
30,50 and 70% of V˙O2max on post-exercise StO2 in the non-exercising forearm
exor muscles.e results showed that StO2 was increased over baseline values
following exercise and furthermore that higher intensity exercise produced greater
increases in StO2, although the actual magnitude of these changes was relatively
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small (between 1.3 ± 0.1% and 2.2 ± 0.3%). Recovery times for StO2 to return to
baseline levels were relatively short: within three minutes for exercise performed at
30 and 50% of V˙O2max ; and ve minutes for exercise performed at 70% of V˙O2max .
A similar study performed using unilateral leg raises, performed at 40, 60 and 80%
of the one repetition maximum (1RM) demonstrated similar ndings except that
the relative rise in StO2 in the non-exercising forearmmuscles was inversely related
to the intensity of exercise performed. Again, increases in StO2 were relatively
small: 1.8 ± 0.2% at 40% 1RM; 1.7 ± 0.2% at 60% 1RM; and 1.4 ± 0.3% at 80% 1RM.
All values returned to baseline within 5 minutes of nishing exercise Nagasawa
(2008b).
At present there is no work examining StO2 changes during exercise in a
military population, although physiologically they are likely to be similar to those
studies that have used athletes as subjects. Nearly all the exercise studies have
used isolation strength work or highly specic cardiovascular endurance protocols.
ere are no studies examining the eects of a mixed exercise protocol, of the type
simulating the demands of military eld work, on muscle oxygenation at sites
likely to be of interest to the clinician monitoring a trauma patient.
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Part II
experimental studies
5. general methods
5.1 selection of nirs device
At the time of investigation there were three commercially available NIRS devices
on the UK market.
1. InSpectra™ StO2 Tissue Oxygenation Monitor 325manufactured by Hutchin-
son Technology.e InSpectra™ 325 was a single channel, single beam NIRS
monitor, marketed as suitable for monitoring from any external somatic
site.e device was unique in accepting probes with dierent interoptode
spacing, enabling it to monitor at dierent tissue depths, however to achieve
this the machine required a 10–15 minute calibration/warm-up time with
each change of probe. Probes were reusable, although they were used with a
disposable light shield. Commercial support for this device was withdrawn
in July 2009, and largely for this reason and the practical limitations of
the calibration time, this device was not considered suitable for further
investigation.
2. InSpectra™ StO2 Tissue Oxygenation Monitor 650manufactured by Hutchin-
son Technology. is device was the successor to the InSpectra™ 325, re-
taining the same single channel and beam capacity, but no longer being
compatible with probes with dierent interoptode distances, and thus lim-
ited to a single depth measurement of approximately 25 mm.e device was
marketed for recording StO2 from the thenar eminence and was supplied
with disposable probes shaped specically for this purpose, although it was
CE marked and FDA licenced to record from any external body surface.
e probes and cables were supplied as a single disposable unit.is had
advantages for sterility but resulted in a high per unit cost.e InSpectra™
625 had a maximum measurement frequency of 5 seconds.
3. INVOS® 5100C Systemmanufactured by Somanetics (shown in Figure 5.1).
is device was marketed for cerebral and somatic monitoring and had CE
marking and FDA licensing for both.e probes were of a single generic
design, with smaller probes available for paediatric monitoring.e probes
were single use, but unlike the InSpectra™ cables and pre-amps were not
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Figure 5.1:e INVOS® 5100C System monitor shown in a four channel conguration.
disposable. e INVOS® System was a dual beam machine taking two
readings using a separation of 30mm and 40mm, subtracting the supercial
reading from the deep one to ensure measurement of deep tissue. e
monitor was capable of recording up to four channels simultaneously, with
a maximum frequency of six seconds. Full details of the INVOS® System’s
technical operating specications are given in Appendix A.
e INVOS® Systemmonitor was selected as the model most suited to studying
StO2 in military trauma subjects based upon the theoretical advantage of isolated
deep tissue measurements, the capacity to simultaneously monitor up to four
channels compared to a single channel for the InSpectra™ model and a smaller
generically designed probe with a lower per unit cost than the InSpectra™ 650.
5.2 data export from the invos® system
e INVOS® System records data in real time and outputs it in an ASCII plain
text format with a xed column width and CRLF line terminators.e machine
has an internal memory capable of storing up to 24 hours worth of data which
can subsequently be exported to a USB stick. If the USB stick is detected by the
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machine while monitoring data is dumped directly to that. A 2 GB stick would
typically provide in excess of 15,000 hours continuous recording.
StO2 data is recorded against a time and date stamp.e time stamp intervals
correspond to the recording frequency set by the user, the minimum setting
(and default value) is every six seconds. When the monitoring period straddles
midnight, the active data le is closed and a new one created.is feature is not
documented by the manufacturer but presumably exists to limit the maximum
size of the data les. When analysing data crossing midnight, it requires the
corresponding les to be correctly identied and concatenated manually.
In addition to StO2 data the machine also records several other elds including
signal strength and the sensor ID for each channel in use. Users may also manually
insert one of 160 pre-dened event marks corresponding to a clinical event, against
the time stamp.is is useful experimentally for synchronising recordings with
other devices. A sample dataset illustrating a four channel output is shown in
Figure 5.2, a list of column descriptors is given in Table 5.1.
5.3 work flow for invos® system data management
e INVOS® Systemhas the potential to produce relatively large data les, especially
when continuously monitoring patients using multiple channels, which presents
practical problems for data management. e manufacturer recommends that
data les be imported directly into a spreadsheet application using merged space
deliminators as the eld separator, where they can subsequently be viewed and
manipulated.is method was used on occasion when working with individual
les, but was found to be impractical when managing large numbers of les or
les of a large size. For the purposes of this work the following schema was used
to clean les to produce input suitable for analysis:
1. Data was exported from USB stick to a host computer running a POSIX
compliant operating system.
2. If the data recording crossed midnight, the contents of matching les was
conrmed by viewing the le in a text editor and the les concatenated using
the GNU core utilities cat command.
3. Data les were cleaned, stripping out duplicate space deliminators and
removing all elds except the date/time stamp and StO2 elds, using a
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Figure 5.2: An example of data output from the INVOS® System in a four channel cong-
uration. For clarity extra spaces have been removed and the column spacing has been
aligned. A list of the column descriptors is given in Table 5.1.
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Column Descriptor Column Descriptor
A Date R Event Mark
B Time S Status
C StO2 (Channel 1) T Baseline
D Event Mark U Area Under Curve
E Status V Upper Alarm Limit
F Baseline W Lower Alarm Limit
G Area Under Curve X StO2 (Channel 4)
H Upper Alarm Limit Y Event Mark
I Lower Alarm Limit Z Status
J StO2 (Channel 2) AA Baseline
K Event Mark AB Area Under Curve
L Status AC Upper Alarm Limit
M Baseline AD Lower Alarm Limit
N Area Under Curve AE Channel 1 Sensor ID
O Upper Alarm Limit AF Channel 2 Sensor ID
P Lower Alarm Limit AG Channel 3 Sensor ID
Q StO2 (Channel 3) AH Channel 4 Sensor ID
Table 5.1: Column descriptors from the INVOS® System ASCII le data output. Columns
speciers are listed alphabetically as they would appear if imported into a spreadsheet
application.
custom BASH script.e script was able to batch process les and accept
arguments to change the eld deliminator and the number of channels in
the output le. A modied version of this BASH script with instructions for
use is reproduced in Appendix B.
4. Custom post-processing of data les, e.g. insertion of additional data elds,
was performed either in a text editor or a spreadsheet application.
5. Visual conrmation of the integrity of the resulting data le was performed
by iterative plotting of the data using gnuplot. For large data sets this process
was automated using an Emacs keyboard macro or BASH script.
5.4 monitoring sites
e INVOS® System is capable of measuring the StO2 of almost any site in the
body. However, for the human studies described in this manuscript only a limited
number of sites were used to allow comparison of StO2 measurements between
experiments.
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a b c
d e
Figure 5.3: Positions of NIRS probes used in the human studies: a) frontal lobe of the
brain; b) deltoid; c) thenar eminence; d) anterior compartment of the leg; e) forearm.
e siting of probes used in the human studies was as follows (see Figure 5.3):
• the frontal lobe of the brain—with the probe positioned one nger breadth
above the orbital ridge, with the probe/cable connection directed laterally
and the distal end of the probe located in the mid-line.
• the deltoid—with the probe positioned two nger breadths above the deltoid
insertion, with the probe/cable connection directed cranially.
• thenar eminence—with the probe positioned with its distal end abutting the
distal palmar crease, and its long axis directed towards the rst web-space.
• the anterior compartment of the leg —with the probe positioned one nger
breadth lateral to the anterior margin of the tibia at the midpoint between
the knee and the ankle.e probe cable/connection was directed distally.
• the forearm—with the probe positioned with its long axis parallel to the
axis of the arm, over the midpoint of exor digitorum profundus muscle.
e probe cable/connection was directed distally.
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6. nirs human volunteer simulated haemorrhage
study
e material presented in this chapter was part of a collaborative work performed
in conjunction with James Cook University Hospital, South Tees Hospitals NHS
Foundation Trust and the Defence Science and Technology Laboratory (DSTL).
Haemodynamic data used in this chapter is presented courtesy of Lt Col Jeremy
Henning.
My contribution to this work was developing and writing the NIRS elements of
the study protocol, training other researchers in the NIRS elements of the protocol,
data collection and data analysis.
6.1 introduction
Most clinical studies examining the application of NIRS in trauma have utilised the
thenar eminence as a site for recording skeletal muscle StO2. Preference for this site
may in part be due to one of the most widely used commercial NIRS monitors (the
Hutchinson InSpectra™ StO2 Tissue Oxygenation Monitor 650) being marketed
almost exclusively for recording from the thenar eminence and having a probe
specically designed for this. As a monitoring site the thenar eminence has several
attractions: it is easily accessible; has only a thin overlying layer of fat — which can
cause problems with signal attenuation particularly in single beam monitors; and
has low levels of pigmentation minimising the problems of melanin associated
absorption/scatting of the infrared beam. Despite these practical merits, there
is no convincing evidence that thenar eminence StO2 provides a more accurate
indicator of the patient physiology than that recorded from other anatomical sites.
In fact the few studies that have attempted to compare NIRS measurements from
dierent sites suggest that StO2 recorded from the thenar eminencemay be inferior
to other skeletal muscle sites.
Soller et al. (2008a) recorded StO2 from the thenar eminence using a Hutchin-
son Inspectra™ monitor, and from the forearm using their own experimental dual
beamNIRS monitor, in human volunteers exposed to a simulated haemorrhage us-
ing lower body negative pressure (LBNP).ey found that forearm StO2 decreased
by 75% at maximal LBNP, while thenar eminence StO2 showed no signicant
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change throughout the whole protocol.e study was limited somewhat by the
forearm and thenar eminence measurements being recorded on dierent (albeit
case matched) subjects, and using dierent machines with dierent algorithms.
While these limitations make a practical interpretation of the results dicult, they
do suggest that there may be better sites than the thenar eminence for detecting
hypovolaemia associated changes in skeletal muscle StO2. In a similar experiment
Bartels et al. (2011) measured thenar eminence and forearm StO2 at two dierent
depths in volunteers subjected to LBNP.ey found that forearm NIRS measure-
ments were more sensitive to hypovolaemia than thenar measurements, but that
depth of measurement had no impact on the sensitivity of the NIRS readings.
Aside from the potentially poor sensitivity in detecting hypovolaemia, the
thenar eminence also has signicant practical limitations as monitoring site.e
injury mechanisms seen in the military environment produce upper limb injur-
ies/amputation with a much higher frequency than that seen in civilian trauma.
In such cases monitoring at more a proximal site is the only option.
Although not as widely studied, deltoid StO2 has been shown to correlate well
with systemic oxygen delivery in severely injured patients (McKinley et al., 2000).
Exactly how the deltoid compares to the thenar eminence or forearm for NIRS
monitoring is unknown, as the sites have never been compared. From a practical
standpoint the deltoid holds signicant appeal as a monitoring site since it is
easily accessible, and at least one site should be available for monitoring in most
patients — signicant bilateral injuries/amputation of the deltoid being unlikely
to be associated with a survivable injury pattern.
Many trauma patients require analgesia. Morphine is probably the most com-
monly used analgesic agent in major trauma in both military and civilian practice.
Morphine is carried by ambulance crews and front line military personnel are
issued with auto-injectors for prehospital use.ere is evidence that morphine
aects the response to haemorrhage, however the nature of this response varies
between the models used. In anaesthetised rats administration of morphine prior
to haemorrhage has been shown to delay the vagally mediated bradycardia asso-
ciated with the biphasic response to hypovolaemia (Ohnishi et al., 1998). When
administered in established shock, morphine appears to attenuate the response
to resuscitation (Molina et al., 2004) and is associated with increased mortality
66
6.2. aim
(Feuerstein and Siren, 1986; Marshall et al., 1998). In a conscious sheep haemor-
rhage model, activation of central opioid receptors is associated with the onset
of the decompensatory phase of haemorrhage, blocking of these opioid recept-
ors delays the decompensatory phase (Frithiof and Rundgren, 2006). Morphine
use in the presence of hypovolaemia is oen cautioned against (Joint Formulary
Committee, 2012), although the nature of its eects on the human haemorrhagic
response are still largely unknown.
6.2 aim
is study aimed to compare the relative sensitivities of StO2 recorded from the
deltoid, forearm, thenar eminence and frontal lobe of the brain, in detecting
degrees of hypovolaemia in human subjects. A secondary objective was to compare
the eects of morphine administration on the haemodynamic response to LBNP
and determine if these would be reected in StO2 measurements.
6.3 materials and methods
e study design was that of a prospective randomised double-blinded cross-over
trial in conscious human volunteers. Subjects were randomised to receive either
morphine or placebo before being exposed to a simulated hypovolaemia with
LBNP. Aer a minimum interval of seven days, the protocol was repeated with
subjects crossing over to the other arm of the study and receiving either morphine
or placebo, depending upon what was administered in the rst trial. Both subjects
and investigators were blinded as to the contents of the infusion during each subject
visit. Ethical approval was obtained from the Northern and Yorkshire Research
Ethics Committee. Regulatory approval for the use of morphine in the protocol
was obtained fromMedicine and Healthcare Products Regulatory Agency.
e study was conducted in the operating theatre department ate James
Cook University Hospital, Middlesbrough between 1 Dec 2012 – 27 April 2013. All
experimental procedures were performed under the supervision of a physiologist,
the investigating clinician, and a research nurse trained in echocardiography
to measure the stroke distance. In addition to the research team there was a
separate welfare team consisting of consultant anaesthetist with nursing/operating
department practitioner (ODP) support.e welfare team were independantly
responsible for subject safety and had the right to end a subject’s study at any time.
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6.3.1 Study Population
e study sample was drawn frommedical students attendingNewcastle University.
Eligible for inclusion was any individual in good health, for the purposes of this
study considered to be ASA (American Society of Anesthesiologists) Grade I,
between the ages of 18–30 years.e health status of volunteers was assessed by a
pre-study clinical interview and examination performed by a qualied medical
practitioner.is included:
• measuring of vital signs e.g. blood pressure and heart rate
• blood sampling for standard haematology and biochemistry
• urine analysis for recreational drugs and dipstick testing
• in female subjects a urine βhCG test (pregnancy test)
is assessment was repeated, minus the blood tests, prior to each arm of the
study.e following exclusion criteria were applied:
1. an ASA Grade II or above
2. a history of lower limb or pelvic trauma within the last three months
3. a family history of thromboembolic disease
4. history of recreational drug use (the use of prescribed drugs was already
excluded by the ASA requirement)
5. known allergies to latex or simple adhesives of the type used by ECG elec-
trode and dressings
6. participation in another trial within the previous three months
7. in female subjects: a positive pregnancy test
Subjects were asked to refrain from consuming alcohol or tobacco products
for a minimum of 24 hours prior to the study, and from caeine from midnight
the day before the study. Following an explanation of the study protocol by the
Principle Investigator, or a medically qualied designated member of the study
team, written consent was obtained from all subjects.
6.3.2 Monitoring and Protocol
Subjects were asked to empty their bladder immediately before the study to prevent
reexes arising from having a distended bladder. Subjects were placed supine in
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Figure 6.1: A subject undergoing experimentation in the lower body negative pressure
chamber.
the LBNP chamber, this was a custom built box — the same one used by van
Hoeyweghen et al. (2001), see Figure 6.1. A neoprene skirt with a polyethylene
liner was used to form an air-tight seal between the subjects’ lower body and the
pressure chamber.
A 16F gauge cannula was placed in the antecubital fossa under 1% lidocaine
local anaesthetic to be used for the infusion and to estimate the CVP using the
technique described by van Hoeyweghen et al. (2001). Zero pressure for CVP
measurements was set at the phlebostatic axis, dened as a horizontal line passing
through the fourth intercostal space. Where intravenous access in the antecubital
fossa was not possible, a 20F gauge cannula was placed in the back of the hand,
although it was not then possible to estimate the CVP in these subjects. Patency
of the cannula was maintained by intermittent ushes with 0.9% saline boluses.
Heart rate was recorded continuously using a three lead electrocardiogram
(ECG). Beat-to-beat systolic and diastolic blood pressures were recorded non-
invasively using a Finometer® MIDI continuous blood pressure monitor (Finapres
Medical Systems) positioned on the middle nger of the le hand raised to the
same level as the heart.e Finometer® also provided a derived measure of stroke
volume. A sphygmomanometer was place on the upper arm not containing the
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cannula to take a manual reading of blood pressure to validate the Finometer® at
the start of the study, and used as a backup in case of Finometer® failure.
StO2 values were recorded using an INVOS® System monitor in a four channel
set up. Four sites were monitored simultaneously, the side of the site being determ-
ined by the positioning of the other monitoring (see Figure 5.3 on page 64 for an
illustration of the probe positions):
1. the deltoid—with the probe positioned two nger breadths above the deltoid
insertion, with the probe/cable connection directed cranially.
2. the forearm—with the probe was position with its long axis parallel to the
axis of the arm, with the cable directed distally, over the midpoint of exor
digitorum profundus muscle.
3. the thenar eminence—with the probe positioned with its distal end abutting
the distal palmar crease, and its long axis directed towards the rst web-
space.
4. the frontal lobe of the brain—with the probe positioned one nger breadth
above the orbital ridge, with the probe/cable connection directed laterally,
and the distal end of the probe located in the midline.
Stroke distance was assessed by echocardiography, all measurements being
taken by the same researcher to avoid inter-observer variability. Stroke distance
was measured twice during the baseline monitoring phase, ve minutes aer the
induction of each LBNP increment and ve minutes aer nishing the suction
protocol. At each interval three separate measurements were taken and the mean
of these used to calculate the stroke distance. Using the recorded physiological
measurements derived values for cardiac output (stroke volume x heart rate) were
calculated.
Following attachment of the monitoring, subjects were then rested for 30
minutes, aer which baseline physiological measurements were made. Morphine
(0.2 mg/kg) made up to a 10 ml volume in 0.9% saline, or the equivalent volume
of placebo (water) made up to 10 ml with 0.9% saline was administered via the
intravenous cannula. Five minutes aer the infusion a further set of baseline
measurements were made. Ten minutes aer the administration of the infusion
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SD1 SDfSDx
Infusion
10 Minutes -30 mmHg 
LBNP
7 Minutes
-50, -60, -70, -80, -90, -100 mmHg LBNP 
at 7 minute intervals until pre-syncope
SD3SD2
5 
Minutes
Figure 6.2: LBNP study timeline. SD denote stroke distancemeasurement. Stroke distances
were measured ve minutes aer the start of each LBNP increment (SD3 and SDx). A nal
stroke distance measurement SD f was taken ve minutes aer the point of presyncope
and the release of the LBNP.
the simulated hypovolaemia protocol was started. A summary of the study protocol
timeline is show in Figure 6.2.
6.3.3 Lower Body Negative Pressure Protocol
Subjects were exposed to progressive increments of LBNP, each lasting seven
minutes, to the point of presyncope. For the purposes of this study, presyncope
was dened as a drop in systolic blood pressure greater than 20 mmHg, sustained
for at least 10 heart beats associated with other autonomic features such as nausea,
sweating, or pallor, with or without a bradycardia.
e rst pressure increment was -30 mmHg followed by -50 mmHg, the pres-
sure was then increased in -10 mmHg steps at 7 minute intervals, to a maximum of
-100 mmHg. At the point of presyncope the pressure was immediately reduced to
half the current pressure for oneminute and then gradually released to atmospheric
pressure (i.e. 0 mmHg) over the following minute.
Five minutes aer completion of the LBNP protocol a nal stroke distance
measurement was made before the monitoring was detached and the subject
released from pressure chamber. Subjects were then transferred to the recovery
area and given something to eat and drink. Once the welfare team were satised
with the subjects’ recovery they were discharged.
6.3.4 Data Analysis
Representative values for the continuously monitored physiological parameters
were derived from the median values recorded between the h and sixth minute
of that pressure step or aer the release of the negative pressure in the case of the
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recovery measurement. For the baseline measurements the median of the values
lying 30 seconds either side of the baseline measurement point were used.ese
points corresponded to the recording of the stroke distance measurements (SD1
and SD2) allowing direct comparison of these parameters.
Testing of the data distribution for normality was performed by examination of
Q-Q plots and performance of a Shapiro-Wilks test. Non-parametric comparison
of means was performed using a Wilcoxon signed-rank and Kruskal-Wallis test.
Correlation analysis was performed by calculating a Spearman’s rank correlation
coecient. All statistical tests were undertaken using the R programming language
and environment for statistical computing (R Development Core Team, 2009),
with a signicance threshold of p≤0.05.
6.4 results
6.4.1 Demographics of Study Population
A total of 12 individuals were screened for the study, two of which were excluded:
one who developed an unrelated medical condition between the two arms of the
study necessitating exclusion; and the other who withdrew aer sustained a lower
limb injury between screening and the study starting. Of the 10 subjects enrolled
into the study, there were six males and four females.e mean age of subjects
was 22.5 years (range 20–26, s.d. 1.9). All 10 subjects completed both arms of the
protocol, although in two subjects the study protocol was ended early. In one
subject the protocol was terminated when the subject started vomiting during the
late stages of the morphine arm. In another subject the study was stopped when
there was loss of the Finometer® reading at a point where the subject was judged
clinically to be close to presyncope.
In one subject there was a technical failure with the time synchronisation
stamp on the NIRS trace during the morphine arm the study, meaning StO2 data
could not be matched to the experimental phase or other physiological parameters.
StO2 data was therefore excluded in this morphine arm of this subject during
analysis.
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Placebo Group StO2 (%)
Site Mean Median Range Q1–Q3 s.d.
Pre-infusion Deltoid 87.8 88 78–95 86–93 6.5
Forearm 80.2 78 69–95 70–88 10.3
enar 62.6 59 49–83 54–72 12.5
Head 77.3 77 66–87 75–83 6.5
Post-infusion Deltoid 88.4 89 74–95 85–94 6.6
Forearm 75.8 78 60–87 70–82 9.1
enar 60.2 60 43–82 53–66 12.7
Head 75.9 77 67–87 71–79 7.1
Morphine Group StO2 (%)
Site Mean Median Range Q1–Q3 s.d.
Pre-infusion Deltoid 89.0 93 77–95 84–95 6.6
Forearm 77.9 77 68–92 70–83 8.6
enar 67.8 67 49–92 57–73 13.8
Head 75.9 77 62–85 69–84 9.0
Post-infusion Deltoid 89.0 93 73–95 86–95 7.9
Forearm 76.6 75 66–89 69–84 8.4
enar 72.8 71 54–95 63–79 13.5
Head 82.9 84 69–94 76–88 8.4
Table 6.1: Summary statistics for the baseline StO2 values in the placebo and morphine
groups.
6.4.2 Baseline Physiological Measurements and Eect of Morphine
Summary statistics for baseline StO2 values are given in Table 6.1.ere was no
signicant dierence in pre-infusion StO2 measurements between the placebo
and morphine groups. ere were signicant dierences in mean StO2 when
comparing anatomical sites, p<0.01 for all comparisons (using the combined data
from the placebo and morphine groups), with the exception of the comparison
between the frontal lobe of the brain and forearm, p=0.27. A summary of the
pre-infusion StO2 values at each site is presented in Figure 6.3. It can be seen
that StO2 in skeletal muscle groups decreased the more distal the monitoring site.
Cerebral StO2 values were similar those of the forearm but fell within a tighter
range.
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Figure 6.3: Box plot of pre-infusion StO2 values at each site based on the combined values
of the placebo and morphine groups. Plot whiskers denote maximum and minimum data
points.
e infusion of placebo had no signicant eect on the baseline StO2 values
recorded from the deltoid (p=0.73), thenar eminence (p=0.25), or head (p=0.37).
In the forearm there was a 4.4±3.67% fall in StO2 following infusion (p=0.02).
Morphine administration was not associated with any change in StO2 in the
deltoid (p=0.97) or forearm (p=0.17). However it was associated with a signicant
increase in the StO2 values recorded in thenar eminence, by 5.02±3.38% (p<0.01),
and the head, by 7±1.93% (p<0.01).
Summary statistics for the baseline values of the other physiological parameters
are shown in Table 6.2.ere were no signicant dierence in baseline measure-
ments between the placebo and morphine groups for any of the physiological
parameters listed in Table 6.2. In the placebo group heart rate fell by 5.7±3.15 bpm,
p=0.004 and CO fell by 569±259 ml/min, p=0.001 following infusion. Morphine
administration was associated with a 4.0±3.6 mmHg increase in DBP, p=0.04.
ere were no other signicant dierences in the pre and post infusion values for
any of the other physiological parameters in either the placebo or the morphine
groups.
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Placebo Group
Parameter Mean Median Range Q1–Q3 s.d.
Pre-infusion HR 68 70 55–80 60–76 9.6
SBP 120 124 99–134 115–127 11.1
DBP 68 68 48–82 62–77 10.6
MAP 89 91 75–100 80–95 9.1
CVP – – – – –
CO 6078 6262 2820–7911 5160–7194 1561.5
Post-infusion HR 63 63 52–73 56–69 7.7
SBP 120 122 88–139 114–129 14.4
DBP 70 67 56–84 64–79 9.7
MAP 89 90 71–104 83–96 10.1
CVP −0.20 −0.10 −2.30–1.20 −0.65–0.45 1.09
CO 5509 5827 2490–7171 4743–6779 1536.1
Morphine Group
Parameter Mean Median Range Q1–Q3 s.d.
Pre-infusion HR 70 72 57–86 61–76 10.6
SBP 124 124 108–137 120–131 9.8
DBP 68 66 51–85 61–75 10.5
MAP 89 86 74–107 81–100 11.9
CVP – – – – –
CO 6598 6393 4496–9341 5998–7162 1329.7
Post-infusion HR 71 69 53–101 57–77 16.1
SBP 127 127 102–158 120–134 16.6
DBP 72 70 60–90 64–79 10.5
MAP 94 91 77–114 88–103 12.6
CVP −1.17 −0.50 −5.30–0.70 −1.39–0.88 2.18
CO 6781 6766 4380–9599 5773–7426 1584.8
Table 6.2: Summary statistics for the baseline physiological measurements in the placebo
and morphine groups, n.b. CVP is expressed as the dierence from the initial baseline
value to correct to calibration errors.
HR = heart rate (bpm); SBP = systolic blood pressure (mmHg); DBP = diastolic blood
pressure (mmHg); MAP =mean arterial pressure (mmHg); CVP = central venous pressure
(mmHg); CO = cardiac output (mL/min).
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6.4.3 Eect of the Simulated Hypovolaemia Protocol
e mean values for physiological data at each stage of the experimental protocol
are presented in Table 6.3. e table also shows the results of a Kruskal-Wallis
test for each parameter by experimental phase. For the purposes of this analysis,
experimental phases were treated as ordinal data rather than continuous variables,
since the volume of simulated hypovolaemia is not necessarily proportional to the
absolute negative pressure applied to the LBNP chamber. Note that the placebo
group only includes pressure increments down to -80 mmHg, since no subject
completed a -90 mmHg increment in that arm of the study.
In the placebo group there was a general trend of decreasing StO2 values in
deltoid and forearm with progressive increments of LBNP.e forearm values
showed a greater change, both absolutely and relatively, when compared to the
deltoid. Both sites demonstrated a rapid recovery to just below baseline values
within ve minutes of the pressure being released. enar eminence and head
StO2 values demonstrated a highly inconsistent relationship with LBNP: the thenar
measurements initially falling then rising, while the head demonstrated very
little change in StO2 values over the course of the protocol. ese changes are
summarised graphically in Figure 6.4. Of all the NIRS sites only the forearm
demonstrated a statistically signicant dierence in values between all phases
of the protocol (p=0.047), the correlation between box pressure and StO2 being
rs=.52.
Stroke distance demonstrated the strongest correlation with increments of
LBNP falling consistently with progressive increments of LBNP (rs=.82, p>0.0001).
Stroke volume also demonstrated a signicant strong correlation with box pressure
(rs=.70, p=0.001). Of the traditional physiological parameters only heart rate had
a signicant correlation with box pressure, rs=-.81, p<0.001. CO fell consistently
with increasing increments of LBNP, although the relationship was not signicant
(p=0.145). Of the other physiological parameters none demonstrated a statistically
signicant relationship with LBNP, although SBP and to a lesser extent MAP
showed a general decreasing trend with LBNP increments. DBP demonstrated no
obvious relationship with LBNP.
e administration of morphine appeared to blunt many of the physiological
responses to simulated hypovolaemia. StO2 changes in the morphine group are
76
6.4. results
Pl
ac
eb
o
G
ro
up
Ph
as
e
D
elt
oi
d
Fo
re
ar
m

en
ar
H
ea
d
H
R
SB
P
D
BP
M
AP
CV
P
SD
SV
CO
Pr
e-
in
fu
sio
n
88
80
63
76
68
12
0
68
89
N
A
21
91
60
78
Po
st-
in
fu
sio
n
88
76
60
77
63
12
0
70
89
(−0.2
0)
21
88
55
09
-3
0
m
m
H
g
85
70
58
77
70
117
71
90
(−1.8
)
17
69
48
04
-5
0
m
m
H
g
83
66
62
77
86
10
8
70
85
(−2.4
0)
12
55
46
75
-6
0
m
m
H
g
83
66
64
76
10
5
10
3
69
82
(−2.3
0)
10
46
45
88
-7
0
m
m
H
g
81
65
67
78
12
2
10
7
73
86
(−3.7
)
7
43
49
70
-8
0
m
m
H
g
82
64
71
74
13
2
10
5
65
83
(−3.6
7)
4
35
41
33
Re
co
ve
ry
87
74
60
78
60
12
1
75
95
(0
.6
2)
19
88
50
38
p-
va
lu
e
0.
06
2
0.
04
7
0.
86
8
0.
98
2
<0
.0
01
0.
06
0
0.
97
3
0.
75
8
N
A
<0
.0
01
0.
00
1
0.
14
5
M
or
ph
in
e
G
ro
up
Pr
e-
in
fu
sio
n
89
78
68
76
70
12
4
68
89
N
A
N
A
94
65
98
Po
st-
in
fu
sio
n
89
77
73
83
71
12
7
72
94
(-
1.1
7)
21
97
67
81
-3
0
m
m
H
g
85
72
70
82
74
12
2
71
90
(-
3.
2)
17
84
60
93
-5
0
m
m
H
g
85
71
72
81
89
116
70
88
(-
3.
2)
15
69
58
97
-6
0
m
m
H
g
86
71
68
81
10
2
11
2
73
88
(-
4.
3)
14
57
55
20
-7
0
m
m
H
g
89
70
67
78
11
3
10
6
70
84
(-
3.
9)
9
49
52
67
-8
0
m
m
H
g
87
69
69
79
12
3
98
65
79
(-
4.
4)
9
45
56
56
-9
0
m
m
H
g
84
60
65
74
16
7
99
68
82
(-
2.
8)
5
28
61
89
Re
co
ve
ry
90
77
71
84
64
12
0
71
93
(0
.9
)
19
98
59
60
p-
va
lu
e
0.
84
9
0.
28
8
0.
98
8
0.
79
4
0.
00
1
0.
04
7
0.
91
0
0.
89
6
N
A
0.
00
1
<0
.0
01
0.
72
6
Ta
bl
e6
.3:
M
ea
n
va
lu
es
fo
rp
hy
sio
lo
gi
ca
lp
ar
am
et
er
sd
ur
in
gt
he
LB
N
P
pr
ot
oc
ol
.n
.b
.C
V
P
is
ex
pr
es
se
d
as
th
ed
i
er
en
ce
fro
m
th
ep
re
-in
fu
sio
n
ba
se
lin
ev
al
ue
to
co
rr
ec
tt
o
ca
lib
ra
tio
n
er
ro
rs
,a
nd
is
sh
ow
in
pa
re
nt
he
sis
.S
tO
2
(%
);
H
R
=
he
ar
tr
at
e(
bp
m
);
SB
P
=
sy
sto
lic
bl
oo
d
pr
es
su
re
(m
m
H
g)
;D
BP
=
di
as
to
lic
bl
oo
d
pr
es
su
re
(m
m
H
g)
;M
A
P
=
m
ea
n
ar
te
ria
lp
re
ss
ur
e(
m
m
H
g)
;C
V
P
=
ce
nt
ra
lv
en
ou
sp
re
ss
ur
e(
m
m
H
g)
;S
D
=
str
ok
ed
ist
an
ce
(c
m
);
SV
=
str
ok
ev
ol
um
e(
m
L)
;C
O
=
ca
rd
ia
co
ut
pu
t(
m
L/
m
in
);
M
D
=
M
in
ut
ed
ist
an
ce
(c
m
/m
in
).
77
6.4. results
Deltoid Forearm
Thenar Head
90
80
70
80
60
40
90
80
70
60
90
80
70
60
Pre Post -30 -50 -60 -70 -80 Rec Pre Post -30 -50 -60 -70 -80 Rec
St
O
2(
%
)
Experimental Phase
Figure 6.4: Box plots of StO2 data over the course of the LBNP protocol for the
placebo group. Sampling points: Pre=Pre-infusion baseline; Post=Post-infusion baseline;
Rec=Recovery; integers denote increments of LBNP in mmHg. Plot whiskers denote
maximum and minimum data points, excluding outliers which are shown separately.
summarised in the box plot in Figure 6.5.ere were smaller changes, in forearm
StO2, stroke distance, stroke volume, heart rate and CO values in response to LBNP
than in the placebo group. Forearm StO2 correlation with box pressure was weaker
(rs=.43), and its relationship with LBNP increments no longer signicant, p=0.288.
Of the other NIRSmonitoring sites, deltoid, thenar and head StO2 appeared largely
discordant with LBNP (thenar eminence StO2 actually increased from baseline
over the course of the protocol), and none of the sites demonstrated a statistically
signicant relationship with LBNP. SBP showed a much stronger relationship with
LBNP than in the placebo arm, consistently falling across all increments of LBNP
(p=0.047), and better correlation with box pressure rs=.47. Stroke distance (rs=.75,
p=0.001), stroke volume (rs=.77, p<0.001), and heart rate (rs=-.64, p=0.001) all
demonstrated a signicant relationship with LBNP, as they also did in the placebo
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Figure 6.5: Box plots StO2 data over the course of the LBNPprotocol in themorphine group.
Sampling points: Pre=Pre-infusion baseline; Post=Post-infusion baseline; Rec=Recovery;
integers denote increments of LBNP in mmHg. Plot whiskers denote maximum and
minimum data points, excluding outliers which are shown separately.
arm of the study, although the correlation was weaker in the morphine arm. None
of the other physiological parameters demonstrated a statistically signicant trend
over the course of the protocol.
6.4.4 Eect of Morphine on LBNP Tolerance
In the placebo group none of the subjects completed a LBNP increment greater
than -80 mmHg, while in the morphine arm two subjects completed a -90 mmHg
increment. e LBNP increments completed by each subject in the two study
arms are shown in Table 6.4. Morphine administration was associated with an
increased LBNP tolerance in ve subjects, and a lower tolerance in two subjects.
In three subject there was no change in LBNP tolerance between the morphine
and placebo arms. Although the morphine arm demonstrated an overall greater
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Subject Placebo Increment Morphine Increment Placebo Time Morphine Time
(mmHg) (mmHg) (mins) (mins)
2 60 60 1170 1398
3 80 90 1998 2550
4 60 80 1055 1884
5 70 80 1626 1962
6 60 50 1152 720
9 60 60 1164 1476
10 70 50 1758 1050
11 80 80 1926 2310
12 30 70 822 1518
13 80 90 2328 2622
Table 6.4: Increments of LBNP completed and duration of the protocol from induction of
LBNP by subject in each arm of the study. Subjects who achieve a greater LBNP increment
in the morphine arm are shown in red, those who achieved a lower increment are shown
in blue.
tolerance to LBNP, this dierence was not statistically signicant when examined
either by increment of LBNP achieved (p=0.34) or duration of the LBNP tolerated
before pre-syncope (p=0.23).
6.5 discussion
e design of this study provided not only an opportunity to examine the eects
of LBNP and morphine administration on StO2, but also to address some broader
questions about StO2 values and trends.e two arms of the study allowed direct
comparison of NIRS measurements at identical sites in the same subject. It is
notable that there was no dierence in the pre-infusion StO2 values of subjects
between the two arms of the study. is suggests that despite the relative large
range of StO2 values recorded at each site, StO2 is consistent within individual
subjects under similar conditions. It also provides some validation of the NIRS
technique and the specically the INVOS® System’s algorithm.ere were however
signicant dierences in StO2 values recorded between dierent sites. In the
skeletal muscle sites StO2 was consistently lower the more distal the monitoring
site.is drop would appear intuitive as blood ows further away from the core,
and there is less muscle mass to supply and hence lower oxygen demands.is
is an important nding, as it indicates that StO2 values cannot be extrapolated
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between dierent sites and used as reference ranges, as has been done in at least one
study (see Arató et al. (2009) for an example of this). Instead reference StO2 ranges
must be established separately for each site of interest. e dierences in StO2
between dierent monitoring sites are examined in more detail in Chapter 7; but
in summary, the ndings presented there conrm the variation in StO2 between
sites observed in this study.
e administration of placebo was associated with a signicant fall in forearm
StO2 from 80.2% to 75.8%. is a surprising nding, since there should be no
dierence, and this probably represents a type I error rather than a real nding.
e administration of morphine was associated with a signicant rise in thenar
eminence and cerebral StO2.is eect is probably due to the vasodilatory eects
of morphine (Afshari et al., 2009), increasing the ratio of arterial blood in the
NIRS monitoring window and thus raising the StO2. But this raises the question
as to why the deltoid and forearm do not show a similar eect? Cerebral blood
ow is recognised to be sensitive to a number of pharmacological and chemical
agents, so the ndings in the brain are possibility a consequence of this. In the
thenar eminence, the lower resting StO2 values compared to other skeletal muscle
sites, means that the eects of vasodilation are more likely to be reected in StO2
measurements here due to a greater change in the ratio of arterial to venous blood
in the NIRS monitoring window. It should be noted that despite the statistical
signicance of some the StO2 changes following infusion, all post-infusion StO2
measurement fell within one standard deviation of the pre-infusion values, i.e.
within the sample control range. us it would not be possible to identify the
eects of morphine administration on StO2 in an subject or group unless the
individuals’ baseline StO2 values were known beforehand.
e main aim of this study was to examine the sensitivities of dierent NIRS
monitoring sites in detecting simulated hypovolaemia. Of the sites studied only the
deltoid and forearmdemonstrated discernible changeswith progressive increments
of the LBNP.e thenar eminence and brain showed no clear pattern of response
to simulated hypovolaemia.e ndings in relation to the brain are not surprising.
In the face of relatively modest degrees of hypovolaemia, such as those used in this
experiment, cerebral autoregulation would be expected to maintain blood ow to
the brain.e relationship of thenar eminence StO2 to LBNP is consistent with
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the ndings of Soller et al. (2008a) and Bartels et al. (2011), who have previously
shown negligible changes in thenar StO2 in response to LBNP. However it should
be appreciated that those studies used dierent NIRS monitors/algorithms to this
study, and the results presented here conrm these ndings with the INVOS®
System.
Forearm StO2 was the most sensitive to simulated hypovolaemia, being the
only site to demonstrate a statistically signicant change in response to incremental
changes in LBNP. Again this nding is consistent with previous studies, although
this is the rst time a direct comparison between the deltoid and forearm has
been performed. Deltoid StO2 has been shown to correlate strongly with systemic
oxygen delivery in clinic studies (McKinley et al., 2009) (see Section 4.4 for a more
detailed discussion), and examining Figure 6.4 the trend in deltoid StO2 is clearly
discernible. It is therefore likely that deltoid StO2 could be used to detect clinically
signicant changes in patients with greater degrees of blood loss.is is fortunate
for military patients who are much more likely than their civilian counterparts to
sustain injuries that make monitoring at distal sites, such as forearm for thenar
eminence, dicult or impossible. Despite demonstrating a statistically signicant
change in StO2 in the placebo arm of the study the absolute change in forearm
StO2 over the course of the experiment was relative small (from 80–64%). e
mean StO2 during the -80 mmHg pressure increment (64%) lay just outside the
pre-infusion reference range (69–95%) and actually inside the post-infusion range
(60–87%).is is a problem also mirrored in the results of Soller et al. (2008a)
and McKinley et al. (2009) and illustrates the point, that in the mild to moderate
hypovolaemia, isolated StO2 measurements are dicult to interpret without a
knowledge of the resting values for that patient. Obviously this is a luxury not
available in the clinical environment, and unless grossly deranged, it is likely that
monitoring the trend in StO2 during the course of resuscitation would be more
useful than knowing the absolute values.
Of all the physiological parameters stroke distance and heart rate demonstrated
the strongest correlation with LBNP increments, rs=.82 and rs=-.81 respectively,
and were superior to forearm StO2 measurement. However these parameters
are not necessarily the best means of monitoring the physiological status of the
trauma patient since they are not without practical limitation. Stroke distance
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requires manual measurement by echocardiography; it is time consuming and
technically demanding to perform. Although the recording are made in real
time, they are intermittent, and thus provide only a snap shot of the patients’
physiology. e measurement of stroke distance requires special training, and
even then there is signicant inter-observer variability (this was avoided in this
study by using the same technician for all measurements). For these reasons the
measurement of stroke distance remains conned to the cardiology clinic and
the research environment. Heart rate has a biphasic response to hypovolaemia,
initially increasing but then demonstrating a ‘paradoxical’ drop as the reduction
in central blood volume approaches 30%. Only with further blood loss is there an
increase in heart rate signalling the progression towards irreversible shock (see
Section 1.3.2 for a more detailed discussion of this phenomenon).is biphasic
response was not seen in this study, either because none of the subjects approached
a 30% reduction in central blood volume (the study being terminated at the point of
presyncope), or the response was absent in this young t group who compensated
well for the hypovolaemia. For this reason heart rate probably performed better in
this study than it does in clinical practice.
Finometer® measurements of stroke volume also correlated well with box
pressure (rs=.70), which is consistent with the ndings of Soller et al. (2012).e
Finometer® provides an interesting technique for assessing volume state in the
hypovolaemic patient: being non-invasive and providing real time, continuous
output. However the device does have signicant practical limitations: it requires
calibration with an arm calibration module; monitoring is performed via the
ngers which may be damaged in trauma patients; and the hand has to be kept in
the same relative position to heart while monitoring.ese limitations make the
Finometer® impractical for use in real trauma patients, and largely limit its use to
the research environment.
None of the other physiological parameters demonstrated a signicant correla-
tion with LBNP. In particular CO, despite being the product of two signicantly
correlated variables (heart rate and stroke volume) did not show a signicant
relationship with box pressure, although it did demonstrate a modest correla-
tion rs=.40.e reasons for this are unclear, but it could represent a non-linear
relationship between independant and response variables.
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Morphine administration attenuated the response of most physiological meas-
urements in response to simulated hypovolaemia when compared to the placebo
group.e pharmacology of morphine’s eects in human trauma patients is still
poorly understood, but vasodilation and eects on the central nervous system
may account for the results seen in this study. Vasodilation would explain the
blunting of the NIRS signals and the fact that StO2 was signicantly higher in the
thenar eminence and head followingmorphine infusion, and generally higher at all
sites throughout the LBNP protocol. Because of the skew le distribution of StO2
values∗ anything that causes a shi to the right in the StO2 curve will compress the
range of values at their upper end leading to an apparent reduction in sensitivity.
A combination of these reasons probably account for the fact that non of the NIRS
monitoring sites showed a statistically signicant relation with box pressure in
the morphine group. However the general trend of decreasing StO2 values could
still be discerned in the forearm (see Figure 6.5), although it was largely lost in
the deltoid. It is probable that the trends would become more obvious in patients
with higher degrees of blood loss, and therefore NIRS may still be of value in the
severely injured trauma patient even aer morphine administration.
Stroke volume, stroke distance and heart rate all correlated well with box pres-
sure in both the placebo andmorphine groups. Although for the reasons discussed
above only heart rate provides a practical tool for clinical use, providing the caveat
regarding its biphasic response to hypovolaemia is understood. None of the blood
pressure parameters provided a reliable indicator of the degree of hypovolaemia.
Diastolic blood pressure in particular had no discernible relationship with box
pressure, as would be expected in cases of mild to moderate hypovolaemia where
a narrowing of the pulse pressure is part of the compensatory mechanisms to
maintain blood ow, only subsequently falling as the hypovolaemia progresses.
6.6 conclusion
e main nding of this study is that there were signicant dierences between
StO2 values recorded at dierent anatomical sites, both in terms of their resting
∗is occurs probably as a result of a combination of physiological factors and algorithmic compres-
sion of StO2 values in the upper range by the NIRS monitor.e distribution of StO2 measurement
is discussed more fully in Section 4.1 and assessed experimentally for the INVOS® System monitor
in the NIRS normal values and response to exercise study described in Chapter 7.
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values and their sensitivity to LBNP simulated hypovolaemia.
Of the NIRS monitoring sites studied here, the forearm was the most sensitive
to changes induced by a mild to moderate simulated hypovolaemia. In cases where
the forearm cannot be used, the deltoid is a possible alternative. Although deltoid
StO2 did not vary signicantly with LBNP in this study it did demonstrate discern-
ible changes which would probably be more obvious in the severely hypovolaemic
patient.e thenar eminence and frontal lobe of the brain appear to be unreliable
monitoring sites, demonstrating no useful trend changes in this study. e ad-
ministration of morphine attenuated the StO2 response (and that of conventional
haemodynamic parameters) to hypovolaemia, but did not completely eliminate it.
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7. normal nirs values and response to exercise
study
7.1 introduction
To interpret the results of NIRS measurements from experimental studies and in
clinical practice, it is necessary to have a working knowledge of the normal range
of StO2. Unfortunately, despite a large body of ongoing work in the eld, to date
there has only been one published description of the range of normal StO2 values.
Crookes et al. (2005) recorded StO2 values from the thenar eminences of 707
ambulatory volunteers, using an InSpectra™ Tissue Spectrometer (Hutchinson
Technology). A detailed discussion of their ndings is presented in Section 4.1,
however in summary their work found that there was a wide range of normal
StO2 values with a skew le distribution (see Figure 4.1 on page 42). Mean StO2
for all subjects was 87 ± 6%, however signicant dierences were found between
males (mean StO2 88.38 ± 5.51%) and females (mean StO2 85.4 ± 6.69%), p <0.001;
between smokers (mean StO2 89.59 ± 4.57%) and non-smokers (mean StO2 86.03 ±
6.54%), p <0.001; and between dierent ethnic groups (although these dierences
were small enough to probably be of limited clinical signicance).
It should be appreciated that Crookes et al. (2005) ndings apply only to StO2
recordings made with the same model InSpectra™ Tissue Spectrometer. Machines
using dierent algorithms or dierent physical designs, such as dual beam monit-
ors, would be likely to record dierent absolute values, although the distribution
of the population values would be expected to be similar. Furthermore it cannot
be assumed that StO2 values at other anatomical sites would record the same
values, or even necessarily the same distribution pattern. How StO2 values vary
between anatomical sites is currently unknown, although Crookes et al. (2005)
report observing dierences in resting StO2 values at dierent anatomical sites in
their previous animal work. It is therefore important that when establishing nor-
mal StO2 values as a basis for further work that it should performed using similar
apparatus, and for each anatomical site that is intended to be studied. Given the,
albeit small, dierences observed between sexes and ethnic groups, the normal
range of StO2 values should ideally be established in a population group similar to
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the one of interest.
In military and civilian environments, trauma oen occurs following a period
of exertion, for example the soldier injured during combat, the cyclist involved
in a road trac collision, or the patient with chronic exertional compartment
syndrome. Exercise is known to have an eect on StO2 values in both working
and non-working muscle groups, and has been well studied (see Section 4.5 for a
more detailed discussion). However, the NIRS changes during recovery following
exercise, particularly in non-working muscle groups, are still not well understood.
It has been shown that StO2 increases in non-working muscle groups following
exercise, the increase being proportional to the work performed, and that values
typically return to normal within ve minutes of cessation of exercise (Nagasawa,
2008a,b). Unfortunately, these studies used isolation exercises (leg raises) or highly
specic exercise protocols (cycling), and it is unclear how these ndings may relate
to ‘uncontrolled’ mixed exercise of the type that commonly precede trauma.
7.2 aim
e primary aimof this studywas to establish descriptive data for StO2 values at rest
from a number of anatomical sites of use to clinical practice, in the most clinically
relevant population for the military — young infantry males. A secondary aim
was to determine if a mixed exercise protocol caused signicant changes in StO2,
that would need to be considered when interpreting StO2 values in post-exercise
subjects.
7.3 materials and methods
e experimental design was that of a prospective cross-sectional study in human
volunteers. Full ethical approval for the study protocol was obtained from the
Ministry of Defence Research Ethics Committee (MoDREC) and written consent
obtained from all participants. e study was conducted at 42 Royal Marine
Commando Regiment (Cdo Reg), Plymouth and Commando Training Centre
(CTC) Royal Marines, Lympstone between the dates of 8–16 th November 2011.
7.3.1 Study Population
e study sample was selected to be representative of the injured military popu-
lation seen in recent conicts from Iraq and Afghanistan.e study group was
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drawn from 42 Cdo Reg, Plymouth, an infantry regiment and Hunter Troops 2
and 3 CTC, Lympstone, an infantry training regiment. Hunter Troops 2 and 3
are advanced rehabilitation groups within CTC and similar in composition to a
standard infantry regiment.
Eligible for inclusion in the study were all male military personnel in the
participating Commando units between the ages of 18–35 years, subject to the
following exclusion criteria:
1. any medically downgraded individual below Joint Medical Employment
Standard (JMES)∗: MFD (Fully Deployable) A4 (t be own in a passenger
aircra) L2 (Fit for unrestricted duties but with a medical risk marker)
M1 (t for unrestricted duties) or M6 (maritime assessment not currently
required) E1 (t for worldwide service in all environments).
2. any individual currently in receipt of light duties, excluding them from
physical training.
3. any conrmed or suspected bony injury, i.e. fracture or stress fracture, to
either the arms or legs within the previous 8 weeks.
Eligible subjects were identied from unit personnel tables; downgraded and
medically unt individuals were identied by unit company commanders and
excluded. Eligible subjects received a written and verbal brief at least 48 hours in
advance of the study day, individuals wishing to volunteer for the study were then
allocated a study day and time, and asked to refrain from exercise for 24 hours
prior to participation, and from smoking or alcohol consumption from midnight
the day before.
On the study day subjects were asked to read the subject information leaet,
before undergoing a brief screening interview to conrm they had no medical
conditions meeting the exclusion criteria.
∗JMES is standardised record of an individuals’ employability based on their physical and mental
condition. An equivalent standard was taken for members of Hunter Troop 2 and 3 who, having
not completed basic training, are not eligible for deployment. A summary of JMES codes is given
in Appendix D.
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7.3.2 NIRS Monitoring Protocol
e studywas conducted indoors in the gymnasiumhalls of 42CdoReg andCTC to
minimise the variations in ambient temperature. Subjects were requested to attend
in standard physical training clothing, t-shirt and shorts, with appropriate running
shoes.e study protocol was performed in pairs to encourage competition during
the exercise phase.
Subjects were rested supine on an exercise mat for 10 minutes aer which
they moved across to the designated monitoring mats to allow attachment of
the NIRS monitoring. Two INVOS® System NIRS monitors were used in a four
channel setting.e internal clocks of the two machines were synchronised with
the investigators’ watches to ensure consistency between the time stamped data
and the time of exercise completion. StO2 readings were taken from the following
sites (see Figure 5.3 on page 64 for an illustration of the probe positions):
1. the le deltoid—with the probe positioned two nger breadths above the
deltoid insertion, with the probe/cable connection directed cranially.
2. the right deltoid—with the probe positioned two nger breadths above the
deltoid insertion, with the probe/cable connection directed cranially.
3. the le leg — with the probe positioned one nger breadth lateral to the
anterior margin of the tibial, midway between the knee and the ankle so as
to monitor the anterior compartment of the leg.e probe cable/connection
was directed distally.
4. the le frontal lobe of the brain — with the probe positioned one nger
breadth above the orbital ridge, with the probe/cable connection directed
laterally and the distal end of the probe located in the midline.
To ensure accurate readings, the hair over the monitoring site on the leg was
clipped with an electric razor prior to probe attachment. In one individual it was
also necessary to clip the hair over the deltoid regions. Probes were reused between
subjects. To ensure adequate adhesion and exclude extraneous light, probes were
secured at each site with medical tape. NIRS readings from the four anatomical
sites were recorded every six seconds for 10 minutes in the rested (pre-exercise)
state, aer which the probes were removed and the subject allowed to get up and
prepare for the exercise protocol.
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7.3.3 Exercise Protocol
To simulate the physical demands of a soldier working in the eld, the US Marine
Corps (USMC) Fitness Test was chosen as a widely used standard protocol testing
range of physical attributes. All exercises were performed under the supervision
of a qualied unit physical training instructor (PTI). A complete description of
the requirements of the USMC Fitness Test are given in Appendix C, in summary
the test consists of:
1. Overarm pull-ups—maximum number possible in a single set.
2. Sit-ups—maximum number possible in two minutes. A weighted barbell
was provided for secure the feet for those individuals who chose to use it.
3. ree mile run— completed at individual best eort. For the purpose of
standardisation, this test was performed on a Technogym Run 700 model
treadmill set to a 1% incline to simulate outdoor running.
Each exercise was separated by a two minute rest and the performance in
each element recorded by the PTI. At the end of the run it was expected that
most individuals would be working at their VO2max, thus standardising the eort
between subjects. Upon completion of the run, subjects were returned to the
monitoring mat.e monitoring sites were towel dried and a further 10 minutes
of StO2 monitoring performed using the same protocol as that used for the pre-
exercise monitoring. Owing to the practicalities of performing the monitoring
and run in separate rooms, there were dierences in the length of time subjects
took to return to the monitoring mat.is, coupled with dierences in the time
required to reattach the probes and ensure a good reading led to variations in
the time interval between subject nishing the exercise protocol and starting the
post-exercise monitoring. To correct for this time discrepancy each individual
had the exact time at which they nished their run recorded, which was then used
to adjust the time stamp on the NIRS data to ensure all comparisons of data in
the post-exercise phase were performed at the same time period with respect to
completing the exercise protocol.
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No Field Comments
1 Study specic number Generated by study
2 Regimental Number
3 Date of Birth
4 Age Calculated from date of birth
5 Smoker Binary eld (yes/no)
6 Estimated current tobacco consumption Packs per day
7 Estimated tobacco pack year history Packs per day per year
8 StO2 values in le leg pre-exercise
9 StO2 values in le deltoid pre-exercise
10 StO2 values in right deltoid pre-exercise
11 StO2 values in le frontal lobe pre-exercise
12 StO2 values in le leg post-exercise
13 StO2 values in le deltoid post-exercise
14 StO2 values in right deltoid post-exercise
15 StO2 values in le frontal lobe post-exercise
16 Number of pull-ups performed
17 Number of sit-ups performed
18 Run time
19 Time of nishing run GMT
20 Time of starting post-exercise monitoring GMT
21 Lag time between run and starting post- Calculated from elds 19 & 20
exercise monitoring
Table 7.1: Data elds used in the NIRS exercise study. N.B. one packet of cigarettes is taken
to be 20 cigarettes; a pack year is the equivalent of smoking one packet of cigarettes every
day for a year.
7.3.4 Data Collection
In addition to the NIRS data and exercise performance results, additional basic
demographic data and details of subjects’ smoking history were collected. A
summary of the separate data elds for which information was collected is given
in Table 7.1.
7.3.5 Data Analysis
Testing the data distribution for normality was undertaken by examining Q-Q
plots and conrmed with a Anderson-Darling test. Comparisons of parametric
data was performed using a paired t-test. Comparison of non-parametric data was
performed using Wilcoxon rank-sum and Kruskal-Wallis tests. All statistical tests
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were undertaken using the R programming language and environment for statist-
ical computing (R Development Core Team, 2009) with a signicance threshold
of p≤0.05.
7.4 results
7.4.1 Demographics of Study Population
A total of 107 (88 at 42 RM Cdo and 19 at CTC) male subjects were screened for
the study, two subjects, both at CTC, were excluded on the grounds of sustaining a
lower limb injury within the previous eight weeks. All of the 105 eligible volunteers
completed the whole of the study protocol.e mean age of subjects was 22.7 years
(s.d. 4.0, range of 18–36 years). All subjects were Caucasian with the exception of
one black (African ethnicity) subject.
ere were 33 current smokers in the cohort, accounting for 31% of the subjects.
ere were no ex-smokers, i.e. everyone who had previously smoked was still a
current smoker. Within the smoking group the mean number of cigarettes smoked
per day was 9.5 (s.d. 5.1, range 0.25–20).e mean pack year history was 2.9 (s.d.
3.3), but there was a wide range of 0–15 pack years due to one outlier at the upper
end. e breakdown of current tobacco consumption and pack year history is
give in Table 7.2.ere was no signicant correlation between smoking and StO2
values in the resting or post-exercise state.
7.4.2 Exercise Performance
All 105 subjects completed the exercise protocol. Summary statistics for the ex-
ercise performance data are presented in Table 7.3 as an indicator of the physical
conditioning of the study population.
7.4.3 NIRS Values at Rest
Histograms for the raw pre-exercise data are shown in Figure 7.1. Sample data for
both deltoids showed a skew le distribution, data for the brain and leg appeared
normally distributed, but did not conform to normality when assessed with a
Q-Q plot or Anderson-Darling test. Transformation of the data to conform with
normality was not possible. Assessment of the median StO2 values for each subject
did conform to normality, thereby allowing statistical analysis with parametric
tests.
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Subject Current Tobacco Pack year Subject Current Tobacco Pack year
Consumption History Consumption History
1 10 1 18 1 0
2 10 0.25 19 4 1
3 5 0.5 20 12 1
4 10 0.5 21 10 2.5
5 20 10 22 2 8
6 10 1 23 10 4
7 10 2.5 24 6 0.5
8 5 3 25 5 0.5
9 5 4 26 10 4
10 20 4 27 7 6
11 1 0 28 15 2
12 10 1 29 4 1
13 10 1 30 20 6
14 10 1.5 31 20 15
15 10 0.5 32 10 3
16 10 0.5 33 10 3
17 10 2
Table 7.2: Data for tobacco consumption in smokers.
Exercise Mean Median Standard Deviation Range
Sit-ups 79 80 11 55–114
Pull-ups 16 15 5 6–37
Run time (mins) 20:47 20:43 1:17 17:00–23:11
Table 7.3: Exercise performance data for each of the elements of the USMC tness test.
Descriptive statistics for median StO2 values at rest are presented in Table 7.4.
Comparison of StO2 values between the le and right deltoid with a two sample
t-test showed no signicant dierence NIRS values recorded at the two sites (p-
value 0.302).ere were signicant dierences in StO2 measurement between the
deltoids and the leg, deltoid and brain and leg and brain (all p-values <0.001).
e eect of time, as an independant variable during the recording period, on
StO2 measurements was assessed with Kruskal-Wallis test.e respective p-values:
le deltoid 0.996; right deltoid 0.988; leg 1.00; and brain 1.00, suggest that the time
of measurement has no inuence upon StO2. However, plots of StO2 against time,
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Figure 7.1: Histograms of the raw pre-exercise StO2 data at each monitoring site. Note the
skew le distribution of StO2 measurement in the deltoids. StO2 values in the brain and
leg appear to be normally distributed but did not conform to normality when analysed
with the Anderson-Darling test.
appeared to demonstrate a ‘warm-up’ period of rising StO2 values during the rst
1–2 minutes of recordings, which then plateaued to stable values (Figure 7.2). To
examine this phenomenon further median StO2 values of each of ten successive
observations corresponding to the rst and h minutes of measurement were
compared.e h minute was selected as an arbitrary point at which steady state
recordings appeared to have been achieved as assessed by visual inspection of the
traces shown in Figure 7.2. StO2 values from the rst and h minute for each
anatomical site were compared with a Wilcoxon rank-sum test. e respective
p-values were: le deltoid 0.03; right deltoid 0.044; brain 0.156; leg 0.15. is
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Mean 95% CI for Mean Range Q1–Q3 s.d.
Raw data Le Deltoid 80.0 79.8–80.2 42–95 75–87 9.1
Right Deltoid 78.8 78.6–79.0 41–95 73–86 9.7
Leg 67.7 67.7–68.0 42–92 62–74 8.1
Brain 72.9 72.8–73.1 43–95∗ 69–78 7.9
Median Le Deltoid 80.1 78.4–81.8 49–95 75–87 8.9
Right Deltoid 78.8 77.0–80.4 46–95 74–85 9.5
Leg 67.7 66.2–69.2 47–85 63–74 7.8
Brain 73.0 71.6–74.5 47–95 69–78 7.6
∗ ere was a single outlying lower reading of 35% recorded in the brain.
Table 7.4: Descriptive statistics for pre-exercise raw and median StO2 data.
conrms signicant dierences between the one and ve minute points for both
deltoids, but not for the brain or leg. To conrm the validity of using the ve
minute data as representative sample of steady state recording, i.e. the ve minute
is not part of the warm of ‘warm-up’ period, a signicance test was performed
between the ve minute dataset and the subsequent recordings (the 6–10 minute
period). A further comparison of the one minute dataset against the 6–10 minute
period was also performed to see if dierences could be detected between these
datasets.e results of the Wilcoxon rank-sum test for these analyses are shown
in Table 7.5.ese results show signicant dierences in the StO2 values at one
minute compared to those recorded aer six minutes at all sites except for the
brain.e ve minute values did not show a signicant dierence when compared
to the post six minute data, for any site. ere was no evidence to suggest that
ve minute data and subsequent measurements are from dierent populations,
implying that the ‘warm-up’ period is complete at the ve minute point.
7.4.4 Response of NIRS Values to Exercise
As discussed in Section 7.3.2, for practical reasons there were dierences in the
length of time between subjects nishing the exercise protocol and starting the
post-exercise monitoring. Examining this time dierence, it was found that all
subjects had a common monitoring period ten minutes aer completion of the
exercise protocol. To avoid the confounding eect of subjects being at dierent
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Figure 7.2: StO2 measurements over time for each monitoring site in the pre-exercise
phase.e 95% condence interval for the data is shown in grey. Note the gradual rise in
StO2, most obvious in the deltoid traces, during the rst minute of recording.
p-value
One Minute Five Minute
Le Deltoid 0.005 0.924
Right Deltoid 0.008 0.856
Brain 0.059 0.999
Leg 0.029 0.794
Table 7.5: Results for Wilcoxon rank-sum tests comparing the pre-exercise data recorded
from the rst and h minutes to that from the 6–10 time period.
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Figure 7.3: Histograms of the raw post-exercise StO2 data at each monitoring site. Note
the peak at 95% corresponding to maximum recording limit of the INVOS® System.is
peak is more obvious than in the pre-exercise data due to the right shi in StO2 following
exercise.
stages of post-exercise recovery, StO2 data from the 10-min to 11-min period
following completion of the run were used for the post-exercise data analysis.
Histograms of the raw post-exercise NIRS data at all time points are shown
in Figure 7.3.is data need to be interpreted with care as the raw data is taken
from individuals at dierent stages of the post exercise recovery period. Despite
this the data patterns are similar to those seen in the pre-exercise data (Figure 7.1),
although the curves are slightly shied to the right — most obvious in the brain
and leg data. Again when assessed with Q-Q plots and an Anderson-Darling test,
none of the raw datasets conformed with normality and it was not possible to
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p-value
One Minute Five Minute
Le Deltoid 0.031 0.849
Right Deltoid 0.112 0.955
Brain 0.373 0.630
Leg 0.830 0.044
Table 7.6: Results for Wilcoxon rank sum tests comparing the post-exercise data from
minutes one and ve to the data from the 6–10 time period.
transform them.
Descriptive statistics for the post-exercise median StO2 values are presented
with a box plot representation of the same data in Figure 7.4, for reference the
pre-exercise data is also shown. StO2 was signicantly higher at all sites in the
post-exercise NIRS data compared to the pre-exercise data.e dierences at each
site for the raw data being: le deltoid by 3.1±2.0% (p=0.002); right deltoid by
2.6±2.3% (p=0.003); leg by 8.0±2.3% (p<0.001); and brain by 8.6±1.9% (p<0.001).
Similar dierences were seen when comparing the median data: le deltoid by
3.1±3.0% (p=0.002); right deltoid by 1.4±2.7% (p=0.025); leg by 7.3± 2.1% (p<0.001);
and brain by 4.7±3.9% (p<0.001)
Examination of the raw post-exercise data from each site did not demonstrate
any time related phenomenon. A Kruskal-Wallis test applied to this data using
the same procedure as that applied to the pre-exercise data returned p-values of
1.00 for all sites, suggesting that there was no relationship between StO2 and the
time at which the measurement was taken. To further examine the possibility of
a ‘warm-up’ eect being present in the post-exercise values, the same analysis
comparing the NIRS values from the one minute and ve minute intervals to
the 6–10 minute period was performed.e results of this analysis, presented in
Table 7.6, show that the values recorded at one minute in the le deltoid and ve
minutes in the brain dier from those data recorded between 6–10 minutes at 95%
condence.e other six data subsets show no evidence of this dierence.
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Mean 95% CI for mean Range Q1–Q3 s.d.
Pre-exercise Le Deltoid 80.1 78.4–81.8 49–95 75–87 8.9
Right Deltoid 78.8 77.0–80.4 46–95 74–85 9.5
Leg 67.7 66.2–69.2 47–85 63–74 7.8
Brain 73.0 71.6–74.5 47–95 69–78 7.6
Post-exercise Le Deltoid 83.3 81.8–84.9 36–95 77–90 7.9
Right Deltoid 81.7 80.0–83.4 44–95 75–90 8.8
Leg 75.8 74.6–77.0 15–95∗ 72–80 6.2
Brain 81.6 80.1–82.9 24–95 76–86 6.9
Figure 7.4: Box plot and summary statistics for median StO2 values from each monitoring
site for the pre and post-exercise. Outliers are included in the summary statistics but
are shown separated from the main data in the box plots.e data shows a statistically
signicant increase in StO2 at all sites following exercise. Plot whiskers denote maximum
and minimum data points, excluding outliers which are shown separately.∗ In the post-exercise leg group there were two outliers recording a consistently low StO2
of 15%, which represents the lowest value of the INVOS® System’s recording scale.
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7.5 discussion
e main nding of this is study is that there is a wide range of normal StO2
measurements and descriptive data for values recorded from the deltoid, anterior
compartment of the leg, frontal lobe of brain have been presented. Although all
sites demonstrated a similar range of StO2 values (between approximately 46–95%),
they had dierent distributions and mean values. Mean StO2 values in the head
(73%) were signicantly lower than those recorded in either deltoid (le deltoid
80%, right deltoid 79%, p<0.001), and the values in the leg lowest of all (68%,
p<0.001 for comparisons with the deltoid and cerebrum).is is an important
observation, since it means StO2 reference ranges cannot simply be extrapolated
between sites and should be established for each monitoring site of interest.e
exception to this is when comparing identical contralateral sites.ere was no sig-
nicant dierence between the mean StO2 values recorded from the le and right
deltoids (p=0.302) — the 1% dierence observed being within the ±1% accuracy of
the INVOS® System quoted by themanufacturer (see Appendix A).is is as would
be expected, providing there was no signicant dierence between contralateral
sides, such as injury or vascular compromise, and validates the internal consistency
of the technique, demonstrating that when monitoring for systemic physiological
changes either side may be used. Although not demonstrated by this study, this
nding is likely to be equally applicable to anatomical sites other than the deltoids.
At least one clinical study has used StO2 reference ranges established from one
site to interpret values recorded from a dierent locations. Arató et al. (2009)
used thenar eminence reference ranges as baseline for comparing to StO2 values
recorded from the lower limb in compartment syndrome. e nding of such
studies should be reevaluated in the light of this understanding of the dierences
in StO2 between dierent sites.
Examining the raw pre-exercise data shown in Figure 7.1, the dierence in StO2
distribution between sites can be appreciated. Deltoid StO2 demonstrates a skew
le distribution which is noticeably dierent from that of the leg or cerebrum
(although the median values do demonstrate a normal distribution). It is unlikely
that such a dierence should arise as a result of physiological phenomenon as the
mechanisms controlling the resting blood supply to the deltoid and the anterior
compartment of the leg are fundamentally the same. More probably this dierence
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arises as a result of compression of the data at the upper end of the monitoring
range. Similarly, the isolated peak seen at 95% in the distribution is a result of the
arbitrary upper limit in themachine’s monitoring scale, rather than a physiological
phenomenon.is compression of themonitoring scale at its upper end is probably
a deliberate decision on the part of manufacturer to reduce the range of ‘normal’
StO2 values and improve granularity at the more clinically useful lower end.
Despite the dierences in mean StO2 between monitoring sites, the absolute
range and spread of values were very similar. Standard deviations for the raw
data were between 7.9–9.7, meaning 95% of measured normal values would be
expected to fall within 20% of the mean for that site. All sites demonstrated a
similar absolute minimum of between 41%–43%.is provides a potential clear
cut o of 40%, at which the distinction between potentially normal and clearly
abnormal StO2 values can be made. While this may provide a convenient means
of identifying gross pathology, the very wide range of normal values are likely to
limit the utility of the device in the trauma setting once the initial resuscitation
is complete and StO2 values approach or enter the lower range of normality. It
is possible that trend changes in StO2 values in the normal range would be of
more use in monitoring the response to resuscitation than the absolute values
themselves.
e ‘warm-up’ of gradually increasing StO2 measurements at the start of
the pre-exercise recording was an unexpected nding. Since individuals had
rested supine for 10 minute prior to monitoring, it is dicult to explain this as a
physiological phenomenon. It is more likely that this is a machine or technique
related factor. One possible explanation is that the heating eect of the infrared
light causes local vasodilation, thereby increasing the ratio of arterial to venous
blood in the monitoring window and raising StO2. If this is the case, then it might
be argued that the same eect should be seen in the post-exercise data.ere are
at least two confounding factors in the post-exercise state that are not present at
rest and may explain why this does not occur:
1. in the post exercise state, the tissues (particularly in the leg and deltoid)
are already warm and vasodilated and the small amount of heating from
NIRS probe has no eect.e only way to exclude this as factor would be
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to leave individuals attached to the monitor throughout the exercise and
post-exercise monitoring period.
2. in the post exercise period subjects are recovering from the exercising state
and experiencing a progressive reduction in cardiac output as they pay o
the oxygen debt. We know from the studies of individual muscle groups,
that StO2 progressively falls to baseline during this period∗. is would
make detecting the small eect of a simultaneously occurring ‘warm-up
eect very dicult.
is study is unable to distinguish between these simultaneously occurring events,
not least because the time interval before starting the post-exercise monitoring
varied between subjects—but this was never one of the study aims. What this study
does demonstrate is that ‘warm-up’ is complete at ve minutes. When performing
experimental studied this should be considered, but waiting ve minutes for a
stable reading defeats one of the main advantages of NIRS and is not practical
for the trauma scenario. However, to put the results into context, the eect of the
‘warm-up’ is at most a 3% change in StO2.is falls only just outside the quoted±1% tolerances of the machine and around one third of a standard deviation of
the deltoid measurement. As such the eect of this phenomenon in the clinical
environment is likely to be negligible.
Comparing the resting and post-exercise StO2 values, there was a statistically
signicant increase in StO2 observed at all sites, which persisted for at least 10
minutes following cessation of exercise.e increase in StO2 was greater in the
brain (+8.6%) and leg (+8.0%) than the deltoids (+3.1%).e reason for this dier-
ence in magnitude of changes between dierent sites is probably multi-factorial.
Firstly the deltoids recorded a higher StO2 at rest and therefore have less room to
increase before being subject to the previously discussed compression eects at
the top end of the scale.e order and type of exercises used in the protocol are
also likely to impact upon the relative increases in StO2.e pull-ups were the rst
exercise to be performed, and although they have an upper body focus, they only
∗e studies of Nagasawa (2008a) and Nagasawa (2008b) suggested that StO2 in exercised muscles
should return to base line within ve minutes of completing exercise, but this is not consistent
with the results presented here where a statistically signicant increase in StO2 was seen to persist
for at least 10 minutes following exercise.
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really involve the posterior deltoid. On average there was a 35 minute time lag
between completion of the pull-ups and the 10 minute point of the post-exercise
monitoring. is may be sucient to allow recovery from the deltoid specic
pull-ups, although it would still be expected that they would show a rise in StO2
as result of the run. is would be consistent with ndings of previous studies
which have demonstrated a rise in StO2 in non-workingmuscles following exercise
(Ogata et al., 2007; Nagasawa, 2008b,a), but what is interesting here, is that eect
persists for considerably longer than the other studies report.is may be a result
of some deltoid work during the pull-up phase interacting with the rise that would
be expected globally from the other two exercise, and it is not possible to separate
these two eects with this study design. It may also be a consequence of this study
targeting a higher workload, i.e./ the subjects’ V˙O2max , or the much greater size of
this study (105 subjects vs the 7–8 subjects used in most other exercise studies)
providing greater power in detecting much smaller changes in StO2. Similarly
the large change in leg StO2 measurement, compared to the deltoids, is probably
at least partly due to this being the last exercise preformed before post-exercise
monitoring, and that the anterior compartment of the leg is intensely worked by
running.
Two subjects recorded leg StO2 values of 15% post-exercise, which represents
the lower limit of the INVOS® System’s range. Both individuals denied any lower
limb symptoms and had no history of chronic exertional compartment syndrome,
both the monitors and probes used on these subjects recorded as expected in
subsequent subjects, and there was no eect of repositioning the leg probes in
these individuals. It is therefore unclear if this data reects a subclinical condition
or an unexplained technical failure with the monitoring, however as the readings
for these individuals atlined at the lower limit of the monitor’s range, it is likely
to be the latter.
e relatively large change in cerebral StO2 is interesting, as it initially appears
counterintuitive to many clinicians, who expect cerebral auto-regulation to min-
imise the changes in oxygen supply to the brain and may attribute this nding
to changes in scalp perfusion. While this may have an eect, the dual-beam al-
gorithm of the INVOS® System should minimise the contributions of the scalp
signal to the overall reading. Cerebral auto-regulation functions to protect the
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brain from reductions in cerebral perfusion, not reduce blood ow in the face of
increased cardiac output. Although exercise does not signicantly increase the
brain’s global oxygen demands, it has been shown to increase regional cerebral
blood ow, believed to be a consequence of increased systemic arterial blood
pressure and cardiac output, and regional metabolic changes(Herholz et al., 1987;
Ide et al., 1999; Ide and Secher, 2000).e increase in StO2 seen here is likely a
reection of this.
Due to the variable period of the post-exercise monitoring, it is not possible
to comment on how StO2 changes during the post-exercise period; nor, due to the
duration of the post-exercise monitoring, is it possible to determine when StO2
returns to baseline. However, this is probably not important in the trauma scenario
for the reason that despite the fact there was a statistically signicant increase in
StO2 value following exercise, nearly all post-exercise StO2 measurements fell
within the resting value range, and the actual increase in StO2 aer exercise was
less than one standard deviation of the resting measurement. It is thus unlikely
that this increase in StO2 following exercise is clinically signicant, at least in the
uninjured normovolaemic patient, however falls in StO2 recorded immediately
following exercise may represent clinical pathology. In the injured patient the
exact eect of interaction between the eects of exercise and the physiological
consequences of varying degrees of hypovolaemia on StO2 are still unknown.
Agewas not associatedwith any dierences in either the resting or post exercise
StO2 measurements.is is at odds with the ndings of Crookes et al. (2005), but
not necessarily surprising, as the study population here was deliberately drawn
from a narrow range.
While performing the study no problems recording StO2 values were en-
countered that could be attributed to skin pigmentation, although only one Black
subject (Fitzpatrick Skin type V) was included in the study, all other subject
were various shade of Caucasian (Fitzpatrick Skin type I–III)∗. Problems were
∗e Fitzpatrick Scale is a numerical grading scale of skin colour based on genetic background
and reaction to sun exposure.ere are six grades: Type I — white, very fair/albino skin (always
burn and never tans); Type II — white, fair (usually burns, tans with dicultly); Type III — Beige
(sometimes burns mildly, tans to light brown); Type IV — Beige with brown tint, Mediterranean
type (rarely burns, tans with ease to moderate brown); Type V — Dark Brown (very rarely burns,
tans easily); and Type VI — Black (never burns, tans easily)
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Figure 7.5: Examples of tattoos over the deltoid region that caused diculty obtaining
StO2 readings during the study. Note the dark pigmentation and dense patterning of the
tattoos (reproduced with permission of the subjects).
encountered obtaining deltoid StO2 reading in several subjects with tattoos over
the monitoring site, requiring slight adjustments of the probe position to obtain a
signal. Tattoos causing problems were typically dense and darkly coloured, see
Figure 7.5 for examples. is is the rst time this problem has been described,
although issues of recording StO2 in dark skinned individuals, due to the light
absorbing and scattering properties of melanin, have been previously reported
(Wassenaar and den Brand, 2005; Shuler et al., 2009). It is likely that dark tattoo
pigments behave in a similar fashion. Given the present popularity for such tat-
toos amongst infantry soldiers, this is an issue military physicians using NIRS,
particularly in the acute setting, should be aware of.
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7.6 conclusion
is work has established reference ranges for resting StO2 in an infantry popula-
tion at three sites likely to be interest to military clinical practice. It has shown that
typical StO2 values dier depending upon the site of monitoring, and that normal
ranges established at one site can not simply be extrapolated to another, unless it
is an identical site on the contralateral side. Despite the dierences observed in
mean StO2, the actual range of values were very similar for all sites. Importantly
an StO2 of 40% appears to represent the absolute lower limit of normality, values
recorded below this in the deltoid, anterior compartment of the leg, or frontal
lobe of the brain are highly suggestively of abnormal physiology. Above 40% the
normal range of StO2 values is wide, which makes interpreting them in the clinical
environment very dicult, and it is likely that trend changes, rather than absolute
values, will be more useful in this situation.
Exercise was associated with a statistically signicant increase in StO2 at all
sites that persisted for at least 10 minutes into the recovery period. However this
change was relatively small, and all post-exercise StO2 measurements fell within
the reference range of the resting values. As such this phenomenon in isolation
is unlikely to cause problems with the interpretation of StO2 values in clinical
practice.
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8. nirs animal trauma and haemorrhage model
e material presented in this chapter formed part of a collaborative work per-
formed in conjunction with the Defence Science and Technology Laboratory
(DSTL), Porton Down. Physiological data used in this chapter is presented cour-
tesy of and by permission of DSTL.
My contribution to this work was developing and writing the NIRS elements of
the study protocol, training other researchers in the NIRS elements of the protocol,
data collection, and all data analysis.
8.1 introduction
Conventionally hypoperfusion in the trauma patient is assessed (at least during
the early stage of resuscitation) against a range of simple clinical signs and basic
physiological measurements. ese include assessments of cerebration, capil-
lary rell, looking for signs of increased sympathetic activity such as pallor and
sweating, and measuring heart rate and blood pressure. While such features have
value when evaluated in the context of the clinical picture, taken alone they lack
specicity or sensitivity.
Blood pressure and heart rate are the simplest objective clinical signs of cardi-
ovascular status and are relied upon by most clinicians assessing volume status in
the trauma patient. Unfortunately the relationship between heart rate and blood
pressure and blood loss is not linear, and is widely misunderstood (Secher and
Bie, 1985). Both heart rate and blood pressure demonstrate a biphasic response
to haemorrhage. Small reductions in central blood volume are associated with a
modest rise in heart rate and a narrowing of the pulse pressure, with or without a
fall in systolic pressure. As the reduction in the central volume approaches 30%,
there is oen a ‘paradoxical’ drop in heart rate, mediated by a Bezold-Jarish-like
vagal reex associated with a loss of peripheral sympathetic activity (Campagna
and Carter, 2003). Further reductions in blood volume are associated with an
increase in heart rate as the patient progresses towards uncompensated shock.
Unfortunately this pattern is not consistent: young or athletic individuals will
oen maintain their blood pressure in the face of signicant hypovolaemia, only
to rapidly fall at the point of decompensation; in the elderly β-blocker may inhibit
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the tachycardia; in the trauma patient sympathetic stimulation as a result of tissue
injury and pain may ‘override’ the baroreex induced relative bradycardia and
lead to an elevation in blood pressure and heart rate. e end result is that the
assessing clinician has little idea where on the biphasic phase response curve the
patient is, or if it will occur at all.
To mitigate the limitations of heart rate and blood pressure a number of other
measurements of volume status are commonly used. Central venous pressure
(CVP) and pulmonary artery catheters provide an accurate means of assessing
volume state.e problemwith CVPmonitoring is that it provides no indication of
cardiac output (CO), and a low CVPmany be a reection of low central volume or
reducedmyocardial contractility— of which trauma is associated with both (Abou-
Khalil et al., 1994; Yang et al., 2004). For this reason it is sometimes suggested
that a pulmonary artery catheter is required to provide the distinction, although it
has been demonstrated that CVP alone can be used to successfully guide trauma
resuscitation (McKinley et al., 2009). Unfortunately the measurement of CVP
and pulmonary artery pressures are invasive, require specialist skills, equipment
calibration and take time to insert, which largely limits their use to the intensive
care or theatre environments.
e principle problem with hypovolaemic shock is organ hypoperfusion, and
the goal of resuscitation is to restore adequate tissue perfusion.erefore measures
of end organ perfusion should provide a good indicator of the patient’s true
resuscitation state. Of all the assessment techniques in common clinical use it is
arterial blood gas (ABG), and in particular lactate and base excess, that have been
shown to correlate most closely with oxygen delivery and utilisation in trauma
patients (Davis et al., 1991; Kincaid et al., 1998). Both parameters have certain
caveats regarding their interpretation in the trauma subject (see Section 1.3.2 for a
detailed discussion), however the main limitation remains a practical one. ABG
measurements are invasive, dicult to draw repeatedly without an arterial line,
and intermittent — providing only a ‘snap-shot’ of the patient’s physiological state
which typically lag behind the true clinical condition. Some of these problems
can be partially ameliorated by using venous samples; and the base excess and
lactate of venous samples have been shown to correlate well with those of arterial
specimens (Davis, 1994). However the need for carefully calibrated equipment to
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process blood gas samples, largely limits their use to the hospital environment.
e idealised tool for assessment of the trauma patient should provide an
accurate measure of end organ perfusion. Parameter values should be recorded
continuously and read o in real time. Ideally the tool would be non-invasive,
robust, compact and easy to use. NIRS meets these practical requirements. It has
been shown to correlate well with volume of blood loss in human and animal hy-
povolaemia models. However the number of conicting studies and the dierent
NIRS algorithms used make interpreting the accuracy of StO2 compared to con-
ventional physiological parameters dicult. In particular the relationship between
StO2 and ABG parameters has not been studied in a controlled haemorrhage
model.
Fluid resuscitation protocols have undergone signicant changes in the last
30 years.e early aggressive blind uid resuscitation protocol, best epitomised
by the old ATLS® guidelines (Amercian College of Surgeons, 1997) have fallen
out of favour. is approach being associated with higher mortality rates than
early hypotensive resuscitation (Bickell et al., 1991; Stern et al., 1993; Solomonov
et al., 2000), or even no uid resuscitation during the prehospital period (Martin
et al., 1992; Bickell et al., 1994). However once in hospital, where denitive means
of haemorrhage control are available, there appears to be no survival benet to
continuing hypotensive resuscitation (Dutton et al., 2002). In fact animal evidence
suggests that prolonged periods of hypotensive resuscitation are associated with an
increase in mortality compared to normotensive resuscitation (Garner et al., 2010).
For this reason British Military practice has adopted ‘novel-hybrid resuscitation’:
one hour of hypotensive resuscitation aer which normotensive resuscitation is
attempted regardless of the patient location or estimated evacuation timelines;
and it is this approach to resuscitation that is modelled in this study.
8.2 aim
e aim of this study was to evaluate NIRS as a tool for assessing global perfusion
and resuscitation in an animal model designed to simulate military trauma and
contemporary resuscitation practices, principally ‘novel-hybrid resuscitation’.e
primary objective was to compare StO2 to ABG measurements and examine the
phase relationship, if any, between these parameters. Secondary objective included
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Figure 8.1: A Large White Sow.
comparing StO2 to conventional physiological assessments; and assessing the eect
of recording StO2 in hypovolaemic subjects from an injured limb.
8.3 materials and methods
e experimental design was that of a prospective animal model study.e study
was performed on terminally anaesthetised Large White pigs (see Figure 8.1),
and conducted in accordance with the Animals (Scientic Procedures) Act 1986.
All experiments took place
, between the period June 2012–July 2013.e chosen model
was one of muscle injury and haemorrhage followed by one hour of hypotensive
resuscitation with crystalloid (simulating the prehospital casualty management)
followed by 21⁄2 hours of normotensive resuscitation with blood products. e
protocol was based on previous studies and model development work described
by Garner et al. (2009, 2010).
8.3.1 Preparation of the Animal Model
Seven Large White pigs ( ) weighing between
48–56 kg were studied.e animals were housed at a indoor facility for
one week before each study where they were fed a wheat-soya based ration at
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1.5–1.7 kg/day and allowed free access to water. Prior to the study the animals were
fasted for 18 hours, but still allowed water freely.
e pigswere sedatedwith intramuscularmidazolamhydrochloride (0.1mg/kg)
before gaseous induction with 5% isourane via a ‘snout-mask’.e animals were
intubated and anaesthesia maintained with isourane in nitrous oxide and oxygen
with the FiO2 maintained at 0.33.e le carotid artery and vein were canulated
with an 8F gauge intravenous line, aer which anaesthesia was maintained us-
ing a total intravenous anaesthesia (TIVA) technique with alfaxalone (Alfaxan®,
Ventroquinol UK Ltd, UK), at a rate of 50–200µg/kg/min. e animals were
weaned o isourane and allowed to breath spontaneously for the remainder of
the experiment.e right internal jugular vein and le femoral artery and vein
were canulated. A ow directed balloon tipped catheter (Swan-Ganz catheter) was
passed via the right internal jugular vein, and the pressure changes at the catheter
tip were monitored to conrm positioning in the pulmonary artery.
Following preparation with povidone-iodine solution a midline laparotomy
was performed.e spleen was pre-contracted by topical application of adrenaline
soaked gauze prior to splenectomy∗. A 14F gauge suprapubic catheter was placed in
the bladder and used to drain the bladder at hourly intervals to prevent autonomic
responses associated with bladder distension.e abdomen was then closed with
a mass closure technique. Temperature was monitored throughout the experiment
and maintained at approximately 38°C through the use of warming blankets or
the application of external cooling.
8.3.2 Experimental Protocol
e framework for experimental timeline is shown in Figure 8.2. Approximately
one hour following laparotomy baseline physiological measurements were taken.
e animals were then subject to a controlled muscle trauma by the application of
four shots with a penetrating captive bolt pistol to the right hind leg, the location
of the shots is shown in Figure 8.3.e shots were angled so as to cause only so
tissue trauma and avoid bony injury. Immediately aer the shots the animals were
subject to a controlled haemorrhage of approximately 35% of total blood volume at
∗Splenectomy is necessary in the porcine model to prevent autotransfusion by splenic contraction,
which is a prominent response to hypotension (as part of the broader contraction in the splanchnic
circulation) in pigs but less important in humans.
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Shock
Phase
Hypotensive
Resuscitation
Normotensive
Resuscitation
40 Minutes
B2B1 Muscle 
Trauma
R210R0
60 Minutes
R60
150 Minutes
Haemorrhage Start
10 Minutes{
Figure 8.2: Animal haemorrhage and trauma model experimental timeline and key time
points. B1 and B2 denote baseline ABG sampling points. Rx denotes time aer start of
resuscitation protocol.
an exponentially decreasing rate designed to simulate major arterial haemorrhage.
e rate of blood loss was in accordance with the following formula:
V = Bo × (1 − e−0.04t)
where V equals the total blood loss (in mL/kg) at time t, and Bo is the estimated
total blood volume of the animal described by the formula:
Bo = 161.4751 ×W−0.2197
whereW is the body weight of the animal in kg (Garner et al., 2010).
e total duration of haemorrhage was approximately 10 minutes aer which
the animal was subject to a 30minute shock phase, with a target systolic blood pres-
sure of 60 mmHg maintained by saline infusion at a rate of 3 mL/kg/min to a max-
imum total volume of 500 mL. Aer this the animal received a 60 minute period
of hypotensive resuscitation with a target systolic blood pressure of 80 mmHg
maintained by resuscitation with saline.is period was designed to simulate the
resuscitation strategy and timelines of the prehospital military environment. Aer
60 minutes the animal entered the ‘hospital resuscitation phase’, and was resuscit-
ated to a ‘normotensive’ target blood pressure of 110 mmHg with crossmatched
packed red cells and plasma in a 1:1 ratio, drawn from DSTL’s animal blood bank.
Normotensive resuscitation was performed for 2 1⁄2 hours, aer which the animal
was killed with an intravenous overdose of sodium pentobarbitone.
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Figure 8.3: Site of application of shots (shown in yellow) with the penetrating captive bolt
pistol to produce a controlled muscle injury.
8.3.3 Physiological Measurements and NIRS Monitoring
Heart rate was monitored by electrocardiogram electrodes placed on the ventral
surface of the animal, and non-invasive SpO2 by a pulse oximeter probe attached
to the tail. Arterial blood pressure was monitored invasively via the carotid artery
cannula using a strain gauge manometer (Sensonor 840, SensoNor, Norway),
and central venous pressure (CVP) monitored via the right internal jugular vein
with the pressure transducer zeroed at the level of the heart. e Swan-Ganz
catheter was used to record pulmonary artery pressure and estimate the cardiac
output (CO), recorded as six minute rolling average. Arterial and venous blood
gas samples were drawn o in heparinised syringes from the femoral lines at xed
intervals according to the schedule in Table 8.1, and analysed using a Gem Premier
3000 Blood Gas Analyser (Instrumentation Laboratories, Warrington, UK).
StO2 measurements were taken at six second intervals from both the injured
and uninjured hind legs using an INVOS® System NIRS monitor in a two channel
conguration. e probes were positioned over the mid-portion of the lateral
aspect of the upper leg with the probe/cable connection directed distally. To
ensure accurate reading the hair over the probe site was shaved prior to probe
attachment, and further secured with medical tape to achieve rm adhesion and
exclude extraneous light.
8.3.4 Data Acquisition and Collection
Cardiovascular data was recorded continuously using a computerised data acquis-
ition system (Maclab 8/s, ADInstruments, Oxford UK); and associated soware
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Time (mins) Sample Comments and Timing
5 B1 Baseline measurement
15 B2 Second baseline taken 10 minutes aer B1
30 PREINJ Taken 15 minutes aer B2 and 5 minutes before delivery of
leg shots
65 H1 Taken approximately 25 minutes aer start of haemorrhage
80 H2 Taken approximately 40 minutes aer start of haemorrhage
(Immediately before start of resuscitation protocol)
95 R15 Taken 15 minutes aer start of resuscitation protocol
110 R30 Taken 30 minutes aer start of resuscitation protocol
125 R45 Taken 45 minutes aer start of resuscitation protocol
140 R60 Taken 60 minutes aer start of resuscitation protocol
(end of hypotensive resuscitation phase)
155 R75 Taken 75 minutes aer start of resuscitation protocol
170 R90 Taken 90 minutes aer start of resuscitation protocol
200 R120 Taken 120 minutes aer start of resuscitation protocol
230 R150 Taken 150 minutes aer start of resuscitation protocol
260 R180 Taken 180 minutes aer start of resuscitation protocol
290 R210 Taken 210 minutes aer start of resuscitation protocol
Table 8.1: Timing of ABG samples.
(Chart v4.2.3, ADInstruments) used for data extraction and analysis. Cardiovas-
cular data was read o at 12 second intervals during the shock and hypotensive
resuscitation periods, and at one minute intervals during all other parts of the ex-
periment. ABG data was read directly from the blood gas analyser, the machine’s
clock having previously been synchronised with the main data acquisition system.
To ensure synchronisation between cardiovascular data and StO2 measure-
ments a synchronised event stamp was inserted into the output of both systems.
e StO2 data was then exported using the schema described in Sections 5.2 and 5.3
and the NIRS timestamps adjusted in a spreadsheet application to correct for the
time dierence between the two data acquisition systems.
8.3.5 Data Analysis
Cardiovascular andABGdatawerematched to the nearest corresponding timestamp
in the NIRS dataset using a custom AWK script. e six second sampling fre-
quency of the NIRS data meant that the time discrepancy between the dierent
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datasets would never be more than three seconds. Tests of normality were per-
formed using Q-Q plots and a Shapiro-Wilks test. Non-parametric comparisons
of means between two groups was performed using a Wilcoxon signed-rank test.
Non-parametric comparisons betweenmultiple groups was performed using Fried-
man’s ANOVA.
To perform the time lag analysis between ABG measurements and other
physiological variables the data was rst standardised. Spline interpolation was per-
formed on the ABG data to produce a continuous curve which was compared by
cross-correlation to other physiological parameters.e time dierence between
parameters at the point ofmaximal correlation, i.e. the time lag, and the correlation
coecient at that point, were recorded for each analysis.
All statistical tests were undertaken using R (RDevelopment Core Team, 2009)
with a signicance threshold of p≤0.05.
8.4 results
Seven animals weighing between 48–56 kg (mean 51.7 kg) were studied. All animals
completed the whole of the study protocol.
8.4.1 Baseline Measurements
Summary data for baseline values from B1 and B2 for key physiological meas-
urements are presented in Table 8.2. Baseline StO2 values were not normally
distributed when analysed with a Q-Q plot or Shapiro-Wilks test, and therefore a
comparison of means was performed with a Wilcoxon signed-rank test.e mean
StO2 was 5.7% greater in le (control) limb compared to the right (injured), how-
ever this dierence was not signicant in either the B1 (p=0.057) or B2 (p=0.106)
data.
8.4.2 Eect of the Hypovolaemia Protocol
e eect of the hypovolaemic protocol on StO2 is shown on a per animal basis in
Figure 8.4, and for all combined measurements in Figure 8.5. In all cases StO2 fell
sharply in both limbs at the start of the shock phase. Hypotensive resuscitation
was associated with a modest rise in StO2 in most animals improving throughout
the duration of the phase. In the majority of animals the start of normotensive
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Mean Median Range s.d.
NIRS StO2 Le (%) 67.3 65.5 59.0–81.0 7.4
StO2 Right (%) 61.6 62.5 52.0–69.0 5.6
Haemodynamic HR (bpm) 154 159 134–168 12
Measurements SBP (mmHg) 164 161 151–184 9
DBP (mmHg) 128 126 120–139 7
MAP (mmHg) 143 142 134–159 8
CVP (mmHg) 3.38 3.17 2.44–5.35 0.78
CO (l/min) 7.70 7.59 7.08–8.89 0.56
ABG Hb (g/dl) 12.2 12.3 11.6–13.0 0.4
Parameters pH 7.43 7.44 7.37–7.45 0.02
HCO3 (mM) 32.52 32.80 29.20–35.00 1.60
BE (mEq/l) 7.78 8.10 4.50–10.10 1.68
Lactate (mM) 1.16 0.90 0.70–3.10 0.75
Table 8.2: Descriptive statistics for baseline values of the main physiological parameters.
Data has been calculated from the combined values of the B1 and B2 sampling points (HR
= heart rate; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean
arterial pressure; CVP = central venous pressure; CO = cardiac output; BE = base excess).
resuscitation coincided with a rapid increase in StO2. Two animals demonstrated
signicant deviation from this pattern.e trace in animal 1 shows a rise in StO2
in the le limb during the shock phase with little response during normotensive
resuscitation. In contrast the right limb in this animal appeared to at-line for
most of the shock and hypotensive resuscitation phases but otherwise followed
a similar pattern to other animals. Examination of individual data points from
the right limb during this stable period demonstrated a static StO2 of 37%, which
would suggest a technical error in NIRS recordings since even ‘stable’ recordings
usually demonstrate some noise. Animal 2 demonstrated a swi StO2 drop in
both limbs at the start of the shock phase but little response to either hypotens-
ive or normotensive resuscitation.e StO2 during these periods continued to
demonstrate variability and noise, suggesting that these are true values.
Examining Figure 8.5 it can be seen that StO2 recorded from the le limb
was greater than the right limb for the duration of the experimental protocol.
Comparison of raw StO2 data from the le and right limbs for the whole of the
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Figure 8.4: StO2 in each limb by animal. e experimental phase is denoted by the
background colour: shock phase; hypotensive resuscitation (with saline); and normotens-
ive resuscitation (with whole blood). Note to remove noise in the dataset and improve
readability, data has been plotted as a LOESS curve.
experimental protocol conrmed a signicant dierence of approximately 3.6%
between the limbs (p<0.0001).
Mean values for the key physiological parameters at the ABG sampling points
are shown in Table 8.3, and selected parameters are graphed in Figures 8.6 and 8.7.
All physiological andABGparameters demonstrated signicant dierences between
the four phases of the experiment (baseline, haemorrhage/shock, hypotensive re-
suscitation and normotensive resuscitation) compared using measurements from
the representative time points B1, H2, R45 and R150 respectively), p<0.01 for all
comparisons (Friedman’s ANOVA).
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Figure 8.5: Mean StO2 for all animals during the course of the protocol.e 95% condence
interval for the data is shown in grey.
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Figure 8.7: Mean values for the main ABG parameters over the course of the protocol.
Parameter values are expressed in the respective unit for that parameter: Bicarbonate
(HCO3) mM; Base Excess (BE) mEq/l; lactate (mM). Note at ABG parameters appear to
change prior to the shock phase, this is an artefact of ABG recording intervals rather than
a physiological phenomena.
8.4.3 Correlation Between Physiological Parameters
A correlation matrix for the main physiological parameters is shown in Table 8.4,
demonstrating strong correlations between most measurements.e correlation
between the StO2 data recorded from the le and right limbs was rs=.75 (p<0.0001)
for the raw (noisy) data, rising to rs=.94 (p<0.0001) when comparing smoothed
data with the noise removed (eectively a comparison of the curves presented
in Figure 8.5). NIRS measurements correlated well with most other parameters
although recordings from the le limb tended to demonstrate a stronger correlation
than those from the right. Both StO2monitoring sites had similar correlations with
all blood pressure recordings (rs=.70–.79, p<0.0001) and also strongly correlated
with CO (rs=.73–.78, p<0.0001). Le limb StO2 demonstrated amodest correlation
with all ABG parameters (all p<0.05), except for pH for which there was only a
weak correlation (rs=0.29). Similar, but slightly weaker, correlations were seen
in the right limb StO2 values.e relationship between blood pressure and ABG
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parameters was similar to that of StO2, but the correlation slightly stronger (all
p<0.05). Of the blood pressure measurements DBP demonstrated the strongest
correlation with ABG parameters and SBP the weakest.
All ABG parameters were very strongly correlated with each other (rs=.87–.98,
all p<0.0001). ABG measurements were the only variables to show a strong cor-
relation with Hb. ere was no signicant relationship between Hb and either
le (rs=.13, p=0.19) or right limb StO2 (rs=.05, p=0.59). Of the standard haemody-
namic measurements DBP and to a lesser extent MAP were the only parameters
to demonstrate a signicant correlation with Hb (rs=.46, p<0.0001 and rs=0.37,
p=0.0002 respectively), although these correlations were quite modest.
8.4.4 Eect of Limb Injury on StO2
Table 8.5 presents summary statistics for StO2 values during the three periods most
relevant for interpreting the eects of limb injury on StO2:
1. prior to limb injury (using values from one minute either side of the PREINJ
sampling point)
2. aer limb injury but before haemorrhage (using those values in the two
minute interval immediate before haemorrhage)
3. for the duration of the hypovolaemia (including the haemorrhage phase)
and resuscitation protocol
StO2 measurements from the le limb (control) were approximately 5.5%
greater than the right limb (injured) prior to injury.is is a similar relationship
to that seen at the baseline sampling points, however unlike the B1 and B2 points
this dierence was statistically signicant, p<0.0001.is dierence was reversed
during the period following limb trauma in the period prior to haemorrhage with
the right limb StO2 being approximately 1.7% greater than the le limb, p<0.0001.
is dierence reversed again during the rest of the protocol with le limb StO2
being on average 3.3% greater than the right limb, p<0.0001.
e dierences between the limbs during the pre-injury phase meant that the
le limb could not reliably be used as a control to assess the eect of limb injury
on StO2 values recorded from the right limb, and the only comparison that could
be made was between the right limb StO2 values before and aer injury, but before
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Mean Median Range s.d.
Prior to limb injury
StO2 Le (%) 67.5 66.0 55.0–89.0 7.3
StO2 Right (%) 62.0 62.0 51.0–74.00 5.4
Post limb injury
StO2 Le (%) 63.2 62.0 53.0–71.0 7.1
StO2 Right (%) 64.9 65.0 54.0–76.00 6.6
During hypovolaemia protocol
StO2 Le (%) 53.0 54.0 33.0–73.0 7.9
StO2 Right (%) 49.7 51.0 33.0–75.0 9.2
Table 8.5: Summary statistics for all StO2 values from the periods prior to limb injury,
aer limb injury but before haemorrhage, and for the duration of the hypovolaemia and
resuscitation protocol.
haemorrhage. Injury was associated with a signicant increase in StO2 in the right
limb, by 2.9±1.2%, p<0.001.is change occurred during a period when the StO2
in the le (control) limb fell signicantly by 4.2±1.3%, p<0.0001.
8.4.5 Phase Relationship Between Physiological Parameters
Comparing Figures 8.5, 8.6 and 8.7 it can be seen that all parameters followed
a similar pattern in their response to the hypovolaemia protocol, however the
ABG curves lagged behind the StO2 and blood pressure curves. is is most
obvious comparing the initial descent curves during the haemorrhage phase and
the location where the curves ‘bottom out’ — shortly aer the 100–110 minute
point in the StO2 and blood pressure curves but around the 140 minute in the
HCO3 and BE curves.
To formally assess the time lag a cross-correlation analysis was performed
comparing StO2 and haemodynamic parameters to the principal ABG measure-
ments.e results of the cross-correlation, showing the time lag at which maximal
correlation occurred and the correlations coecient at that point, are shown in
Table 8.6. It can be seen that ABG measurements phase lagged all other physiolo-
gical parameters.is lag was greatest for pH (between 37–52 minutes, mean 47
minutes), lag times were similar for base excess (between 18–32minutes, mean 26.7
minutes) and lactate (between 23–37 minutes, mean 29.7 minutes). Diastolic blood
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Physiological Variable Correlation Coecient Lag (minutes)
pH Le StO2 0.69 52
Right StO2 0.69 52
Heart rate -0.60 46
Systolic Blood Pressure 0.67 52
Diastolic Blood Pressure 0.73 37
Mean Arterial Pressure 0.71 43
Base Excess Le StO2 0.69 31
Right StO2 0.67 32
Heart rate -0.63 24
Systolic Blood Pressure 0.66 32
Diastolic Blood Pressure 0.78 18
Mean Arterial Pressure 0.74 23
Lactate Le StO2 -0.65 36
Right StO2 -0.63 37
Heart rate 0.59 27
Systolic Blood Pressure -0.65 37
Diastolic Blood Pressure -0.75 23
Mean Arterial Pressure -0.72 28
Table 8.6: Results of a cross-correlation analysis comparing haemodynamic and StO2
data to the principle ABG measurements (pH, base excess and lactate).e maximum
correlation and the point at which this occurred for each comparison are presented.
pressure demonstrated the greatest maximum correlation with ABG parameters,
followed by mean arterial pressure and then StO2. Heart rate demonstrated the
lowest correlation with the principle ABG measurements of all the parameters
assessed.
8.5 discussion
Examining the StO2 response to the study protocol, most obviously demonstrated
in Figure 8.4, it can be seen that StO2 values responded quickly and appropriately
to each phase of resuscitation protocol. In all cases there was an immediate fall
in StO2 in both limbs in response to haemorrhage.e response to hypotensive
resuscitation was muted but overall there was a modest increase in StO2 which
rose sharply in most animals at the start of the normotensive resuscitation phase,
but quickly plateaued thereaer.is clearly demonstrates the utility of NIRS in
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tracking the patient’s response to major haemorrhage and immediate resuscita-
tion, however once the patient is adequately resuscitated it is unclear how NIRS
may be used to guide further management other than in detecting signicant
deteriorations.
Although most animals followed the same general trend of NIRS recordings,
two animals demonstrated a noticeable deviation from this. In Animal 2 there was
a large drop in StO2 during the haemorrhage/shock phase, and a small increase
with hypotensive resuscitation aer which the StO2 plateaued at low levels.e
response of the other physiological parameters to the experimental protocol for
this animal also demonstrated a similar pattern, suggesting that this animal appears
to have had a poor response to resuscitation rather than there being an isolated
problem with NIRS monitoring. Animal 1 showed a rise in the le limb StO2
part way through the haemorrhage phase.is change was also seen in the pulse
rate (which decreased) but was not reected in the blood pressure traces. e
right limb StO2 measurements demonstrated almost no response aer the initial
haemorrhage to either shock or hypotensive resuscitation. Examining the raw data
from this period it was observed that the StO2 atlined at 37% for this period.is
would strongly suggest there was a technical problem with the NIRS recording
since, as can be appreciated from examining other traces, even when StO2 values
are stable there is always some noise in the signal. is illustrates one of the
problems with the current generation of NIRS devices — that they give little
indication of when they are not recording correctly. Although a at line trace is
obvious in retrospect, it may not be appreciated for some time in a real life clinical
scenario.is presents a strong argument for monitoring two sites simultaneously;
if the traces start to diverge and one site is recording seemingly stable values this
may be an early indicator of technical problem with that probe or monitoring site.
e novel nding of this study is a formal demonstration of the lag time
between haemodynamic and NIRS measurements, and ABG recordings. Whilst it
is well known that it takes time for physiological disturbance to be reected in the
ABG measurements, the size of the lag between haemodynamic and ABG record-
ings has been largely unstudied.e ABG parameters of primary interest were
base excess and lactate, since these are the ones which have been previously shown
to most closely correlate with anaerobic metabolism in trauma patients (Davis
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et al., 1991; Kincaid et al., 1998). For completeness pH was also analysed, which
demonstrated signicantly greater lag times than base excess or lactate, and lower
correlations with other physiological parameters.is occurs probably as a result
of compensation in the spontaneously breathing porcine model. Base excess and
lactate demonstrated broadly similar lag times for all comparisons with haemody-
namic parameters and StO2. Diastolic blood pressure had the shortest lag time
and the greatest maximal correlation for comparisons with both base excess (r=.78,
with a lag of 23 minutes) and lactate (r=-.72, with a lag of 28 minutes). Mean
arterial pressure demonstrated the next highest maximum correlation, which is
not necessarily surprising since it is derived from the diastolic blood pressure.
Both StO2 monitoring sites had a similar lag time and correlation for base excess
(r=.67–.69, with a lag time of 31–32 minutes) and lactate (r=-.63– -.65, with a lag
time of 36–37 minutes). Heart rate demonstrated the lowest maximal correlation.
Although diastolic blood pressure demonstrated the highest time lagged cor-
relation, as has been discussed blood pressure monitoring has signicant practical
limitations when applied in the acute trauma setting — principally the dicultly
of obtaining frequent readings without an arterial line. NIRS does not suer from
this problem, providing a non-invasive, continuous, real time means of monit-
oring resuscitation.e same argument can be made for heart rate monitoring,
although as discussed previously heart rate response in trauma is subject to mul-
tiple confounding factors, and it had the weakest (but still reasonable) time lagged
correlation of all the parameters in this study.
Tissue injury is known to cause an increase in StO2 in the aected muscle due
to a presumed hyperaemic eect.e rise in StO2 values seen immediately aer
the controlled muscle injury (but before the start of haemorrhage) in the injured
limb suggests that this eect occurs within a matter of minutes. Despite the eect
of injury, the right limb accurately tracked the physiological changes during the
protocol in a similar fashion to the uninjured le limb, the correlation between
the two limbs being rs=.75. is correlation may not be as high as expected
for identical sites, but much of the discrepancy is probably accounted for by
the degree of noise in the raw StO2 measurements (illustrated in Figure 8.8).
When the analysis was repeated with the noise removed (in eect a comparison
between the curves presented in Figure 8.5) the correlation rose to rs=.94.ese
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Figure 8.8: An example of raw StO2 data (yellow) recording from the le leg of animal 3,
with the same data smoothed as LOESS curve (red), demonstrating the high signal noise
of the NIRS trace when recorded with a six second frequency.
results demonstrate that an injured limb can be used to accurately monitor StO2
changes in the hypovolaemia patient, and that the hyperaemic response to injury
is apparently ‘overridden’ by the eects of hypovolaemia. Unfortunately it is
dicult to fully assess the eects of limb injury on StO2 during hypovolaemia as
there were signicant dierences in StO2 between the injured and control limbs at
the PREINJ point.e uninjured limbs on average recording an StO2 5% higher
than the control limbs, which is much larger than the 1% dierence demonstrated
between identical contralateral sites in the normal NIRS values and response to
exercise study (see Chapter 7). Dierences in StO2 values between the le and right
limb were also observed at the baseline measuring points (B1 and B2), although
unlike those at the PREINJ point these were not signicant. It is therefore possible
that the dierences seen at the PREINJ point represent a type I error. Another
explanation is that it is a consequence of the insertion of a femoral line on the le
side, which may account for why the uninjured limb StO2 measurements were
paradoxically higher than those of the injured limb. Unfortunately the use of
a femoral line was an unavoidable part of the experimental protocol. To avoid
committing any errors in interpretation, the le limb was therefore not treated as
control for assessing the eect of injury on StO2 values during the protocol.
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Haemoglobin concentration had no meaningful correlation with StO2 values,
r=.13 for the le limb and r=.05 for the right, and at best only a weak correlation
with other non blood gas measurements.is is not surprising since haemoglobin
concentration is not an indicator of resuscitation, but the particularly poor cor-
relation with StO2 serves to illustrate a commonly misunderstood point: StO2 is
a measure of the ratio of oxygenated to deoxygenated haemoglobin, and is not
dependant on the haemoglobin concentration per se.
8.6 conclusion
is work has demonstrated that NIRS can be used to detect signicant degrees of
blood loss and monitor the response of hypovolaemic subjects to initial resuscit-
ation. StO2 values recorded from injured limbs are able to adequately track the
response to haemorrhage and resuscitation, despite the hyperaemic eect of limb
injury reported in normovolaemic subjects.
StO2 measurements phase led changes in base excess and lactate by 31–37
minutes. Although diastolic and mean arterial blood pressure correlated most
strongly with ABGmeasurements, StO2 also performed well (and better than heart
rate), and has signicant practical advantages over conventional haemodynamic
parameters used in the assessment of hypovolaemic patients.
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9. nirs trauma resuscitation study
9.1 introduction
Despite the good body of work examining NIRS as a tool for assessing blood loss
in hypovolaemia models there have been relatively few clinical studies in trauma
patients. In an early small study (n=8), McKinley et al. (2000) demonstrated that
deltoid muscle StO2, but not subcutaneous StO2, was highly correlated to systemic
oxygen delivery index (DO2I), and outperformed conventional haemodynamic
parameters. Subsequent studies almost exclusively used thenar eminence StO2
in their assessment of the trauma patient. Crookes et al. (2005) attempted to use
thenar eminence StO2 to identify degrees of shock in 145 trauma patients — the de-
gree of shock being determined by conventional haemodynamic parameters.ey
found that although NIRS could identity patients in the most severely shocked
group it was unable to distinguish between lesser degrees of shock. In two sub-
sequent studies by the same group thenar StO2 was recorded for 24 hours in 383
major trauma patients. It was found that the lowest recorded StO2 values within
the rst hour of admission could identify patients likely to develop MODS with a
sensitivity of 78% and specicity of 39%.e negative predictive value of StO2 was
91%, but the positive predictive value was only 18% and NIRS was not found to
perform any better than conventional measures of perfusion status (Cohn et al.,
2007). In a subgroup analysis of the patients who underwent massive transfusion,
StO2 was the only factor shown to predict MODS or death consistently at one, two
and three hours aer admission. Although NIRS was unable predict the need for
massive transfusion in this group (Moore et al., 2008).
ere have been two studies of NIRS in the deployed military environment,
both in Iraq. e rst of these was a report of a small case series (n=8) which
demonstrated that NIRS could be used in the deployed setting and suggested
that StO2 measurements below 70% accurately tracked the patients’ response to
resuscitation (Beilman and Blondet, 2009). In a study of 147 combat causalities,
thenar StO2 measurements were recording during initial resuscitation in ED to
determine if NIRS might have a triage role.enar StO2 values were not found to
be a useful predictor of the need for ‘life-saving intervention’ or transfusion. But
in the cohort of patients with a systolic blood pressure greater than 90 mmHg it
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did predict the need for transfusion, leading the authors to conclude that NIRS
may have a triage role in those patients who initially appear haemodynamically
stable (Beekley et al., 2010).
One of the principle problems with these studies is that they have all, with
one exception, used StO2 values recorded from the thenar eminence. As has been
demonstrated by the experimental evidence presented in Chapter 6 the thenar
eminence is not the most sensitive site for detecting hypovolaemia. Furthermore
the IED related blasted injuries that have characterised military deployments in
Afghanistan in the early part of the 21st century oen result in injuries to the
thenar eminence rendering it an unsuitable monitoring site in these cases. Soller
et al. (2008a), Bezemer et al. (2009) and the evidence presented in Chapter 6
demonstrated the forearm to be the most sensitive site for detecting hypovolaemia.
Unfortunately the forearm suers from the same practical limitation as the thenar
eminence of being frequently injured by IEDs.erefore in this study the deltoid
was selected as the primary monitoring site. Although not as sensitive as the
forearm, it has been shown to be able to detect relatively small changes in volume
state, and it is unlikely that signicant bilateral injuries/amputations of the deltoid
would occur in the presence of a survival injury pattern.
9.2 aim
e aim of this study was to test NIRSmonitoring in a deployedmilitary setting on
patient cohort with a high injury burden and identify any practical constraints to
its use in the military environment. Secondary aims included comparing deltoid
StO2 to ABG parameters with a view to assessing if the phase relationship between
StO2 and BE and lactate reported in Chapter 8 could be demonstrated in seriously
injured human trauma patients. Cerebral StO2 was also monitored to determine
how this responded in severe trauma and evaluate its relationship to deltoid StO2.
9.3 materials and methods
e experimental design was that of a single centre, prospective, observational,
cohort study. Ethical approval was obtained out of committee from the Chairman
of the Ministry of Defence Research Ethics Committee (MoDREC).e study was
conducted at the Role 3 facility, Camp Bastion, Afghanistan between the period 21
October 2010 to 15 October 2011.
130
9.3. materials and methods
Role 3, Camp Bastion was originally tented, but during the time of this invest-
igation it was established as a hard standing facility serving allied forces in the
Helmand province and extended areas of Southern Afghanistan. e hospital
was a tri-service, multinational facility with consultant level specialists in gen-
eral surgery, orthopaedic surgery, plastic surgery, emergency medicine, general
medicine and radiology. Despite the multinational nature of the facility all care
was delivered withing a UK clinical governance framework. During the period
of study, the hospital had four major trauma bays in the ED, a four table theatre
capacity, eight bedded ITU and two general wards with additional isolation and
overow capacity.
9.3.1 Study Population
Eligible for inclusion in the study were all patients admitted to Bastion Role 3 facil-
ity, as a trauma alert, who were managed either in Trauma Bay One (the primary
trauma bay) or by ‘right turn∗ ’ directly into theatre. e following exclusion
criteria were applied:
1. patients with signicant injuries to both deltoids or those with bilateral
humeral fractures — due to the potential for inference of such injuries with
the StO2 recording.
2. patients judged by the duty surgeon or anaesthetist to be obviously not T1†
upon arrival in the Emergency Department (ED). If there was any ambiguity
about the patients’ treatment priority upon arrival there were enrolled in
the study.
3. patients aged 16 years or under.
9.3.2 Materials
StO2 measurements were recorded with an INVOS® System NIRS monitor in a
two channel setting. During the study it was found necessary to use the INVOS®
∗ ‘Right turn’ was the term adopted for critically unstable patients who bypassed ED and went
straight to theatre for simultaneous resuscitation and surgery. It was named aer the layout of the
department with theatres being accessed through a door on the right upon entering the ED.
†T1 is one of the ve patient treatment priority categories dened by NATO and British Military
doctrine.e T1 category describes patients requiring immediate, life saving treatment. A detailed
description of treatment categories is given in Appendix E
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System monitor with a bespoke power cable encompassing a surge protector to
protect the machine from the unstable power supply in Camp Bastion. Blood gas
measurements were taken using an i-STAT® System hand-held blood gas analysis
unit (Abbott Point of Care, Princeton, USA). Pulse rate, blood pressure and SpO2
(measured as a routine part of patient care) were also recorded.
To ensure data integrity, prior to any monitoring a clock synchronisation
between all monitoring apparatus and other sources of time-stamped data was
performed.is included:
• INVOS® System Monitor
• wall clocks in ED and theatres
• i-STAT® System hand-held blood gas analysis units in ED, theatres, ITU and
the laboratory
9.3.3 Monitoring Protocol
Monitoringwas initiated upon patient arrival in trauma bay one in ED, or in theatre
for ‘right turn’ patients. It was continued for 12 hours aer arrival in the Intensive
erapy Unit (ITU) or ward, or up until the point of casualty evacuation from the
facility, which ever was sooner. If during the ITU monitoring phase the patient
returned to theatre, this was considered a further signicant physiological insult
and the monitoring period extended for an additional 12 hours aer returning to
the ITU or ward.
All patients underwent continuous StO2 monitoring from one deltoid site
with or without monitoring of cerebral StO2—which was not performed in cases
of head/scalp injuries over the cerebral monitoring site. Deltoid measurements
were recorded on channel one of the NIRS machine and cerebral StO2 on channel
two. By default StO2 recordings were taken from the le hand side unless there
was an injury to that side precluding monitoring. Where the skin overlying the
monitoring site was contaminated with blood or dirt the site was cleaned with
chlorhexadine before siting the probe.e positions of the NIRS probes at each
anatomical site were identical those used in the previous studies (see Figure 5.3,
page 64):
1. the deltoid muscle— recorded with the probe positioned two nger breadths
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Management Period ABG Frequency
Initial resuscitation in ED Every 15 minutes
Operating theatre management Every 15 minutes
ITU management Every 15 minutes for the rst hour
Hourly aer the rst hour
Table 9.1:e proposed ideal protocol for frequency of ABG measurements.
above the deltoid insertion with the probe/cable connection directed crani-
ally. If the le deltoid was injured then the right deltoid was monitored. If
both deltoids were injured then the patient was excluded from the trial.
2. the frontal lobe of the brain— recorded with the probe positioned one nger
breadth above the orbital ridge with the probe/cable connection directed
laterally and the distal end of the probe positioned approximately in the
midline. If the le side of the forehead or frontal lobe of the brain was
injured then right side was monitored. If both sides were injured the brain
was not monitored but the patient remained in the study with just deltoid
monitoring.
At times when patients were moved, i.e. between ED to theatres, theatres to
ITU, or to the CT scanning room, it was necessary in some circumstances to detach
the INVOS® Systemmonitor to facilitate transport. Monitoring was recommenced
as soon as possible aer completing the transfer.
Regular ABG measurements were taken targeted to the idealised protocol
outlined in Table 9.1. In practice, clinical and environmental constraints (in partic-
ular limited personnel, and cartridges for the i-STAT®) limited the frequency with
which ABG measurements could be taken.
All other standard physiological parameters (i.e. pulse rate and blood pressure)
were recorded as a routine part of patient care, whichwere extracted retrospectively
from the patient records.
9.3.4 Data Collection
Patient demographic information was collected contemporaneously along with
basic clinical details, and recorded on a study specic template along with ABG
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Field Comment
Hospital number
Sex Male | Female
Date of Birth
Age Calculated from date of birth
Nationality
Date and time of injury Local time
Date and time of arrival in ED Local time
Date and time of arrival in theatre Local time
Date and time of arrival in ITU Local time
Mechanism of injury IED | GSW | RTA | Assault | Accident
Injuries sustained By region
Haemoglobin Recorded against time sampled
ABG Data Recorded against time sampled
Haemodynamic parameters Pulse rate | Blood pressure
Table 9.2: Data elds used in the study.
data. NIRS data was recorded on the machine’s USB stick and subsequently trans-
ferred to CD-R. Photocopies of the ED charts, intra-operative anaesthetic charts
and ITU documentation along with the CD containing the NIRS data were mailed
back through a secure military system to the Royal Centre for Defence Medi-
cine (RCDM) where physiological data was manually extracted to a spreadsheet.
A summary of the data elds for which information was collected is shown in
Table 9.2.
9.3.5 Data Analysis
Comparison of non-parametric distributions was performed using a Wilcoxon
signed-rank test. Comparison of multiple non-parametric distributions was per-
formed using as Kruskal-Wallis test.
All statistical tests were undertaken using R (RDevelopment Core Team, 2009)
with a signicance threshold of p≤0.05.
9.4 results
A total of 71 patients were enrolled in the study. Due to the practical constraints
of collecting data in a deployed multinational operational clinical environment
many datasets were found to be of poor quality, lacking either sucient ABG or
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standard physiological measurements to allow meaningful interpretation. Aer
examining the datasets, 20 subjects were found to have sucient data for analysis.
9.4.1 Demographics of Study Population and Injury Burden
Of the subgroup of 20 subjects all were male with a mix of nationalities: six British;
ve Americans; and nine local nationals. Ages were not recorded for 5 subjects
(for the Afghans age is oen not known and usually estimated), but of the age data
available the mean age was 25.4 years with a range of 16∗–54 years.
e injury mechanism was by IED in 18 cases and gunshot wound in two cases.
A summary of the principle injuries in each patient by anatomical location are
shown in Tables 9.3 and 9.4. Twelve patients suered major traumatic lower limb
amputation or required completion amputation, nine of which were bilateral. Ten
patients underwent laparotomy either for primary injury or to obtain vascular
control for a high amputation. Two patients required thoracotomy.
e overall injury burden was extremely high. ISS (injury Severity Score) and
TRISS (Trauma Injury Severity Score) predicted mortality values for subjects are
shown in Table 9.5. For subjects with an unknown age the mean age for the group
was used.e median ISS score for all subjects was 20.ere was one death during
the monitoring period — subject 1 who died in ITU 10 hours 21 minutes aer
admission.
Time of injury was recorded for 10 subjects. In those subjects the mean time
to arrival in ED was 66 minutes (range 30–175 minutes, s.d. 40 minutes). e
mean time spent in ED (including time in CT if performed before theatre) was
28 minutes (range 5–69 minutes, s.d. 18 minutes), and the mean time in theatre
(including CT if performed before arrival in ITU) was 227 minutes (range 97–510
minutes, s.d. 120 minutes).
9.4.2 StO2 and Physiological Parameter Response to Resuscitation
e general trend among patients was one of signicantly deranged physiological
measurements responding rapidly to resuscitation in ED with this improvement
extending into the theatre phase. Patients oen demonstrated some instability in
theatre but usually stabilised before transfer to the ITU. In ITU patients generally
∗Estimated age.
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Patient ISS TRISS Predicted Patient ISS TRISS Predicted
Mortality (%) Mortality (%)
1 29 98.8 (P) 11 20 89.3
2 29 94.6 12 9 76.9
3 26 93.2 13 20 97.9 (P)
4 17 86.6 14 17 86.6
5 22 98.1 (P) 15 21 98.0 (P)
6 29 94.6 16 16 85.6
7 26 93.2 17 27 93.7
8 16 85.6 18 19 97.8 (P)
9 9 76.9 19 5 70.4
10 16 85.6 20 54 99.3
Table 9.5: Injury Severity Scores (ISS) and Trauma Injury Severity Score (TRISS) predicted
mortality values for patients. For gunshot wounds and blast injuries where the principle
injuries were due to fragmentation the penetrating TRISS predicted mortality, denoted by
(P), was been used.
recorded physiological and StO2 values within normal limits∗, or demonstrated
a steady improvement. For this reason most of the following analysis focuses on
the ED and early theatre phases of the patient journey where the greatest physiolo-
gical change occurred and hence the relationships between dierent physiological
parameters can be best observed.
Figure 9.1 shows the deltoid and head StO2 data for the ED and theatre phases of
the study from all subjects tted to a LOESSmodel, illustrating the StO2 response to
resuscitation. Deltoid and head StO2 follow a broadly similar pattern — starting at
low levels upon arrival rising rapidly as resuscitation commences, before plateauing
around the 60 minute point aer completion of the initial resuscitation, although
there is still signicant variability in StO2 in many subjects in the recording period
aer this.ree subjects (subjects 14, 15 and 16) demonstrated a marked fall in
StO2 values upon arrival prior to responding to resuscitation.
A box plot of StO2 values during each phase of the study is shown in Figure 9.2.
ere were signicant dierences in StO2 during each phase (ED, theatre and
ITU) of the study for both the deltoid (p<0.0001) and cerebral (p<0.0001) sites
(Kruskal-Wallis test). In the deltoid, mean StO2 rose during each phase of the
∗e normal range of StO2 values is described in the experimental data presented in Chapter 7.
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Figure 9.1: Deltoid and cerebral StO2 data by patient from the ED and theatre phase of the
study.
study: from 59.4% during the ED phase, 72.5% in theatre, to 73.8% in the ITU phase.
e dierences between the theatre and ITU phases were relatively small and were
separately tested with a Wilcoxon rank-sum test which conrmed signicance
(p<0.0001). Cerebral StO2 did not follow the same pattern of progressive rises
recording mean values of: 68.8% in ED; 76.2% in theatre; and 72.8% in ITU.
ere were signicant dierences between deltoid and cerebral StO2 values
during the study (p<0.0001). Although the actual dierence in the mean StO2
between the deltoid (73.1%) and cerebral (73.5%) for the whole study duration was
relatively small, there were larger dierences during each study phase. During the
ED phase cerebral StO2 was 7.5±0.5% higher than deltoid StO2 (p<0.0001). During
the theatre phase this dierence was reduced to 4.0±0.5% (p<0.0001). In the ITU
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Figure 9.2: Box plot of StO2 values during each phase of the study. Plot whiskers denote
maximum and minimum data points, excluding outliers which are shown separately.
phase this relationship reversed and deltoid StO2 was 1.0% (p<0.0001) higher than
cerebral StO2 (p<0.0001). e relationship between deltoid and cerebral StO2
also appeared to vary across their range of values. Figure 9.3 shows a scatterplot
of deltoid StO2 against cerebral StO2, with linear and LOESS models tted to
the data. It can be seen that for deltoid StO2 values greater than 50% the linear
and LOESS models closely match. Linear regression analysis for deltoid StO2
values ≥ 50% demonstrated the relationship between cerebral and deltoid StO2
could be predicted by:
cerebral StO2 = 0.53 × deltoid StO2 + 34.7, R2=0.31 (p<0.0001)
Below deltoid values of 50% the curves diverge and there is a separate linear
component in LOESS curve, most obvious for deltoid values between 25%–40%.
Linear regression analysis on values in this range demonstrated the relationship
between cerebral and deltoid StO2 could be predicted by:
cerebral StO2 = 2.02 × deltoid StO2 – 27.5, R2=0.40 (p<0.0001).
Mean values for the other principle physiological and ABG parameters are
summarised in Table 9.6. Patients were generally tachycardic for the duration of
the study, although heart rate did fall during each stage of the hospital admission.
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Figure 9.3: A scatterplot of deltoid against cerebral StO2.e alpha transparency of the data
points has been reduced to demonstrate the data distribution.e linear regression line is
shown in red and a LOESS model tted to the data drawn in blue. Note that for deltoid
StO2 values above 50% the LOESS and regression curves are closely related, but below
50% they become disconcordant, suggesting a dierent relationship between cerebral and
deltoid StO2 in the lower range.
Mean blood pressures during each stage were notmarkedly deranged, being within
normal limits for the majority of the ED phase, although they did fall slightly
during the theatre phase. All blood pressure measurements subsequently rose
again during the ITU phase, but the average values were still below those recorded
in ED.e ABG parameters (pH, BE and lactate) behaved in a more predictable
way, although lactate measurements were only available in theatre and ITU since
the i-STAT® cartridges used in ED did not have the lactate module.e pattern
was one of signicant acidosis in ED which gradual improved during the time in
theatre and ITU.
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Phase
Physiological Parameter ED eatre ITU
HR (bpm) 113 108 102
SBP (mmHg) 123 109 116
DBP (mmHg) 77 62 65
MAP (mmHg) 92 78 82
pH 7.15 7.30 7.38
HCO3 (mmol/L) 19.7 22.3 27.0
BE (mmol/L) -10.29 -4.15 2.34
Lactate (mmol/L) — 6.51 2.78
Table 9.6: Mean values for physiological parameters during each of the study phases. Note
that is no lactate value during the ED phase since the i-STAT® cartridges used in ED did
not have the lactate module.
9.4.3 Correlation Between Physiological Parameters
A correlation matrix for the main physiological variables during the combined
ED and theatre phases is shown in Table 9.7.ere was a moderate correlation
between deltoid and cerebral StO2 throughout the study, rs=.55 and during each
phase of the study: in ED rs=.56; in theatre rs=.64; and in ITU rs=.55.
StO2 and standard physiological measurements generally correlated poorly
with ABG parameters. Of the variables examined only heart rate demonstrated a
modest correlation with any of the ABG measurements (specically with lactate,
rs=.49).ere were poor corrections for all comparisons of StO2 recorded from
the deltoid or cerebrum with heart rate or blood pressure measurements.
9.4.4 Phase Relationship Between StO2 and ABG Parameters
e variability in the frequency of ABG data collection provided a limited number
of time-points with which a phase comparison with StO2 could be made. is
coupled with the dierences in patients’ degree of injury, resuscitation state on
arrival in ED, and response to resuscitation at dierent time-points meant it was
not possible to build a robust model examining the phase relationship between
StO2 and ABG parameters.
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9.5 discussion
is study set out to assess the practical constraints of using current generation
NIRS devices in the deployed military environment. With respect to that goal
it was clearly demonstrated that StO2 can be successfully measured in the role 3
environment. It proved easy to train end-users how to use the INVOS® System
monitor, and the technique was universally reported as being simple to use and
understand. It is a testament to the ease of recording StO2 data that the limiting
factor in addressing the other study aims was the diculty in collecting conven-
tional physiological data rather than StO2 data which was of high quality in nearly
all of the patients studied. Although not documented by the manufacturer the
INVOS® probes are largely radiolucent to x-rays and it was found that they did
not impact CT image quality when le in place during head or body scans.
Along with pulse rate and SpO2 monitoring (assessed with pulse oximetery),
StO2 was the only objective physiological measurement that could be initiated
immediately upon patient arrival and that provided a continuous, real time assess-
ment of the patients’ response to the initial resuscitation. In this respect NIRS
has signicant advantages over blood pressure monitoring which cannot be recor-
ded continuously without an arterial line, while non-invasive measures of blood
pressure have several practical problems and questions about their true accuracy.
A few practical limitations of NIRS use in the deployed clinical environment
were identied during the study. One of the early problems was the sensitivity of
the INVOS® System monitor to the unstable electricity supply (particularly from
the backup generator) in CampBastion.ere was a regular requirement to replace
blown fuses until a custom inline surge protector was built into the device’s power
supply cable. Obviously this is a device specic issue rather than a generic problem
with NIRS per se. A more insidious problem was the tendency of the device to
record seemingly valid StO2measurements when not attached to a patient or when
the probe became partially detached. is is a problem that has been noted in
previous studies, but it is a particular issue in the clinical environment where
patients are frequently dirty, wet, bleeding or sweating, and ensuring adequate
probe adhesion can be dicult. Outside the controlled experimental environment
constant vigilance was required to ensure the probe stayed in place; for this reason
the deltoid probe was frequently secured with an additional layer of adhesive tape.
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Hopefully this problemwill be xed in the next generation of devices which should
either warn or stop recording once the probe becomes detached.
Assessing the StO2 response to resuscitation (shown in Figure 9.1) it can be
seen that in most patients StO2 responded rapidly to the initial resuscitation rising
from initially low values to reach a peak/plateau within 30 minutes of arriving
in the ED. Once patients had been resuscitated to within the normal range of
StO2 values the role of NIRS in guiding further resuscitation was less clear and
this is reected in the small dierence between the mean StO2 in the theatre and
ITU phases. It is likely at this point that trend changes in StO2 are more useful
than the absolute values, particularly for identifying acute deteriorations in a
patient’s condition.is was demonstrated in part by the StO2 traces of several
subjects where, aer initial resuscitation, there were signicant uctuations in
StO2 values corresponding to resuscitative or intraoperative events. Cerebral StO2,
in particular, appeared to be sensitive to the induction of anaesthesia, usually
occurring in the late ED phase. Given the known eects of several anaesthetic
agents on cerebral blood ow this is not necessarily surprising. Unfortunately
the eect was too inconsistent between subjects to demonstrate any denitive
relationship between induction of anaesthesia and StO2.
ere were signicant dierences between the cerebral and deltoid StO2 during
all phases of the monitoring protocol. is point is not surprising, given the
dierences in their resting values (demonstrated in Chapter 7). Both sites appear
to track the resuscitation process in most patients, a nding which seemingly
contradicts those presented in the human volunteer simulated haemorrhage study
(Chapter 6) where cerebral StO2 was shown to correlate poor with degrees of
hypovolaemia, presumably as a consequence of cerebral autoregulation. e
reason cerebral StO2 provides a reliable indicator of resuscitation in this study is
probably due to the much greater hypovolaemic insult experienced by this group
of patients overwhelming the cerebral autoregulatory process. It is noticeable
however that cerebral StO2 values were preserved in several subjects (subjects
3, 4, 12 and 13) in the face of very low deltoid StO2. It is not clear why cerebral
autoregulation should have been preserved in some subjects but lost in others,
although anaesthetic agents and other drugs may have played a part.
Cerebral StO2 was signicantly greater than deltoid StO2 during the ED and
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theatre phases, by between approximately 4–8%.is is the reverse of the normal
relationship at rest, where cerebral StO2 are typically around 7% less than that of
the deltoids. is would appear to support the idea that there is an element of
cerebral autoregulation preserving StO2 in the presence of hypovolaemia. Further
evidence for cerebral autoregulation can be seen in Figure 9.3 where two distinctly
dierent linear relationships between cerebral and deltoid StO2 can be seen in the
upper and lower ranges. In the higher range (for these purposes considered to
be deltoid StO2 values greater than 50%) cerebral StO2 values increased by 0.53%
for every 1% increase in deltoid StO2. In the lower range (analysed for deltoid
values between 25–40%) cerebral StO2 values increase by 2.02% for every 1% rise
in deltoid StO2 strongly suggesting that in this range cerebral StO2 is preserved
relative to deltoid StO2.
Although cerebral StO2 tracked the resuscitation process in most patients,
several of the ndings in this study indicate it is likely to have a lower sensitivity for
detecting hypovolaemia compared to the deltoid. Firstly, cerebral autoregulation
will blunt the response to hypovolaemia. Secondly, the fact that cerebral StO2
recorded higher values than the deltoid during the key resuscitative phases means
that cerebral StO2 values will be subject to greater degrees of compression of
their upper values potentially reducing the granularity of measurement scale (see
Section 7.5 for a discussion of this phenomenon).ese ndings are consistent with
those presented in the human volunteer simulated haemorrhage study (Chapter 6)
which suggested that deltoid StO2 was a more sensitive indicator of hypovolaemia
than cerebral StO2. How deltoid StO2 compares to values recorded from the
forearm, reported to be the most sensitive site in experimental studies, in real
trauma patients remains unknown.
Unfortunately it was not possible to examine the phase relationship between
physiological parameters and ABG measurements. Although an attempt at build-
ing a model using the methodology described in Chapter 8 was performed, it
was found that the limited frequency of haemodynamic data, in particular ABG
data, coupled with the heterogenicity of the injuries and resuscitation pathway
meant that a phase relationship between the resuscitation curves of the dierent
parameters could not be identied. However a lag between StO2 and the ABG
response could be observed examining the data for individual subjects (see Fig-
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9.5. discussion
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Figure 9.4: StO2 (shown in red) and base excess (shown in blue) data from patient 2,
demonstrating the delayed response in the base excess curve compared to the StO2 curve.
ure 9.4), even it if could not be mathematically demonstrated. StO2 and ABG
parameters correlated poorly (see Table 9.7).is is not surprising given that the
values are being compared eectively out of phase∗; and equally the correlation
between haemodynamic and ABG parameters was also poor, with the exception of
heart rate which had a moderate correlation with lactate.e overall impression
is that NIRS along with the other conventional physiological measurements all
assess slightly dierent elements of the patients physiology. NIRS has signicant
advantages over other means of assessing physiology, principally its ease of use and
non-invasive nature. However NIRS is not a panacea for the problem of assessing
the trauma patient, and the experience of this study suggests it is best used in
conjunction with other means of assessment to provide additional information
on the physiological status of patient and their response to the early stages of
resuscitation.
∗ABG measurements were demonstrated to lag changes in StO2 by approximately 35 minutes in the
animal trauma data presented in Chapter 8.
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9.6. conclusion
9.6 conclusion
is study has demonstrated that NIRS can be successfully and usefully used in the
deployed military environment. StO2 values accurately track patients’ response to
initial resuscitation however once the values are in the normal range then changes
in StO2 are of more clinical use than the absolute values themselves.
Cerebral StO2 demonstrates a degree of autoregulation in many patients and
as such is likely to be a less sensitive indicator of global physiological state than
most skeletal muscle sites. Although NIRS has signicant practical advantages
over conventional means of patient assessment it has not been demonstrated to
be superior to them. As such, NIRS at present can only be recommended as an
adjunct, albeit a very useful one, to the assessment of the trauma patient.
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10. conclusion
e introductory chapters to this work attempted to illustrate that signicant im-
provements in the early and late mortality associated with major trauma can be
achieved by goal directed correction of hypovolaemia.e problem in delivering
this care lies with the current means of assessing the degree hypovolaemia and
response to resuscitation. Conventional assessments of physiology all have signi-
cant shortcomings either in their sensitivity, specicity or practicality. Crookes
et al. (2005) identied ve properties of the ‘ideal tool’ for assessing end organ
consequences of hypovolaemia associated with trauma:
1. it should be non-invasive
2. provide continuous reading of the measured parameter
3. provide an objective parameter of tissue perfusion, ideally at a cellular level
in end organs
4. be robust and portable
5. should inuence management leading to an improved patient outcome
As a tool for assessing the trauma patient NIRS certainly meets the rst two of
these criteria; this work aimed to examine how it performed in the last three.
In laying the groundwork for subsequent eld testing of the NIRS device
several important considerations for the clinical application of StO2 in trauma
patients have been addressed. Firstly the normal range of NIRS values was es-
tablished from a number of anatomical sites relevant to trauma management. It
was found that StO2 varies signicantly between sites, except for anatomically
identical contralateral sites (conrmed for the deltoids but the nding is likely to
be equally applicable to other sites). is means that reference ranges for StO2
values cannot simply be extrapolated between sites but must be established for
each site of interest, a point that has not always been appreciated in the published
literature. In the upper limb StO2 values appear to decrease progressively with
more distal monitoring sites, unfortunately the lower limb was not studied in
sucient detail to determine if a similar relationship exists there.e distribution
of NIRS values was also observed to vary, with some sites demonstrating a skew le
distribution, while others appeared to be more normally distributed.is would
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appear counterintuitive for a physiological measurement that would be expected
to demonstrate a normal distribution. It seems this nding is a function of the
monitoring algorithm used by the INVOS® System, which compresses values at the
upper end of its monitoring scale, rather than a true physiological phenomenon.
us sites with a high StO2, such as the deltoid, have their upper ranges compressed
and appear to have a skew le distribution, while sites with a lower StO2, such as
the frontal lobe of the brain, experience less compression in their upper values
and demonstrate a distribution more closely approximating to normal.
In establishing the normal range of StO2 values one of the major limitations
of NIRS has been demonstrated: the large range over which normal values lie.
Interestingly despite the dierent distribution of StO2 values, all the sites studied
in this work had a similar lower end cuto in their resting values of around 40%. It
would seem then that StO2 values below this point can be condently interpreted
as abnormal — in the context of trauma this is likely to mean signicant blood
loss (assuming there are not local phenomena which may account for a low StO2,
e.g. disruption of regional blood supply). For StO2 measurements above 40%,
and certainly above the lower quartiles of the resting values for that site, the
interpretation of the StO2 becomes more dicult and the experience of the NIRS
trauma resuscitation study was that in this range trend changes become more
important than absolute values.
Exercise was found to signicantly increase StO2 at all of the sites investigated
(deltoid, anterior compartment of leg and frontal lobe of the brain) — an eect
that persisted for at least 10 minutes. However the size of the increase at 10
minutes aer cessation of exercise was relatively small, between 3–7%, and fell well
within the interquartile ranges of the resting StO2 values. As such it is unlikely
this phenomenon in isolation would cause problems with the interpretation of
StO2 values in clinical practice. However exercise is known to modulate the
physiological response to hypovolaemia and the eect of this on StO2 in the
hypovolaemic patient remains unknown.
Most human trauma studies investigating NIRS have recorded StO2 from
thenar eminence.e preference for this site appears to be driven at least in part
by the fact that one of the most widely used commercial NIRS monitors (the In-
Spectra™ Tissue Spectrometer) is marketed almost exclusively for recording from
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the thenar eminence. e thenar eminence certainly has several attractions as
monitoring site: it is easily accessible; has only a thin layer of overlying fat; and
has low levels of melanin pigmentation which can absorb or scatter infrared light
distorting the StO2 measurement. However there is no convincing evidence that
thenar eminence StO2 provides a more accurate assessment of patient physiology
than that recorded from other sites.e data presented in the human volunteer
simulated haemorrhage study (described in Chapter 6) suggests that the thenar
eminence is not sensitive to small degrees of hypovolaemia. Of the sites studied
only the forearm (over exor digitorum profundus) demonstrated a statistically
signicant change in response to lower body negative pressure (LBNP) induced hy-
povolaemia, although discernible but non-signicant changes were also observed
in the deltoid. Cerebral StO2 did not respond signicantly to increments of LBNP
which was presumed to be a consequence of cerebral blood ow autoregulation.
is phenomenon was demonstrated more convincingly in the trauma resuscita-
tion study (Chapter 9) where regression analysis demonstrated that cerebral StO2
was preserved relative to deltoid StO2 in the lower ranges.
e administration ofmorphine attenuated the StO2 response to hypovolaemia
across all sites, an eect also observed in most of the other physiological measure-
ments. However, as the evidence of the trauma resuscitation study demonstrates,
where morphine administration was near universal, morphine cannot mask the
StO2 changes associated with signicant hypovolaemia.
Examination of NIRS in major trauma/haemorrhage subjects was performed
in an animal haemorrhage model and in human trauma patients in the deployed
military environment. In the animal model the relationship between StO2 and
ABG parameters was examined, where it was found that StO2 phase led changes in
base excess and lactate by 31–37 minutes. A similar relationship was also observed
in human patients, although it could not be robustly demonstrated due to a lack
of ABG data points and the variability between subjects. Limb injury, known to
aect StO2 in resting subjects, does not appear to inuence StO2 trend changes
in hypovolaemic subjects (although the absolute values may change) which sug-
gests that injured monitoring sites can still be used to track patients’ response to
resuscitation. Both the animal and human studies demonstrated that NIRS could
be used to accurately assess the response of subjects to resuscitation in real time.
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However the greatest utility appears to be during the initial triage and resuscitation
of the patient when StO2 values are outside the normal range. As discussed above
once the patient is resuscitated to within the normal range, absolute StO2 numbers
become hard to interpret, however signicant trend changes, i.e. sudden drops
in StO2 suggesting ongoing blood loss, continue to be useful.e human trauma
resuscitation study proved that NIRS can be successfully used in the deployed
military environment at role 3 as a useful adjunct to patient assessment. It is a
testament to the ease of use of the technique that continuous high quality StO2 data
was recorded from nearly every subject enrolled in the study, while the frequency
of routinely collected physiological data was to prove the major limiting factor in
interpreting the study outcomes.
In the course of performing the experiments described in this work consider-
able experience with the INVOS® System monitor has been accrued, and several
previously undescribed practical problems encountered.e diculties described
by other researchers obtaining StO2 measurements from deeply pigmented indi-
viduals were not encountered. However problems obtaining readings from sites
with darkly coloured tattoos were experienced and this represents the rst descrip-
tion this issue. Although the INVOS® System has a measure of signal quality this
was not always found to be reliable, and technical failings of monitoring were
oen only obvious in retrospect, such as the at line recording in the right limb
of the animal 1 in the animal trauma and haemorrhage model (see Figure 8.4,
page 117). A more insidious problem was the tendency of the device to record
seemingly valid StO2 measurements when not attached to the patient or when the
probe became partially detached. A clear example of this is demonstrated in the
photograph of the INVOS® System monitor shown in Figure 5.1, page 60, where
the machine appears to be recording valid StO2 values despite the probes being
stuck to a cotton sheet overlying a wooden table. Hopefully problems such as these
will be addressed in the next generation of devices.
In assessing the role of NIRS in the management of trauma patients, it has
been demonstrated that it reasonably meets the rst four criteria of Crookes et al.
(2005) ‘ideal tool’ described at the start of this chapter.e technique provides
a continuous real time measure of an objective assessment of tissue perfusion.
Current devices are portable and robust enough to withstand use in the deployed
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military environment with potential for pre-hospital roles.e superiority of NIRS
over conventional physiological assessments of resuscitation status has not been
demonstrated. However NIRS has signicant practical advantages over measuring
blood pressure or ABGs and provides useful information complimenting that
of conventional means of assessment. It has yet to be shown that NIRS meets
the last of Crookes et al. (2005) criteria — that it can positively inuence the
clinical outcomes of real trauma patients, and it is here that future research eorts
should be directed. e computer controlled closed-loop NIRS resuscitation
model described by Chaisson et al. (2003) presents one potential approach for
examining this issue. Unfortunately StO2 resuscitation endpoints have not yet
been determined (and are likely to vary between devices), without which the
interpretation of such studies would be dicult. Even if an StO2 resuscitation
endpoint could be dened, a closed-loop protocol is unlikely to nd application
in current models of real-life resuscitation, which perhaps explains why this study
design has not seen further development in the literature.
One way to examine the eects of NIRS monitoring in a clinical setting would
be to monitor StO2 in trauma patients randomised into two groups: one where the
StO2 measurements are available to clinicians to facilitate their decision making
process; and the other where clinicians are blinded to the StO2 values. Patients
could then be case matched or grouped according to injuries, and management
and outcomes between the groups compared.is has the advantage of assessing
NIRS as it would be used in the clinical environment, i.e. as an adjunct to clinical
assessment and decision making, rather than as an absolute endpoint in itself.
However determining dierences between the groups would be likely to require a
large study population, probably necessitating a multi-centred design.e experi-
ence of the NIRS Trauma Resuscitation Study (Chapter 9) found that familiarising
clinicians with StO2 monitoring to the extent that they are comfortable to use it
to guide their decision making process takes one to two months even in a high
volume trauma centre. While undertaking such a training and familiarisation
exercise on a multi-centre basis, in civilian trauma centres, is certainly feasible the
eort involved should not be underestimated.
In addition to the issue as to whether StO2 monitoring can positively aect
the outcomes of trauma patients, several other unresolved questions remain from
153
this work.e range of normal StO2 values has at present only been established
for the deltoid, anterior compartment of the leg and frontal lobe of the brain.
Determining the range of values from other sites, particularly the forearm, should
be a priority if these sites are to be investigated in future studies. Although it
was established that StO2 remains elevated up to 10 minutes aer completion of
exercise, the pattern of StO2 during recovery and time taken to return to baseline
are unknown. However, how clinically useful an understanding of these eects
would be is questionable given the very small increases in StO2 seen shortly aer
exercise. A more interesting problem is the eect of prior exercise on the StO2
(and other physiological parameters) response to haemorrhage. Animal studies
examining this issue have given conicting results, and the response in humans
remains unstudied. is problem could be addressed with a cross-over study
similar to that presented in the NIRS Human Volunteer Simulated Haemorrhage
Study (Chapter 6), but with the two arms of the study being exercise or no exercise
prior to the lower body negative pressure simulated hypovolaemia.e interaction
of other relevant factors, such as the administration of morphine or the eect of
(simulated) limb injury, could then also be easily examined by the addition of
extra arms to the study.
Given the aforementioned diculties demonstrating a positive impact of StO2
monitoring on trauma resuscitation outcomes it seems plausible that widespread
adoption of NIRS will occur rst in other clinical areas where assessments of local
tissue perfusion are required. Of the possible applications relevant to trauma,
monitoring for compartment syndrome and free ap failure have shown the most
promise (Barker et al., 2011; Chen et al., 2015). In both these conditions NIRS
directly measures the outcome of interest (oxygenation of the target tissue), rather
than using peripheral tissue oxygenation as a proxy measure of global resuscit-
ation; and both, rightly or wrongly, are usually treated as binary conditions, i.e.
patients either have compartment syndrome or they do not, providing a clear
endpoint against which StO2 can be assessed. e fact that NIRS has not seen
more widespread use in these areas is probably a consequence of the relatively
high cost of the equipment and a lack of familiarity with the technique. However
as the cost of the technology falls, NIRS will probably see more frequent use for
these or similar applications leading to an increased awareness and uptake of the
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technique in other areas.
With regards to the future role of NIRS in the military, development in this
eld is likely to parallel or follow that of the civilian experience — both in the
pre-hospital and secondary care environments.is work has demonstrated the
diculties of performing robust research in the deployed military environment,
manifest not least by the fact that 51 of the 71 patients enrolled in the NIRS Trauma
Resuscitation Study (Chapter 9) were excluded from analysis due to diculties col-
lecting ‘routine’ haemodynamic and ABG data. Compared to the civilian setting,
deployed military research faces several additional challenges including: reduced
numbers of sta; potentially unreliable logistical support; unstable power supplies;
and security concerns. Even tasks as simple as recording and transmitting study
data securely can become major challenges and a variety of dierent approaches
were required during the course of this work in response to changes in the security
environment and local policy in Afghanistan. e end of British operations in
Helmand and the closure of the Role 3 facility in Camp Bastion with the return
to contingency operations will further limit the opportunities for NIRS research
in the deployed environment. Future operations are likely to be smaller and even
more resource constrained, with no single static site providing a focal point for
the study of a large volume of military trauma. As a consequence it is probable
that future military applications of NIRS will rst be developed at Role 4/civilian
major trauma centres before being translated to the deployed environment.
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appendices
A. invos® 5100c system specifications
e INVOS® System complies with the international regulatory standards: IEC
60601 − 1, UL 60601 − 1, CSA 22.2.601 − 1, CE 0197. Physical specication and
operation ranges, as dened bymanufacturers’ literature (Somanetics Corporation,
2008), are as follows:
Physical Height 24cm
Dimensions: Width 29cm
Depth 19cm
Weight 4.95kg
Preamplier Cable Length 4.5m
Sensor Cable Length 1.5m
Operational StO2 Measurement Range 15–95%
Limits: Repeatability Within 1 StO2 index point
from unit to unit (in vitro)
Alarm Limit Range High 20–95%
Low 15–90
Trend Memory 24 hours (2 samples/min)
Safety Class Continuous Operation
Type BF Class I
Environmental Operating Temperature 16°C– 32°C
Operating Range: Storage Temperature –20°C– +45°C
Humidity 20%–80%, non-condensing
Altitude Max 3048 m
Electrical Power AC mains or backup battery
Specifications: Input Voltage 100–240 V AC
Frequency 50/60 Hz
Current 1.0 A (100 V) – 0.5 A (240 V)
Fuse 2.5 A 250 V
Backup Battery 12 V DC (approx 20 mins)
Digital Output RS-232 communications
Data Export USB 2.0 Flash Memory
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B. bash script for cleaning invos® system data
files
is script was used clean les produced by the INVOS® SystemMonitor, undergo-
ing several additions and modications throughout its use. It strips out duplicate
space deliminators and removes all elds except the date/time stamp and the
specied StO2 elds.
e script can process either individual les or batch process all les in the
current directory. It accepts arguments to change the eld deliminator and the
number of channels retained in the output le, default values are space and one
channel. e script has been tested on a system running Linux kernel 3+ with
GNU Core Utilities and BASH version 4+, although it should be easily portable to
other shells with only minor modications. Instructions for use are given in the
script help output.
#!/bin/bash
function help-output() {
cat <<EOF
nirs-clean-file
NAME
nirs-clean-file - cleans data files produced by Inspectra INVOS
System monitor
SYNOPSIS
nirs-clean-file [-f filename] [-c 1|2|3|4] [s space|comma|semi] [-h]
DESCRIPTION
Cleans the data files produced by the InSpectra INVOS System monitor
removing all columns except the date, time stamp and the selected
number of channels outputs between 1-4. Field deliminators can be
selected as space, comma or semicolon. Default options are 1
channel output with comma deliminators. NIRS values recording "0"
are replaced with "NA". When call called on individual files those
files will be processed and outputted to the current directory with
a .csv post-fix. If a file with that name already exists in the
current directory it will be overwritten without warning. If
called without any options or no file specified the program will
run in batch mode processing every file in the current directory
with the output placed in nirs_output_file directory. If the
nirs_output_files directory already exists the
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nirs_output_directory is created with the current time stamp.
EXAMPLES
Clean file "file_name" leaving data from channels 1-2 and use comma
separators.
$ nirs-clean-file -f file_name -c 2 -s comma
Clean all files in the current directory using default values (1
channel and space separators).
$ nirs-clean-file
Clean all files in current directory using channels 1-4 and comma
separators.
$ nirs-clean-file -c 4 -s comma
EOF
}
# Sets the fields to be removed in the cut command
CHANNEL_1="1-3"
CHANNEL_2="1-3,10"
CHANNEL_3="1-3,10,17"
CHANNEL_4="1-3,10,17,24"
CVS_SEPARATOR=","
SPACE_SEPARATOR=" "
SEMI_SEPARATOR=";"
# Default values
type_of_file="$CVS_SEPARATOR"
type_of_file_descriptor="comma"
no_of_channels="$CHANNEL_1"
no_of_channels_descriptor="1"
nirs_output_dir="."
target_file=""
# Parse script options
while getopts f:c:s:h opt
do
case $opt in
f) if [ -f $OPTARG ]; then
target_file="$OPTARG"
else
echo "$OPTARG is not a valid file in the current directory."
exit 1
fi
;;
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c) if [ $OPTARG -eq 1 ]; then
no_of_channels="$CHANNEL_1"
no_of_channels_descriptor="1"
elif [ $OPTARG -eq 2 ]; then
no_of_channels="$CHANNEL_2"
no_of_channels_descriptor="2"
elif [ $OPTARG -eq 3 ]; then
no_of_channels="$CHANNEL_3"
no_of_channels_descriptor="3"
elif [ $OPTARG -eq 4 ]; then
no_of_channels="$CHANNEL_4"
no_of_channels_descriptor="4"
else
echo "$OPTARG is an invalid number of channels, select a
number between 1-4"
exit 1
fi
;;
s) if [ $OPTARG = space ]; then
type_of_file="$SPACE_SEPARATOR"
type_of_file_descriptor="space"
elif [ $OPTARG = comma ]; then
type_of_file="$CVS_SEPARATOR"
type_of_file_descriptor="comma"
elif [ $OPTARG = semi ]; then
type_of_file="$SEMI_SEPARATOR"
type_of_file_descriptor="semicolon"
else
echo "$OPTARG is an invalid separator"
exit 1
fi
;;
h) help-output
exit
;;
*) echo "Invalid option. Use the -h option to see help.";
exit 1
;;
esac
done
function clean-command() {
output_file=${target_file%.*}${target_file#*.}
tr -s ’ ’ "$type_of_file" < "$target_file" | cut -d "$type_of_file" \
-f "$no_of_channels" | sed "s/\b0\b/NA/g" > \
"${nirs_output_dir%/}/${output_file}.csv"
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echo "$target_file cleaned with $type_of_file_descriptor separators \
and $no_of_channels_descriptor channels"
}
function directory-processing() {
# check output directory does not exist and if so create it, otherwise
# make a directory with a timestamp
if [ ! -d nirs_output_files ]; then
nirs_output_dir="nirs_output_files"
mkdir $nirs_output_dir
else
nirs_output_dir="nirs_output_files_$(date "+%F-%T")"
mkdir "$nirs_output_dir"
fi
# process all files in target directory and place in output directory
for target_file in *
do
if [ -f "$target_file" ]; then
clean-command
else
echo "$target_file is not a valid file, therefore ignored"
fi
done
}
# if script is invoked with a target file then process that file with the
# given or default options.
if [ -n "$target_file" ]; then
clean-command
exit
fi
# if script is invoked without a target file then batch process all files
# in that directory with the given or default options.
if [ -z "$target_file" ]; then
directory-processing
exit
fi
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C. us marine corps physical fitness test
protocol
e US Marine Corps (USMC) Physical Fitness Test is a widely used and standard-
ised tness protocol.e protocol consists of three exercise performed in order,
with two minutes rest between each exercise:
1. Pull-ups
Pull-ups begin in the ‘dead-hang’ position with the palms facing forward on
the bar, the arms locked out and the body motionless. A successful pull-up
is completed by raising the body until the chin is above the bar, and then
lowering to the locked out position.e legs may be held in any position
as long as they are kept below waist level. Excess movement, swinging of
the trunk or legs is not allowed and pull-ups completed in that style are not
counted. A change in grip position is allowed but only the hands may touch
bar; if the feet touch the ground at any time the exercise is over.
Standard: Maximumnumber of pull-ups that can be achieved before coming
o the bar.ere is no time limit.
2. Sit-ups
Must be completed on a at surface. In the starting position, individuals lie
on their backs with knees bent to 45° and both feet at on the oor. Arms
must be folded across the chest and should remain in contact with the chest
for the repetition to be counted. A single repetition consists of raising the
upper body from the starting position until the body is vertical and then
returning to the starting position.
Standard: As many repetitions as possible in two minutes.
3. 3Mile (4.8 km) run
Performed over a reasonably at course, this is a timed event.
Standard: Individual best eort.
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D. joint medical employment standard
e Joint Medical Employment Standard (JMES) was introduced on 23 November
2009, with the aim of simplifying unifying themedical employment standard codes
across the three services (Army, Navy and Air Force). A JMES description consists
of elements describing its date of award and next review, whether it is temporary
or permanent, a Medical Deployment Standard, a Medical Employment Standard
— composed of four elements, and a descriptor of anymedical limitations. Defence
Instructions andNotices (DIN) 2009DIN01−183—e JointMedical Employment
Standard (Surgeon General’s Department, 2009) is the primary reference in this
area.
d.1 medical deployment standard
eMedical Deployment Standard (MDS) describes themedical capacity to deploy,
it has three categories:
1. MFD—Medically Fully Deployable
2. MLD—Medically Limited Deployability
3. MND—Medically Not Deployable
d.2 medical employment standard
e Medical Employment Standard (MES) ascribes a numerical value to four func-
tional areas, describing the individual’s standard in relation to their branch/trade.
e four functional areas are: Air, Land, or Maritime environments, and any re-
quirement for Environmental and Medical Support denoted by the four prexes
A, L, M and E respectively. All four functional elements are always described for
each individual, a typical description for a medically fully deployable soldier being
A4 L1 M1 E1. Details of MES codes are summarised in Table D.1.
163
d.2. medical employment standard
MES code Description Comments
Air
A1 Fit for ying duties without restriction Aircrew only
A2 Fit for ying duties but has sub-optimal hearing or
eye sight
Aircrew only
A3 Fit for limited ying duties Aircrew only
A4 Fit to be own in a passenger aircra
A5 Unt to be taken into the air
A6 Air assessment not currently required Not normally used
Land
L1 Fit for unrestricted duties
L2 Fit for unrestricted duties but with a medical risk
marker
e.g. early noise induced
hearing loss
L3 Fit for limited duties but with some restriction sub-
ject to medical risk assessment
L4 Fit for specic limited duties within branch/trade
L5 Unt for service in the Land environment
L6 Land assessment not currently required Not normally used
Maritime
M1 Fit for unrestricted duties
M2 Fit for unrestricted duties with caveats to be stated
M3 Fit for limited duties in harbour or ashore with
caveats to be stated
M4 Fit for limited duties ashore only, may not be in
own trade or skill with caveats stated
M5 Unt for service in the maritime environment
M6 Maritime assessment not currently required Not normally used
Environment andMedical Support
E1 Fit for worldwide service in all environments
E2 Restricted employment outside UK e.g. unt for hot or cold
environments
E3 Employment in UK only
E4 Employment subject to single Service manning re-
striction
E5 Medically unt for duty and under medical care Holding category
E6 Pregnant
Table D.1: JMES codes
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E. nato triage treatment categories
NATO and British Military Doctrine describe ve priority treatment categories,
these are dened with prex T (for treatment). Although mainly intended for
triaging patients in mass causality situations, categories are oen assigned to
individual patients as a simple, albeit limited, means of communicating injury
severity and urgency of treatment.e ve categories are as follows:
T1 (P1) — individuals requiring immediate, life saving, treatment. In the mass
casualty situation this treatment should be simple, non-time consuming
procedures in an individual likely to survive, e.g. airway manoeuvre, applic-
ation of tourniquet or emergency amputation.is category may be given
the sux A, B, or C denoting if the primary problem is with the airway,
breathing, or circulation.
T2 (P2) — individuals who will tolerate a delay in major surgery or medical treat-
ment, without signicantly impairing their chance of survival. Patients
may enter this category from T1 following simple treatment measures. Ex-
amples include the management of open long bone fractures and large joint
dislocations.
T3 (P3) — individuals requiring minimal treatment (‘the walking wounded’) who
can take care of themselves or be helped by medically untrained individuals,
and whose outcome will not be prejudiced by a delay in the provision formal
medical care. Examples include lacerations and simple fractures.
Dead — as determined by the person performing the categorisation.is is only
a category class and not a formal declaration of death as under UK law death
can only be declared by a licenced medical practitioner.
In the mass casualty situation one further category may be invoked:
T4 (P1 Hold) — expectant treatment.ese are individuals whose injuries are so
severe they have a poor chance of survival regardless of the treatment instig-
ated.ese individuals can receive supportive measures, such as adequate
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analgesia, but would not get denitive treatment in preference to less sever-
ally injured individuals. Once the backlog of T1 and appropriate T2 cases
has been cleared, T4 casualties become eligible for medical intervention —
if they have survived. is category is not applied to single casualties, or
multiple casualties in a compensated situation.
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